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ABSTRACT
INVESTIGATION OF FUNGICIDE RESISTANCE MECHANISMS AND DYNAMICS OF THE MULTIPLE
FUNGICIDE RESISTANT POPULATION IN SCLEROTINIA HOMOEOCARPA
MAY 2017
HYUNKYU SANG, B.A., CHUNGNAM NATIONAL UNIVERSITY
M.A., CHUNGNAM NATIONAL UNIVERSITY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Geunhwa Jung

A filamentous ascomycete fungus Sclerotinia homoeocarpa causes dollar spot, which is
the most important disease of turfgrasses in the United States. Despite the increased number of
reports of site-specific fungicide resistance and a recent report of multidrug resistance (MDR) in
S. homoeocarpa field populations, the genetic mechanisms behind resistance or reduced
sensitivity to fungicides remain poorly explained in the fungus. In order to prevent further
development of fungicide resistance in the dollar spot pathosystem, a detailed elucidation of
mechanisms of site-specific fungicide resistance and MDR is needed. In addition, the previous
studies of MDR in fungi mostly focused on efflux transporter mediated drug/xenobiotic
detoxification. However, the recent release of fungal genome sequences has revealed that
ascomycete filamentous fungi including S. homoeocarpa possess a large number of cytochrome
p450s (CYP450s) that are involved in xenobiotic metabolism.
Chapters 2 and 3 of this dissertation describe demethylation inhibitor (DMI)
fungicide/MDR mechanisms in S. homoeocarpa through Phase I xenobiotic metabolizing
enzymes (CYP450s) and Phase III efflux transporters using functional genomic and genetic
techniques. We identified a fungal specific transcription factor (Shxdr1) that regulates the Phase
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I and III genes and a novel gain of function mutation of the transcription factor found from a
MDR field strain is responsible for constitutive and induced overexpression of the Phase I and III
genes, resulting in MDR. In Chapter 4, the mechanisms of qualitative and quantitative resistance
of a dicarboximide fungicide have been determined using field and lab mutant S. homoeocarpa
strains. We confirmed that S. homoeocarpa field isolates gained qualitative and quantitative
dicarboximide resistance through the polymorphism in the histidine kinase gene Shos1 and the
overexpression of ABC efflux transporter ShPDR1, respectively. Chapter 5 studies the
management of a S. homoeocarpa population with different combinations of resistance to
dicarboximide, DMI, and benzimidazole fungicides to find the best fungicide options for
controlling the S. homoeocarpa population and further understanding the dynamics of how the
population responds to fungicide applications, and to long-term lack of exposure to fungicides
during winter. Succinate dehydrogenase inhibitors (SDHI; fluxapyroxad and boscalid (high rate)),
multi-site fungicide (fluazinam), and the fungicide mixture (chlorothalonil, iprodione,
thiophanate methyl, and tebuconazole) controlled the S. homoeocarpa population very well.
The isolates with resistance to DMI and dicarboximide were most frequently selected by
iprodione or propiconazole applications and the isolates with resistance to DMI and
benzimidazole were selected by boscalid applications, but these multiple fungicide resistant
isolates decreased after overwintering.
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CHAPTER 1
INTRODUCTION

1.1 The Pathogen Sclerotinia homoeocarpa
Sclerotinia homoeocarpa is a filamentous ascomycete fungus and causes dollar spot, which
is the most important disease of turfgrasses in North America (Smiley et al., 2005). More money
is spent to control dollar spot than any other turfgrass disease (Allen et al., 2005). Dollar spot
can cause considerable damage to annual bluegrass (Poa annua L.) and creeping bentgrass
(Agrostis palustris Huds.) on golf course fairways, tee boxes, and putting greens. Furthermore, S.
homoeocarpa also infects less intensively managed turfgrasses grown in athletic field, home
lawns, and recreational facilities (Goodman and Burpee, 1991; Walsh et al., 1999). Mycelium of
S. homoeocarpa in and on the surface of leaf blades is spread by foot traffic, carts, athletic
equipment, mowers, and maintenance equipment (Liberti et al., 2012). S. homoeocarpa is
dormant during the winter as mycelium inside infected plant tissue or stromata on the leaf
surface until temperatures reach 15 °C (Smiley et al., 2005). The symptoms of dollar spot are
white to straw-colored lesions surrounded by a brown to purple border on affected grasses and
the lesions spread up, down and laterally across leaf blades. White to straw-colored lesions
expand and coalesce, resulting in blighted leaves. Aggregated blighted leaves exhibit 1 to 10 cm
circular and sunken patches (Allen et al., 2005).
In order to control dollar spot, cultural control methods such as dew removal, proper
nitrogen fertility, and frequent rolling are used to reduce favorable conditions for the disease
(Delvalle et al., 2011; Ellram et al., 2007; Giordano et al., 2012; Landschoot and McNitt, 1997;
Williams et al., 1996). However, cultural control methods often do not provide acceptable dollar
spot control, therefore fungicide applications are required to maintain high turf quality
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throughout the season (Smiley et al., 2005; Walsh et al., 1999). Effective fungicide classes used
for dollar spot control include the benzimidazole, dicarboximide, demethylation inhibitor (DMI),
succinate dehydrogenase inhibitor (SDHI), nitrile, and uncouplers of oxidative phosphorylation
(Inguagiato and Martin, 2015). Dollar spot resistant cultivars of creeping bentgrass (cultivars CY2, Memorial, and Declaration) and naturally disease tolerant colonial bentgrass (Agrostis
capillaris) are used (Belanger et al., 2004; Bigelow and Hardebeck, 2007). Biological control
products include a mineral oil derivative (Civitas) and bacteria (e.g. Bacillus subtilis [Rhapsopdy];
B. licheniformis [EcoGuard]) are also used on turfgrass (Allen et al., 2005).
Despite the original placement of S. homoeocarpa in the genus Sclerotinia, the fungus
was excluded from the genus by Whetzel because the fungus does not produce a true
sclerotium (Whetzel, 1946). It was suggested that S. homoeocarpa was reclassified in the
Rutstroemiaceae family based on morphological characteristics (e.g. a flat plat-like substratal
stromata) and phylogenetical analysis of nuclear ribosomal RNA genes (rDNA) sequences
(Carbone and Kohn, 1993; Holst-Jensen et al., 1997; Kohn and Grenville, 1989). However, the
proper classification of S. homoeocarpa has been difficult because of the confusion about the
self-fertility of S. homoeocarpa strains found in United Kingdom (Baldwin and Newell, 1992;
Bennett, 1937; Jackson, 1973) and the apparent sterility (e.g. no sporulating and sterile
apothecia) in contemporary North America strains (Fenstermacher, 1970; Fenstermacher, 1980;
Orshinsky and Boland, 2011). The recent studies of Liberti et al. (2012) and Putman et al. (2015)
characterized the mating type (MAT) locus of the contemporary North America strains as
heterothallic (Liberti et al., 2012; Putman et al., 2015). Further study of the MAT locus of
historical type strains (Bennett, 1937) identified that one of historical type strains that can be
self-fertile is homothallic, but the other historical type strains are heterothallic (Putman et al.,
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2015). Further research is needed to determine the phylogenetic and taxonomical placement of
S. homoeocarpa and understand the biology of this self-fertile pathogen.

1.2 Genetic Mechanisms of Fungicide Resistance
Fungi can become resistant to fungicides through various mechanisms (Ma and
Michailides, 2005; Sanglard, 2016). First, fungicide target alternations confer resistance to
fungicides. The process of DNA replication is imperfect and errors can occur; these errors
(mutations) can change the amino acid sequence of the fungicide target site. This results in
alternation of shape of the target site and the binding of fungicide to the target site may be
reduced. For example, alternations of amino acid sequences in the β-tubulin gene cause
benzimidazole resistance in many plant pathogenic fungi (Albertini et al., 1999; Baraldi et al.,
2003; Koenraadt et al., 1992; Ma et al., 2003; McKay et al., 1998). Second, the overexpression of
the fungicide target can cause resistance to fungicides. If the number of fungicide targets is
increased in a fungal species, the fungus can become resistant if the concentration of the
fungicide is not adequate to saturate all target molecules (Sanglard, 2016). For example,
overexpression of ERG11 caused by a gain-of-function mutation in the zinc cluster transcription
factor UPC2 is involved in azole resistance in Candida albicans (Dunkel et al., 2008). Third, active
efflux or reduced uptake of the fungicide target leads to fungicide resistance. Upregulation of an
efflux pump such as the ATP-binding cassette (ABC) and the Major Facilitator Superfamily (MFS)
transporters result in enhanced fungicide efflux (Sanglard, 2016). In the case of multidrug
resistance (MDR) Botrytis cinerea isolates, overexpression of ABC transporter atrB or MFS
transporter mfsM2 expels different classes of fungicides (Kretschmer et al., 2009). Fourth, a profungicide, which needs drug metabolism by fungal cells to become active, can be poorly
converted to an active drug (Sanglard, 2016). Mutations in cytosine deaminase in C. albicans and
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Candida glabrata affect decreased the metabolism of 5-FC, a pro drug of nucleic acid and
protein biosynthesis inhibitor, to 5-fluorouridine, resulting in 5FC resistance (Edlind and Katiyar,
2010; Hope et al., 2004; Vandeputte et al., 2011).

1.3 Fungicide Resistance in Sclerotinia homoeocarpa
Resistance of S. homoeocarpa to benzimidazoles (benomyl, thioallophanate-methyl,
thioallophanate-ethyl, and thiabendazole) was first reported in the eastern and mid-western
United States where benomyl had failed to control dollar spot (Warren et al., 1974). Since then,
S. homoeocarpa field isolates exhibiting resistance to benzimidazole have been identified across
the United States (Bishop et al., 2008; Detweiler et al., 1983; DeVries et al., 2008; Jo et al., 2006;
Koch et al., 2009; Putman et al., 2010). Benzimidazoles target the fungal cytoskeleton through
the inhibition of assembly of the β-tubulin subunit (Leroux et al., 2002). Benzimidazole
resistance in S. homoeocarpa was associated with an amino acid substitution E198K in β-tubulin
gene (Koenraadt et al., 1992), which was reported for other plant pathogenic fungi with
benzimidazole resistance (Albertini et al., 1999; Baraldi et al., 2003; Koenraadt et al., 1992).
Dicarboximide fungicides were introduced to the turf industries in the mid-70’s and the
first report of dicarboximide (iprodione) resistance in S. homoeocarpa was at a Michigan golf
course with dollar spot control failure in 1983 (Detweiler et al., 1983). Dollar spot exhibiting
resistance to dicarboximide fungicides or reduced sensitivity to dicarboximide fungicides has
been reported in the United States and Italy (Bishop et al., 2008; Jo et al., 2006; Mocioni et al.,
2011; Putman et al., 2010). The detailed mode of action for dicarboximide fungicides (iprodione,
vinclozolin, and procymidone) remains elusive, but it is known that dicarboximide fungicides
interfere with osmoregulation mediated by a Group III histidine kinase and downstream MAP
kinases (Fillinger et al., 2012; Tanaka and Izumitsu, 2010). Mutations in the group III histidine
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kinase have been reported to lead to dicarboximide resistance (Avenot et al., 2005; Fillinger et
al., 2012; Ma et al., 2006; Ma et al., 2007; Oshima et al., 2002), whereas the molecular
mechanism of dicarboximide resistance has not been investigated in S. homoeocarpa field
isolates.
DMI fungicides were available to use on turfgrasses in 1979 (Golembiewski et al., 1995)
and have been extensively used to control dollar spot on golf courses. Reduced sensitivity to
DMI fungicides in S. homoeocarpa field isolates was first reported from Michigan and Ohio
(Golembiewski et al., 1995). S. homoeocarpa resistance to the DMIs has been extensively
reported in the past two decades throughout the United States (Bishop et al., 2008; Gilstrap et
al., 1997; Hsiang et al., 2007; Jo et al., 2006; Koch et al., 2009; Miller et al., 2002; Putman et al.,
2010). Cross-resistance among DMI fungicides (propiconazole, triadimefon, mycobutanil,
metconazole, triticonazole, and tebuconazole) and high correlation coefficients among DMI
fungicides and plant growth regulators (paclobutrazol and flurprimidol) EC50 values in S.
homoeocarpa isolates from Massachusetts, Ohio, and Wisconsin have been reported (Ok et al.,
2011). Additionally, Popko et al. (2012) established the association between in vitro DMI
fungicide insensitivity and decreased field efficacy of S. homoeocarpa populations in New
England (Popko et al., 2012). DMI fungicides bind to the heme iron of CYP51, which catalyzes a
key step in the biosynthesis of ergosterol, inhibiting fungal sterol synthesis (Becher and Wirsel,
2012). DMI resistance caused by mutations in the coding regions of CYP51 genes (Leroux et al.,
2007; Sanglard et al., 1998), overexpression of CYP51 by changes in the promoter of CYP51
(Hamamoto et al., 2000; Luo and Schnabel, 2008), or a gain-of-function mutation in a
transcription factor regulating CYP51 confers resistance to DMIs (Dunkel et al., 2008). Moreover,
overexpression of ABC and MFS efflux transporters are involved in reduced sensitivity to DMIs in
plant and human pathogenic fungi (Cannon et al., 2009; de Waard et al., 2006; Gulshan and
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Moye-Rowley, 2007; Hayashi et al., 2002; Morschhäuser, 2010). In the case of S. homoeocarpa
isolates from New England, DMI insensitive isolates displayed two-fold higher propiconazoleinduced CYP51 gene expression than DMI sensitive isolates. Furthermore, constitutive and
induced overexpression of the ABC transporter ShatrD mined from RNA-seq analysis of DMI
sensitive and insensitive isolates from one golf course in Massachusetts was observed (Hulvey et
al., 2012). ShatrD belongs to the ABC-G subfamily (pleiotropic drug resistance transporters) and
implies that the DMI insensitive isolates could exhibit multidrug resistance phenotypes because
the azole resistant clinical isolates caused by overexpression of ABC-G transporters displayed
reduced sensitivity to structurally different chemicals (Cannon et al., 2009). In addition to
multidrug resistance, S. homoeocarpa populations have exhibited multiple resistance to two and
even three fungicide classes, benzimidazoles, dicarboximides, and DMIs, in the United States
(Bishop et al., 2008; Jo et al., 2006; Koch et al., 2009; Ok et al., 2011; Putman et al., 2010). The
recent discovery of multidrug and multiple fungicide resistance in this pathogen necessitates
new management tools and strategies to combat fungicide resistant populations, and the
development of new forms of resistance.

1.4 Xenobiotic Detoxification Pathways
Living organisms are constantly exposed to toxic compounds in the environment. These
toxins are referred to as xenobiotics, foreign chemical compounds found within living organisms,
such as drugs, pesticides, pollutants, and toxins from foreign organisms (Misra et al., 2011).
Eukaryotes detoxify these xenobiotics through different combinations of metabolizing enzymes
and transporters. Since initial research on xenobiotic metabolism in animals from the mid- to
late 1800’s, the phase I cytochrome P450 enzymes were discovered and characterized in the
mid-1900’s, and further studies have unraveled many aspects of the biochemistry of xenobiotic
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metabolism and found the Phase II conjugation enzymes and Phase III transporters. This
knowledge paired with recent genomic technologies have led to further characterization of
xenosensing receptors, which regulate expressions of metabolizing genes and transporters to
accommodate xenobiotic exposures (Omiecinski et al., 2011).
Phase I enzymes primarily include oxidases, dehydrogenases, and reductases, which
introduce a polar functional group into target substrates to detoxify xenobiotics (Chen et al.,
2012). The cytochrome P450s (CYP450s) account for up to 75% of the Phase I xenobiotic
metabolism in humans (Guengerich, 2007). The CYP450s add a reactive group such as a
carboxyl, hydroxyl, or amino group to xenobiotics through oxidation, reduction and/or
hydrolysis reactions (Danielson, 2002). These CYP450 modified compounds can subsequently be
used for further disposition, onto xenobiotics by Phase II conjugation enzymes (Chen et al.,
2012). CYP450s are membrane bound enzymes that are located in the endoplasmic reticulum
(ER). Certain CYP450s localize to inner mitochondrial membranes and lysosomes (Chen et al.,
2012; Gibbons, 2002; Neve, 2008). Among the 17 families of human CYP450s, families CYP1,
CYP2, CYP3, CYP4, and CYP7 metabolize diverse xenobiotics with low substrate specificity (Chen
et al., 2012; Nelson et al., 1993). In particular, approximately 25% and 20% of all xenobiotics are
metabolized by CYP2B6 and CYP2C enzymes, and 50-60 % of clinical drugs are metabolized by
CYP3A4 alone (Chen et al., 2012; Guengerich, 1999; Quattrochi and Guzelian, 2001; Xie and
Evans, 2001). In fungi, several CYP450s are also known to detoxify xenobiotics encountered in
their environments. Pisatin demethylase (PDA) CYP57A1 from fungal strains of Nectria
haematococca is able to detoxify the pisatin, which is a fungistatic isoflavonoid pterocarpan
produced by pea (Pisum sativum), thus the activity of PDA contributes to virulence on pea
(George et al., 1998). The CYP450 enzymes from subfamily CYP53A from Aspergillus nidulans, A.
niger, Cochliobolus lunatus, and Phanerochaete chrysosporium catalyze the hydroxylation of
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benzoic acid and other monosubstituted benzoate derivatives (Faber et al., 2001; Fraser et al.,
2002; Matsuzaki and Wariishi, 2005; Podobnik et al., 2008). In addition, the activities of
CYP504A1 and CYP504AB1 from A. nidulans degrade aromatic exogenous compounds
phenylacetate and 3-hydroxy-/3,4-dihydroxyphenylacetate to 2-hydroxyphenylacetate and
homogentisate/ 2,3,5-trihydroxyphenylacetate, respectively.
After a xenobiotic becomes more hydrophilic through CYP450 reactions, Phase II
enzymes conjugate endogenous ligands with electrophilic xenobiotics or their Phase I
hydrophilic metabolites through acetylation, esteration, glucuronidation, methylation, sulfation,
and amino acid and glutathione conjugation (Chen et al., 2012). Phase II enzymes glutathione Stransferases (GSTs), UDP- glucuronosyltransferases (UGTs), N-acetyltransferases (NATs),
quinone reductases (QRs), NAD(P)H:menadione reductases (NMOs), methyltransferases,
epoxide hydrolases (EPHs), and sulfotransferases (SULTs) transfer hydrophilic compounds to
substances, thereby enhancing excretion (Chen et al., 2012; Hinson and Forkert, 1995). In
humans, several UGTs play a principle role in the conjugation step among phase II enzymes.
UGTs located in the ER membrane catalyze the glucuronidation of endogenous substrates and
exogenous compounds (Chen et al., 2012; King et al., 2000). Fungi also utilize phase II enzymes
to cope with xenobiotics. The various conjugates have been excreted by different fungal species
during the degradation of various compounds (Bezalel et al., 1997; Campoy and ÁlvarezRodríguez, 2009; Hundt et al., 2000; Morel et al., 2013; Sutherland et al., 1991). The white rot
fungi produce glucosidases and xylosidases to catalyze the conversion of some chlorinated
organic compounds to the corresponding conjugated derivatives that are less toxic than the
parent compound (Hundt et al., 2000; Reddy et al., 1997). Additionally, the activities of three
GSTs identified from the fission yeast Schizosacchromyces prome have been suggested to be
involved in the detoxification of fluconazole (Veal et al., 2002).

8

Xenobiotics and their metabolites are ultimately excreted by Phase III transporters,
which serve as uptake or efflux pumps of structurally unrelated xenobiotics across the cell
membrane. Humans possess ABC transporters and organic cation transporters (OCT)/organic
anion-transporting polypeptides (OATP), which use the ATP hydrolysis generated energy and
proton gradients, respectively (Chen et al., 2012). Due to transporters having a broad spectrum
of substrate specificity, efflux transporters play a significant role in multidrug resistance. Among
48 human ABC transporters, 11 transporters are known to be involved in multidrug resistance in
cancer cells (Szakacs et al., 2006). Constitutive and induced overexpression of mammalian Pglycoprotein (P-gp, MDR1, or ABCB1) and multidrug resistance-associated protein (MRP)
contribute to multidrug resistance phenotypes in a variety of human tumors (Chen et al., 2012;
Scotto, 2003). Fungi also have two main families of efflux proteins, ABC and MFS transporters,
that are associated with multidrug resistance in many fungi of agricultural and clinical
importance (Cannon et al., 2009; Del Sorbo et al., 2000). For example, azole resistant fungal
strains of C. albicans and C. glabrata harboring overexpression of ABC transporters exhibited
reduced sensitivity to chemically different compounds such as cycloheximide, cerulenin, and
R6G (Cannon et al., 2009).
Induced expression of Phase I and II enzymes and efflux transporters in response to a
xenobiotic is subjected to transcriptional regulation. These enzymes and transporters are
regulated by a nuclear receptor superfamily of transcription factors with co-repressors or coactivators in human (Tolson and Wang, 2010). The nuclear receptor PXR (pregnane X receptor)
directly binds to chemically diverse xenobiotics, thereby, upregulating transcription of Phase I
and II enzymes and transporters for xenobiotic detoxification (Ihunnah et al., 2011). Specifically,
Phase I enzymes including CYP3A and CYP2B6, Phase II enzymes including UGTs, GSTs, and SULTs
superfamily, and efflux transporters including P-gp and MRP2 are regulated by PXR to
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coordinate the endobiotic and xenobiotic detoxification (Chen et al., 2012; Ihunnah et al., 2011).
Together with PXR, constitutive androstane/activated receptor (CAR), which also belongs to the
orphan nuclear receptor superfamily, is a chemical sensing transcription factor and regulates
Phase I enzymes including CYP3A4, CYP2Bs, and CYP2Cs, Phase II enzymes including UTGs and
GSTs, and Phase III transporters including MDR1, MRP, and OATP2 (Chen et al., 2012; Kast et al.,
2002; Ueda et al., 2002). These two nuclear receptors contribute to the development of
multidrug resistance in various cancer cells (Chen et al., 2012). Fungi do not possess nuclear
receptor orthologs based on bioinformatics analysis, but members of the fungal zinc cluster of
transcription factors have functional analogs with human nuclear receptors (Näär and Thakur,
2009). Fungal transcription factor Pdr1 orthologues from Saccharomyces cerevisiae and C.
glabrata regulate expression of Phase III efflux transporters in response to direct binding to
structurally diverse xenobiotics (Thakur et al., 2008). Furthermore, the gain of function
mutations in the fungal zinc cluster transcription factors in human and plant pathogenic fungi
cause constitutive upregulation of ABC transporters and increase the level of resistance to
unrelated antifungal drugs (Coste et al., 2006; Ferrari et al., 2009; Kretschmer et al., 2009).
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CHAPTER 2
A PLEIOTROPIC DRUG RESISTANCE TRANSPORTER IS INVOLVED IN REDUCED SENSITIVITY TO
MULTIPLE FUNGICIDE CLASSES IN SCLEROTINIA HOMOEOCARPA (F.T. BENNETT)

2.1 Abstract
Dollar spot, caused by Sclerotinia homoeocarpa, is a prevalent turfgrass disease and the
fungus has exhibited widespread fungicide resistance in North America. In a previous study an
ABC-G transporter, ShatrD, was associated with practical field resistance to demethylation
inhibitor (DMI) fungicides. Mining of ABC-G transporters, also known as pleiotropic drug
resistance (PDR) transporters, from RNA-Seq data gives an assortment of transcripts, several
with high sequence similarity to functionally characterized transporters from Botrytis cinerea,
and others with closest BLASTX hits from Aspergillus and Monilinia. In addition to ShatrD,
another PDR transporter showed significant overexpression in replicated RNA-Seq data, and in a
collection of field resistant isolates, as measured by qPCR. These isolates also showed reduced
sensitivity to unrelated fungicide classes. Using a yeast complementation system, we sought to
test the hypothesis that this PDR transporter effluxes DMIs, as well as chemically unrelated
fungicides. The transporter (ShPDR1) was cloned into the Gal1 expression vector and
transformed into a yeast PDR transporter deletion mutant, AD12345678. Complementation
assays indicated that ShPDR1 complemented the mutant in the presence of propiconazole
(DMI), iprodione (Dicarboximide) and boscalid (SDHI: Succinate Dehydrogenase Inhibitor). Our
results indicate that overexpression of ShPDR1 is correlated with practical field resistance to
DMI fungicides and reduced sensitivity to Dicarboximide and SDHI fungicides. These findings
highlight the potential for eventual development of a multidrug resistance phenotype in this
pathogen. Additionally, this study presents a pipeline for the discovery and validation of
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fungicide resistance genes using de novo Next-Generation Sequencing and molecular biology
techniques in an unsequenced plant pathogenic fungus.

2.2 Introduction
Sclerotinia homoeocarpa (F. T. Bennett) causes dollar spot of turfgrass, which is the
most prevalent and economically significant turfgrass disease (Vargas et al., 1992). Multiple
fungicide applications are required to control dollar spot throughout the growing season (Smiley
et al., 2005), however, the repeated use of fungicides has led to the development of fungicide
resistance. Resistance to chemistries from the benzimidazole and dicarboximide classes has
been confirmed in field isolates of S. homoeocarpa (Cole et al., 1968; Detweiler et al., 1983).
Recent reports also indicate that S. homoeocarpa has developed site-specific resistance to DMI
fungicides in the United States (Jo et al., 2006; Miller et al., 2002; Popko et al., 2012; Putman et
al., 2010).
In the filamentous fungi, three genetic mechanisms of fungicide resistance have been
widely reported. For site-specific fungicides in general, reducing affinity of the fungicide to the
target site by non-synonymous polymorphism in the target gene is known to confer resistance
(Ma and Michailides, 2005). Additionally, overexpression of the target gene can be linked to
resistance (Hamamoto et al., 2000). Another commonly reported mechanism is efflux of
fungicide molecules by the activity of ATP-binding cassette (ABC) efflux transporters, which are
found in all eukaryotes, and can translocate compounds across cell membranes using the
hydrolysis of ATP as an energy source (Del Sorbo et al., 2000; Driessen et al., 2000). The ABC
transporters are thought to evolve through gene duplication events and are grouped into
diverse sub-families based upon protein domain organization (Kovalchuk and Driessen, 2010). In
fungi, full size transporters in the “G” sub-family (ABC-G transporters) contain a nucleotide
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binding domain and transmembrane domain in duplicate, which is denoted by (NBD-TMD)2
(Lamping et al., 2010). These transporters of toxic molecules, also known as pleiotropic drug
resistance (PDR) transporters, are known to have differential specificity for fungicides, and some
have been reported to mediate what has been termed an multidrug resistance (MDR)
phenotype in Botrytis cinerea (Kretschmer et al., 2009). While not necessarily analogous to
multidrug resistance reported for human pathogenic bacteria and yeasts, this phenotype
involves reduced in vitro sensitivity to multiple unrelated fungicide classes and has been
proposed to negatively impact efficacy of multiple fungicides for controlling plant pathogen
populations (Leroux et al., 2013; Leroux and Walker, 2011).
Previously, Hulvey et al. utilized transcriptomic and molecular tools to investigate
determinants of practical field resistance to DMI fungicides in S. homoeocarpa (Hulvey et al.,
2012). This work demonstrates that overexpression of the PDR transporter ShatrD was strongly
associated with practical field resistance (PFR) to a DMI fungicide, while overexpression of the
gene target of DMIs, ShCYP51B, was a minor factor for practical field resistance. Recently, we
mined RNA-Seq data for the complement of PDR transporter genes, and identified another with
statistically significant overexpression. This gene shares significant sequence similarity with the
ABC transporters PMR1 from Penicillium digitatum and atrE from Aspergillus nidulans, both
suspected determinants of DMI fungicide resistance (Hayashi et al., 2002; Nakaune et al., 1998).
We present evidence to support an MDR phenotype in field isolates of S. homoeocarpa
from New England, similar to that presented by Kretschmer et al. for Botrytis cinerea
(Kretschmer et al., 2009). We also demonstrate that decreased sensitivity to multiple fungicides
is partially attributable to the newly described PDR transporter gene, ShPDR1, mined along with
other PDR transporters from RNA-Seq data. In order to confirm involvement of ShPDR1 in
reduced fungicide sensitivity, we utilized a yeast complementation assay to test the hypothesis
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that the cloned full-length cDNA of ShPDR1 will complement a yeast mutant deficient for ABC
efflux transporters. In summary, we show the utility of combining RNA-Seq and molecular
biology techniques for discovery of novel fungicide resistance determinants, and discuss the
implications of our findings.

2.3 Materials and Methods
2.3.1 Isolates and In Vitro Sensitivity Assay
Two sets of field isolates were utilized in this study for in vitro fungicide sensitivity
assays and for qPCR measurements. One panel of eight isolates were recovered from an initial
sampling of five sites, and the other panel of isolates consists of two sets of eight isolates that
were sampled from two golf courses in New England during the study of Popko et al. 2012
(Hulvey et al., 2012). The panel of isolates sampled initially was collected from four golf course
sites with prior exposure to fungicides (HRCC, HGC, Wintonbury Hills Golf Club and Shuttle
Meadow Country Club) and from one baseline site with no prior exposure (Joseph Troll Turf
Research Center at University of Massachusetts, Amherst). The two additional sets of eight
isolates included four each that were found to exhibit “Practical Field Resistance” to a DMI
fungicide, and four sensitive isolates from HRCC and HGC as per (Popko et al., 2012). The initial
panel of isolates and two sets of PFR and sensitive isolates were previously characterized for
EC50 values of propiconazole on potato dextrose agar (PDA) (Difco Laboratories, Detroit, MI)
(Hulvey et al., 2012).
In this study, we used minimal medium (MM) for fungicide sensitivity assays in order to
minimize the effect of additional nutrients in the media on mycelial growth. Minimal medium
has been shown to be preferential for assessing SDHI fungicide sensitivity in other filamentous
plant pathogens, such as Monilinia fructicola (Hu et al., 2011). In vitro sensitivity assays of a total
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of twenty-four isolates were conducted with DMI (propiconazole), dicarboximide (iprodione)
and SDHI (boscalid) fungicides in minimal medium (Hu et al., 2011). Commercial formulations of
propiconazole (Banner MAXX 1.3 ME, Syngenta Crop Protection) (0.001, 0.01, 0.1, 1 and 10 μg
ml-1), iprodione (Chipco 26GT, Bayer Environmental Science) (0.01, 0.1, 1, 10 and 100 μg ml-1)
and boscalid (Emerald 70WG, BASF) (1, 1000, 3000, 5000 and 10000 μg ml-1) were added to
autoclaved MM that had been cooled to 55 to 60 °C, and fungicide-amended and non-amended
media were poured into plates. Isolates from long-term storage were grown on PDA for 2 days,
and agar plugs (5 mm in diameter) were transferred from the margin of actively growing
colonies to the edge of fungicide amended MM and non-amended MM petri plates. Transferred
isolates were replicated in quadruplicate and two separate experiments were performed for a
total of eight plates per isolate. Eight days after transfer, one diameter from agar plug to the
actively growing colony margin was measured with 16EX digital calipers (Mahr, Göttingen,
Germany). Propiconazole and iprodione EC50 values (the mean effective concentration for
reduction of mycelial growth by 50%) and EC95 values for boscalid were calculated as per (Jo et
al., 2006).
2.3.2 DNA Extraction, PCR Amplification and DNA Sequencing
The extraction of DNA was conducted according to methods described previously by
(Hulvey et al., 2012). For PCR amplification and DNA sequencing, primers were designed using
primer3 (Rozen and Skaletsky, 2000). The five sets of primers including internal primers for the
coding region of ShPDR1 (4,492 bp) and two sets of primers for the partial upstream region (459
bp) of ShPDR1 were designed from transcriptomic and partial genome data (Hulvey et al., 2012).
Total volumes of PCR were 20 µl, with final concentration of 1 × PCR buffer, 0.2 µM each
primers, 0.2 mM dNTP with 2.5 nM MgCl2, 1 unit Taq DNA polymerase (New England BioLabs,
Ipswich, MA) and ~250 ng of genomic DNA. The PCR cycling conditions were used as per (Hulvey
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et al., 2012). Purified amplicons by using ExoSAP-IT PCR cleanup reagent (Affymetrix, Santa
Clara, CA) were sequenced at the Genomic Resource Laboratory (University of Massachusetts,
Amherst, MA).
2.3.3 Mycelia preparation, Total RNA Isolation and cDNA Synthesis
The extraction of RNA was performed by modifying methods described previously by
(Hulvey et al., 2012). In brief, isolates were inoculated in 25 ml of half strength potato dextrose
broth (PDB) and grown for 3 days at 23 ºC. Commercial formulations of propiconazole (0.1 µg
ml-1), iprodione (1 µg ml-1) and boscalid (10 µg ml-1) were added to treated samples, and the
same volume of water was placed in untreated samples. Tubes were lightly shaken on a
benchtop shaker for 1 hour. About ~100 mg of mycelial mat was placed in a 2.0 mL screw cap
tube with zirconia/silica bead (BioSpec) and immediately dropped into liquid nitrogen. Frozen
samples were stored in a -80 ºC freezer.
For RNA extraction 1 ml of TRIzol reagent was added to the tubes with frozen mycelia
from a freezer, and then the tubes were inserted into a Mini-beadbeater to homogenize the
samples for 40 s. After sitting the samples at room temperature for 3 min, 200 µl of chloroform
was added to the tubes, which were shaken vigorously by hand for 15 s. The tubes were
incubated at room temperature for 5 min and centrifuged at 10,000 × g for 10 min at 4 ºC.
Upper aqueous phase was removed into a new tube and 1 volume of 1.2 M NaCl-0.8 M
Na3C6H5O7 solution and isopropanol were added to aqueous phase to precipitate total nucleic
acid. After inverting the tubes several times, the tubes were incubated at 4 ºC for 10 min and
then the nucleic acids were pelleted by centrifuging at 9,200 × g at 4 ºC for 10 min. Pellets were
air dried at room temperature for 10 min and suspended in 50 µl RNase-free water at 62 ºC for
10 min. cDNA was synthesized from each sample of RNA using QuantiTect reverse transcription
kit (Qiagen Inc., Valencia, CA).
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2.3.4 Transcriptome Sequencing, Assembly, and Annotation
For the RNA-Seq experiment two biological replicates of sequencing-by-synthesis (SBS)
reads were generated by the method of (Hulvey et al., 2012). In brief, RNA was extracted from
treated and untreated mycelia of HRS10 and HRI11 and sent to Macrogen Inc. (Seoul, South
Korea) for mRNA isolation and cDNA library preparation using the TruSeq mRNA kit, and
sequencing with the Illumina v7 HiSeq2000 platform (Life Technologies). For Illumina
sequencing, 100 cycle reactions were performed yielding over 50 million to 2 X 100 bp pairedend (PE) SBS reads per cDNA library. For each biological replicate, one lane of sequencing was
done for four cDNA libraries (HRS10 untreated, HRI11 untreated, HRS10 treated, and HRI11
treated), as previously described (Hulvey et al., 2012). The PE SBS reads from both replicates
were combined with 454 GS FLX Titanium data from (Hulvey et al., 2012) for performing a de
novo transcriptome assembly using CLC Genomics Workbench (CLC Bio, Aarhus, Denmark)
(2012). The alignment contigs were BLASTX searched against the NCBI non-redundant protein
database (August 2013) using BLAST2GO software with the default settings except for an e value
threshold of less than e-30. In addition, gene ontology and Pfam domain searches were
performed on the assembled contigs in BLAST2GO.
The PDR transporters that were analyzed in this study were parsed from the dataset
based on several criteria: GO terms, e value threshold of e-60 for BLASTX result, nucleotide length
greater than 2 kb, and presence of ABC-G protein domains in the translated amino acid
sequence. Such stringent criteria ensure that mined sequences represent full-size ABC-G
transporters suitable for phylogenetic analysis and high confidence in RNA-Seq analysis.
2.3.5 RNA-Seq Transcriptome Profiling
RNA-Seq analysis was performed by mapping read pairs from each biological replicate of
SBS PE data back to the hybrid assembly in CLC Genomics Workbench with the following criteria:
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Mismatch cost = 2, Insertion cost = 3, Deletion cost = 3, Length fraction = 0.5, and Similarity
fraction = 0.95. In order to analyze differential expression between samples, RNA-Seq
experiments were set up in CLC Genomics Workbench to look for differences between HRS10
and HRI11, in untreated and treated samples separately. Since we analyzed Reads Per Kilobase
per Million mapped reads (RPKM), and thus count-based data, values were first normalized by
read count totals (Bolstad et al., 2003). Baggerly’s test, a proportions-based test, was used to
detect significant differences in expression of mined ABC-G transporters for each experiment
(Baggerly et al., 2003). Normalized RPKM values were analyzed by Baggerly’s test to look for
significant differences in expression data of untreated and treated samples. Mean fold change
was calculated from mean normalized RPKM values, and indicate how many times larger
expression values were for HRI11 than for HRS10.
2.3.6 Upstream and Coding Sequence Analyses of ShPDR1 and Phylogenetic Analysis of ABC-G
Transporters
Sequence analysis of the upstream and coding regions of ShPDR1 followed the method
of (Hulvey et al., 2012). The Neural Network Promoter Prediction (NNPP) software at the
Berkeley Drosophila Genome Project website was employed to search a 500 bp upstream region
of ShPDR1 for promoters.
A phylogenetic analysis was performed for ABC-G transporters amino acid sequences obtained
from (Hulvey et al., 2012) and GenBank, with the addition of PDR transporter contigs from RNASeq data. MAFFT server was used to align amino acid sequences with automated method
selection and Blosum 62 amino acid scoring matrix (Katoh and Toh, 2008). Neighbor Joining
phylogenetic analysis with Poisson model, Gamma distributed rates among sites, complete
deletion of missing data, and 1000 bootstrap replicates were conducted in MEGA v5 (Tamura et
al., 2011).
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2.3.7 Real-Time Quantitative PCR Analysis
The RE of ShPDR1 was assayed with quantitative Real-Time PCR before and after
treatment of propiconazole (0.1 μg ml-1), iprodione (1 µg ml-1) and boscalid (10 µg ml-1) for 1h in
the initial panel of eight isolates. In addition, constitutive expression of ShPDR1 was assayed for
PFR and sensitive isolates from two sites. Additionally, the effect of propiconazole dose on
expression of ShPDR1 and ShatrD genes was assessed in two insensitive isolates HRI11 and
HFI40 in the absence and presence of propiconazole at 0.1, 1 and 5 μg ml-1. The Actin (Shact)
gene in S. homoeocarpa was selected as a housekeeping gene. Primers for qPCR were designed
using the Integrate DNA Technologies qPCR primer design web tool sever to amplify 113 bp
amplicons from ShPDR1 gene and primers for ShatrD and Shact genes amplification were used
as per (Hulvey et al., 2012). Quantitative RT-PCR was conducted in 25 µl reactions containing
12.5 µl of Absolute Blue SYBR qPCR MasterMix (Thermo Fisher Scientific, Waltham, MA), 1.75 µl
of each primer at 1 µM, 8 µl microbiological grade water (Thermo Fisher Scientific, Waltham,
MA) and 1 µl of cDNA at 250 ng/µl. Mastercycler ep realplex thermocycler (Eppendorf) were
used for PCR reactions. PCR conditions were as follow: 1 cycle of 15 min. at 95 °C, and 40 cycles
of 15 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C. The comparative CT method was used to
calculate relative gene expression (Livak and Schmittgen, 2001). Two biological replicates and
three technical replicates per each biological replicate were performed for each isolate and
treatment.
2.3.8 Heterologous Expression of ShPDR1 in Yeast
The full length cDNA sequences of ShPDR1 were amplified using primers
ShPDR1_cloning_F and ShPDR1_cloning_R (Table 2.1) which introduce KpnI and SphI sites at the
5’ and 3’ end of the amplified product, respectively. PCR was performed using Phusion highfidelity DNA polymerase (New England Biolabs) in a PCR reaction with initial denaturation step
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at 98 °C for 30 s, followed by 53 cycles of denaturation (at 98 °C for 15 s) and annealing (at 73 °C
for 30 s, decreasing at increments of 1.0 °C per cycle for the first eight cycles, and at 65 °C for
the remaining 45 cycles) and extension (at 72 °C for 2 min), with a final extension step at 72 °C
for 5 min. The purified 4,514 bp PCR product and the plasmid pYES2 (Invitrogen) were digested
with KpnI and SphI and two digested products were gel-purified using the Zymoclean Gel DNA
Recovery Kit (Zymo research, USA) and ligated. Escherichia coli DH5a was used for propagation
of vector pYES2 containing ShPDR1.
S. cerevisiae strain AD1-8 (MATα, pdr1-3, his1, ura3, Δpdr5::hisG, Δyor1::hisG,
Δsnq2::hisG, Δycf1::hisG, Δpdr10::hisG, Δpdr11::hisG, Δpdr15::hisG, Δpdr3::hisG) (Decottignies
et al., 1998) was transformed with empty expression vector pYES2 (AD1-8-pYES2) and the vector
containing ShPDR1 (AD1-8:PDR1-1, AD1-8:PDR1-2) by a high-efficiency polyethylene glycol
(PEG)/LiAc-based method using the Yeastmaker Yeast Transformation System 2 (Clontech, USA).
Yeast transformants were selected on solid synthetic minimal media (MM) containing bactoyeast nitrogen base (YNB) without amino acids (6.7 g/L), drop-out mix (2 g/L containing amino
acids minus uracil), glucose (20 g/L) and agar (20 g/L). Transformants with the empty vector
pYES2 and the vector pYES2 with ShPDR1 were grown at 30 °C for 3 days in liquid minimal
medium lacking uracil and containing 2% galactose.
For fungicide sensitivity assays, cell suspensions were diluted to an OD600 of 0.5 in liquid
MM using a microplate reader (VERSAmaxTM, USA) and 5 and 10 µl of each yeast transformants
were plated as spots on YNB agar media lacking uracil, containing 2% galactose, and amended
with different concentrations of fungicides. Sensitivity of yeast transformants to fungicides was
qualitatively assessed after incubation at 30 °C for 3 days. The fungicides concentrations (μg ml1

) used in this study were as follows: propiconazole (0, 0.0005, 0.001, 0.002, 0.003), iprodione

(0, 10, 100, 250, 500) and boscalid (0, 10, 100, 250, 500). Two biological replicates and four
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technical replicates per each biological replicate were conducted for each transformant and
treatment.

Table 2.1. Primers used in this study
Primer name
ShPDR1_F

a

Primer sequence (5’- 3’)
TGCTACTTCGTGCGCGCTTATATTTTC

Description
Amplification and sequencing
primer for ShPDR1
Same as above

ShPDR1_R

TTCCCAACTTCAATCCCCTCTTTTTCG

ShPDR1_int1R

TACTAACACGTTTGCGCTCTCCACCAG

ShPDR1_int2F

CAATACCCGCGTAGGCAACGACTATGT

Sequencing internal region of
above
Same as above

ShPDR1_int2R

TGGCATATCGCAAATCATAGACGCAAG

Same as above

ShPDR1_int3F

GCGCTTGCGTCTATGATTTGCGATATG

Same as above

ShPDR1_int3R

GTAGCCGGTTTTCCGTTGAAATGACTG

Same as above

ShPDR1_int4F

AGAGTAACCGTGGGTGTGGTCACAGG

Same as above

ShPDR1_int4R

TTGGCTTGGAAGAAAGAGAATCCGATG

Same as above

ShPDR1_int5F

TCCGCCATCTACATCGGATTCTCTTTC

Same as above

ShPDR1up_F

CTGGTTCAATTGTGTTCGATTGTGTTCG

ShPDR1up_R

GGTTGAGATTAGGGTTGAGATTCCCTA

Amplification and sequencing
upstream of ShPDR1
Same as above

ShPDR1_QF

TCTGTTCACCTCCACCTTTG

ShPDR1_QR

TACATGA AGATCCAGAAGCCG

Quantitative PCR of ShPDR1
gene
Same as above

Shact_QF

TCGTGATTTGACCGATTACCTC

Quantitative PCR of Shact gene

Shact_QR

GGAGAAGCTTTGTTACGTTGC

Same as above

ShatrD_QF

CGGTCTTCAAAGAAACGCTG

ShatrD_QR

CGCGAACTTCATACAGAGAACG

Quantitative PCR of ShatrD
gene
Same as above

ShPDR1_F_cloning

ATGCGGTACCATGTCTTTATTAGGGAATCTCAAC
CCTAAT
ATGCGCATGCTCAAACCTTCGATCGTTTCCCCTTT

Cloning of the full length cDNA
of ShPDR1
Same as above

ShPDR1_R_cloning
a

“F” at the end of the sequence name indicates forward primer and “R” indicates reverse
primer. “int” represents a primer used for sequencing internal portions of the amplicon.
2.3.9 Statistical Analyses of In Vitro Sensitivity Assay and Quantitative PCR Data
EC50 values for propiconazole and iprodione and EC95 values for boscalid were generated
for the three sets of isolates. The first set included the initial panel of eight isolates from five
sites and two additional sets consisted of four PFR and four sensitive isolates from HRCC and
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HGC, respectively. Analysis of variance was conducted on the first set to determine differences
among EC50 and EC95 values of eight isolates and on the additional two sets for examining
differences between the mean EC50 and EC95 values of sensitive and PFR groups of isolates.
Analysis of variance was also conducted between biological replications of EC50 and EC95 values
for all sets.
For the statistical analysis of RE data for ShPDR1 and ShatrD, four independent sets were
generated. The first set contained the initial panel of isolates before and after treatment of
propiconazole, boscalid and iprodione. The second and third sets contained PFR and sensitive
isolates from HRCC and HGC, respectively. The last set included two insensitive isolates from the
initial panel of isolates with increasing doses of propiconazole. Analysis of variance was
conducted on RE levels for ShPDR1 between the sensitive and insensitive groups of isolates and
between constitutive and induced expression for the first set. For the second and third sets,
analysis of variance was conducted on RE values for ShPDR1 between the sensitive and
insensitive groups of isolates. Analysis of variance was conducted to examine differences in RE
values between ShPDR1 and ShatrD in the last set. Analysis of variance was conducted between
biological replications of RE data for all aforementioned sets of isolates.
Linear regression analysis was conducted with propiconazole and iprodione EC50 and
boscalid EC95 values and log10-transformed mean RE values of ShPDR1 constitutive expression
for all 24 isolates. All statistical analyses were conducted by using JMP software package,
version 9.0 (SAS Institute Inc., Cary, NC).
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2.4 Results
2.4.1 Sensitivity of S. homoeocarpa Isolates to Propiconazole, Iprodione and Boscalid
In order to investigate the MDR phenotype of S. homoeocarpa field isolates, in vitro
sensitivity of isolates to unrelated fungicide classes were tested. In vitro sensitivity values
determined using the initial panel of eight isolates for minimal medium (MM) amended with
propiconazole, iprodione and boscalid ranged from 0.016 to 0.753, 0.398 to 0.824 and 3182.4 to
7432.7 µg ml-1, respectively (Table 2.2). Analysis of variance determined propiconazole EC50,
iprodione EC50 and boscalid EC95 values of the 8 initial isolates were significantly different (Table
2.2). The EC50 and EC95 values of all insensitive initial isolates were higher than sensitive isolates,
and those values of SMI27 were the lowest among insensitive isolates. The mean EC50 and EC95
values of propiconazole, iprodione and boscalid for the group of four PFR isolates (HRI1-4) from
Hickory Ridge Country Club (HRCC) were significantly higher than those for the group of four
sensitive isolates (HRS1-4) (P < 0.0001). The group of four PFR isolates (HFI1-4) from Hartford
Golf Club (HGC) were significantly higher in the mean propiconazole and iprodione EC50 and
boscalid EC95 values than those for the group of four sensitive isolates (HFS1-4) (P < 0.0001)
(Table 2.2).
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Table 2.2. Sclerotinia homoeocarpa field isolates used in this study
Propiconazole
Propiconazole
Iprodione
a
b
Isolates
Sensitivity
EC50 (µg/ml)
EC50 (µg/ml)

Boscalid

HRI11
HFI40
WBI7
SMI27
HRS10
HFS35
JTS30
SMS23
P valuecd

I
I
I
I
S
S
S
S

0.753
0.604
0.544
0.199
0.016
0.025
0.020
0.068
***

0.761
0.757
0.824
0.550
0.526
0.540
0.524
0.398
*

EC95 (µg/ml)
7432.7
6599.5
7069.1
4895.7
3499.6
3182.4
3695.3
3564.6
**

HRS1-4
HRI1-4
P valuede

S
I (PFR)

0.054
0.740
***

0.407
0.825
***

3819.1
8891.8
***

HFS1-4
S
0.026
0.495
3516.5
HFI1-4
I (PFR)
0.739
0.800
6629.9
df
P value
***
***
***
a
Isolates are named as per (Hulvey et al., 2012). Location abbreviation (HR: Hickory Ridge
Country Club; HF: Hartford Golf Club; WB: Wintonbury Hills Golf Club; SM: Shuttle Meadow
Country Club; JT: Joseph Troll Turf Research Center at University of Massachusetts, Amherst).
b
Propiconazole sensitivity previously determined by (Hulvey et al., 2012) (I: insensitive; S:
sensitive; PFR: practical field resistance).
c
Statistical differences among EC50 and EC95 values of initial eight isolates.
d
*, ** and *** refer to significance at P < 0.05, 0.01 and 0.001, respectively.
e
Statistical differences between mean EC50 and EC95 values of sensitive and insensitive groups
from HRCC.
f
Statistical differences between mean EC50 and EC95 values of sensitive and insensitive groups
from HGC.
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2.4.2 RNA-Seq Data and ABC-G Transporters from The Transcriptomic Data of S. homoeocarpa
The RNA-Seq method allows for the profiling of the total compliment of expressed
transcripts in an organism, and in this study was used to first define the PDR transportome of S.
homoeocarpa and second to determine which PDR transcripts showed differential expression
following exposure to a DMI fungicide. From the assembled RNA-Seq data, 12,494 contigs over
500 bp were generated. For each library of RNA-Seq data, over 30 million reads were mapped
back in pairs for both biological replicates of treated and untreated samples of HRS10 and
HRI11. Of the assembled contigs, seven were found to represent PDR transporters (Table 2.3).
Six of the seven contigs had a member of the Sclerotiniaceae as a top BLASTX hit, while ShPDR1
(contig 6887) had a top blast hit from A. kawachii (Trichocomaceae). Of the expression data,
only two contigs, one representing ShatrD (contig 4492) and the other ShPDR1 were found to
show significant (< 0.05) overexpression in HRI11 as determined from two-tailed P-values
derived from Baggerly’s test (Table 2.3). The ShatrD and ShPDR1 genes showed high
overexpression in both untreated and treated samples in the DMI-insensitive isolate, HRI11.
Conversely, only one of the identified PDR transporters (contig 2174) showed significant,
although numerically low overexpression (less than three-fold), in the DMI-sensitive isolate,
HRS10 (Table 2.3).
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Table 2.3. Summary of transcriptome contigs encoding PDR transporters from S. homoeocarpa.
Contig #

Contig
length
(bp)

Top BLASTX hit in Botrytis
a
cinerea
(E
value, % query coverage,
% identity, # of amino
acid matches/total amino
acids aligned)
BcatrA, CCD52170.1
(0, 99, 83, 1124/1358)

2174

4063

4492

7129

BcatrD, CAC41639.1
(0, 87, 84, 1242/1482)

4985

5241

BMR1, BAA93677.1
(0, 85, 85, 1257/1485)

6230

2984

BcatrB, CCD54655.1
(0, 99, 83, 847/1020)

6887

5223

BcatrD, CAC41639.1
(0, 83, 64, 937/1471)

7104

2804

Unnamed, BAC67160.1
(0, 89, 87, 728/837)

8448

2401

Unnamed, EMR87975.1
(0, 89, 80, 580/723)

a

Top BLASTX hit
(E value, % query
coverage, % identity, #
of amino acid
matches/total amino
acids aligned)
Botrytis cinerea,
CCD52170.1
(0, 99, 83, 1124/1358)
Botrytis cinerea,
CAC41639.1
(0, 87, 84, 1242/1482)
Sclerotinia borealis,
ESZ99265.1
(0, 87, 86, 1262/1476)
Monilinia fructicola,
AAL80009.1
(0, 99, 84, 860/1020)
Aspergillus kawachii,
GAA89082.1
(0, 87, 77, 1143/1485)
Sclerotinia borealis,
ESZ91198.1
(0, 91, 85, 733/858)
Sclerotinia borealis,
ESZ91198.1
(0, 88, 82, 586/716)

Baggerly’s test,
weighted proportions
b
fold difference
untreate
treated
d
-2.3

***c

8.7

*

-2.3

NS

7.3

*

-1.1

NS

1.3

-1.6

NS

-1.4

***

22.5

11.0

NS

NS

NS

1.0

NS

2.0

NS

1.6

NS

3.4

NS

Top BLAST hits are denoted by either gene name in B. cinerea and reference as in the case of
functionally characterized genes, or as GenBank accession number, as in the case of
uncharacterized genes.

2.4.3 Sequence and Phylogenetic Analyses
In order to characterize the PDR transporters identified from the assembled transcripts,
we utilized BLAST searches, domain characterization of the encoded amino acids, and
phylogenetic analysis with other characterized PDR transporters. BLASTX search results of
ShPDR1 and other PDR transporters mined from the transcriptome data are presented in Table
2.3. Conserved domain searches confirmed that ShPDR1, ShatrD, and three other PDR
transporters encoded two nucleotide-binding domains (NBD), two ABC2 domains and a
pleiotropic drug resistance domain, as was expected (Lamping et al. 2010). The other two were
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partial sequences, but both included ABC2 domains, indicative of PDR transporters and top blast
hits that are PDR transporters. Phylogenetic analysis indicates that ShPDR1, AnatrE, PMR1,
PMR4 and unnamed PDR transporter from A. kawachii cluster together in a group supported by
a bootstrap value of 100 % (Figure 2.1).
Comparison of sequences obtained from PCR and sequencing of genomic DNA and from
RNA-Seq data revealed that the 4572 bp of ShPDR1 is interrupted with one intron (78 bp).
Single-nucleotide polymorphisms (SNPs) from comparison to JTS30 sequence were detected in
the coding region of ShPDR1 at following base pair positions: + 487, +490, +1335, +1638 and
+3825 for WBI7 and HFI40; +4181 for SMS23 and SMI27. Three non-synonymous SNPs (+487,
+490, +4181) were identified (T163A, V163I, S1394T, respectively). The sequences of coding
region in sensitive isolate HRS10 revealed an 81 bp deletion from +1069 to +1149. In the
upstream sequence of ShPDR1, a SNP was detected in one position +325 for WBI7 and HFI40,
however no promoters were detected in the upstream region. The ShPDR1 coding sequences
from HRS10 and HRI11 and upstream region of ShPDR1 from JTS30 were deposited in GenBank
with accession numbers KJ128076-8.
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Figure 2.1. Neighbour-joining phylogenetic tree of amino acid sequences of pleiotropic drug
resistance (PDR) transporters from the dataset of Hulvey et al. (2012), including five additional
full length PDR transporters from Sclerotinia homoeocarpa (ShPDR1, ShPDR1 deletion, contigs
2174, 4985, and 6230), Penicillium digitatum PMR3 and PMR4, and Aspergillus kawachii PDR
transporter (Lamping et al., 2010). The scale bar equals the proportion of amino acid
substitutions.

28

2.4.4 Quantitative PCR Analysis of ShPDR1 for Initial Panel of Eight Isolates and Practical Field
Resistance Isolates
ShPDR1 expressions of initial panel of eight isolates and PFR isolates were assayed to
investigate the possible involvement of overexpression of ShPDR1 in reduced sensitivity to
propiconazole, iprodione and boscalid. Significant differences (P < 0.0001) in constitutive
relative expression (RE) values of ShPDR1 were found between the group of insensitive isolates
from initial panel of eight isolates (mean = 22.8 ± 1.2 standard error (SE)) and the group of
sensitive isolates (mean = 3.1 ± 1.2 SE). Three insensitive isolates (HRI11, HFI40 and WBI27)
significantly increased RE of ShPDR1 after treatment of propiconazole, iprodione and boscalid,
but one insensitive isolate (SMI27) and four sensitive isolates did not increase RE of ShPDR1 in
the presence of three fungicides, except for SMS23 in response to propiconazole (Figure 2.2).
The differences in the constitutive RE values of ShPDR1 were highly significant (P <
0.0001) between the group of PFR isolates (mean = 29.8 ± 1.7 SE) and the group of sensitive
isolates (mean = 3.4 ± 1.7 SE) from HRCC. The differences in the constitutive RE values of
ShPDR1 were also highly significant (P < 0.0001) between the group of PFR isolates (mean = 17.0
± 0.9 SE) and the group of sensitive isolates (mean = 5.3 ± 0.9 SE) from HGC (Figure 2.3).
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Figure 2.2. Relative expression (RE) of ShPDR1 in the initial panel of eight isolates from five sites
in New England in the absence and presence of propiconazole (0.1 μg ml-1), iprodione (1 µg ml-1)
and boscalid (10 µg ml-1) for 1 hour. All bars (white = constitutive RE; light gray = propiconazole
induced RE; dark gray = iprodione induced RE; black = boscalid induced RE) represent mean RE
values. Error bars indicate 1 standard error from the mean. Isolates with an “I” indicate
propiconazole insensitive and with a “S” represent propiconazole sensitive.
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Figure 2.3. Relative expression (RE) values for ShPDR1 in practical field resistant and sensitive S.
homoeocarpa isolates from Hickory Ridge Country Club and Hartford Golf Club. All bars (gray =
constitutive RE of PFR isolates; white = constitutive RE of sensitive isolates from control plots)
represent mean RE values. Error bars indicate 1 standard error from the mean.

2.4.5 Quantitative PCR Analysis of ShPDR1 and ShartD at Different Concentrations of
Propiconazole
Gene expressions of two ABC transporters in two DMI-insensitive isolates at different
doses of propiconazole were assessed to help gain a better understanding of the role of two
ABC transporters in DMI resistance. Induced RE values of ShPDR1 for both isolates HRI11 and
HFI40 (mean of HRI11 = 1321.4 ± 78.4 SE; mean of HFI40 = 679.0 ± 48.7 SE) were significantly
higher than RE of ShatrD for the isolates (mean of HRI11 = 265.2 ± 78.4 SE; mean of HFI40 = 84.0
± 48.7 SE) in the presence of propiconazole at 5 μg ml-1 (P < 0.0001). Significant differences (P <
0.0001) were found between induced RE values of ShPDR1 and ShatrD after treatment of
propiconazole at 0.1 μg ml-1 for HRI11 and at 1 μg ml-1 for HFI40. While no differences were
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found for HRI11 between RE values of ShPDR1 and ShatrD before and after treatment of
propiconazole at 1 μg ml-1, and for HFI40 between RE values of two genes in the absence and
presence of propiconazole at 0.1 μg ml-1 (Figure 2.4).

Figure 2.4. Relative expression (RE) of ShPDR1 and ShatrD in two insensitive S. homoeocarpa
isolates (HRI11 and HFI40) in the absence of propiconazole and presence of propiconazole (0.1,
1 and 5 μg ml-1) for 1 hour. All bars (gray = RE of ShPDR1; white = RE of ShatrD) represent mean
RE values. Error bars indicate 1 standard error from the mean. Significant differences between
RE values of ShPDR1 and ShatrD are indicated: n.s. = not significant, and *** = significant at P <
0.001.

2.4.6. Linear Regression of ShPDR1 Expression and EC50 Values for Propiconazole and
Iprodione and EC95 Values for Boscalid
The linear regression analysis was conducted to examine whether constitutive expression of
ShPDR1 is correlated with the sensitivity to three fungicides. The linear regression of log10-
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transformed mean RE values for constitutive expression of ShPDR1 and EC50 values for
propiconazole and iprodione showed a significant relationship (P < 0.0001), respectively (Figure
2.5A and B). Also, the linear relationships between log10 RE of ShPDR1 and EC95 values of
boscalid were highly significant (P < 0.0001) (Figure 2.5C).

Figure 2.5. Relationship between log10 RE values of ShPDR1 and in vitro sensitivities to A)
propiconazole, B) iprodione or C) boscalid (as measured by EC50 for propiconazole and iprodione
and EC95 for boscalid) for 24 isolates from New England. The denotation of isolates was as per
Hulvey et al. (triangles, PFR isolates from Hartford Golf Club; diamonds, PFR isolates from
Hickory Ridge Country Club; squares, insensitive isolates from four sites; black dots, sensitive
isolates from five sites) (Hulvey et al., 2012). Each color shape indicates the same isolates for
panels A, B and C.
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2.4.7 Heterologous Expression of ShPDR1 in Saccharomyce cerevisiae
The hypersensitive mutant strain AD12345678 (AD1-8) of S. cerevisiae (Decottignies et
al., 1998) was transformed with full length of ShPDR1 cDNA cloned in the yeast expression
vector pYES2 in order to test whether ShPDR1 is involved in decreased sensitivity to multiple
fungicides in yeast. A clear qualitative difference in fungicide sensitivity between two ShPDR1
transformants (AD1-8:PDR1-1 and AD1-8:PDR1-2) and the control transformant (AD1-8-pYES2)
was observed with propiconazole, iprodione and boscalid (Figure 2.6).

Figure 2.6. Complementation of S. cerevisiae strain AD1-8 with ShPDR1 from S. homoeocarpa.
Sensitivity assays of the transformants were conducted on YNB agar media that lacking uracil,
containing 2% galactose, and amended with increasing concentrations of propiconazole,
iprodione and boscalid fungicides, respectively.
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2.5 Discussion
This study provides key pieces of evidence confirming for the first time in S.
homoeocarpa that overexpression of a PDR transporter is involved in reduced sensitivity to
multiple fungicide classes. This evidence includes constitutive and induced overexpression of
ShPDR1 in a diverse panel of field resistant isolates (Figure 2.2 and 2.3), high correlation of
fungicide sensitivity with RE of ShPDR1 (Figure 2.5), and ShPDR1 complementation of the yeast
transporter mutant AD1-8 for growth in the presence of different fungicide classes (Figure 2.6).
Previously, overexpression of ShCYP51B and ShatrD was reported for S. homoeocarpa isolates
exhibiting practical field resistance (Hulvey et al., 2012). Taken together, Hulvey et al. (2012) and
the current study illustrate that insensitivity to DMI fungicides in S. homoeocarpa is governed by
multiple genes (multigenic), as opposed to monogenic resistance, which would entail only
polymorphism and/or overexpression of the gene target of DMI fungicides, ShCYP51B. Recent
RNA-Seq studies on pesticide resistance in bedbug (Cimex lectularius) and monoterpene
resistance in the fungus Grossmania suggest there are certainly additional genes from multiple
gene families that are driving this phenotype in S. homoeocarpa (Mamidala et al., 2012; Wang et
al., 2013). Further studies involving RNA-Seq data and methods presented here will seek to
verify additional novel genes and gene families underpinning fungicide resistance and reduced
sensitivity to multiple fungicides.
In the human pathogenic fungus, Candida albicans, a multidrug resistance phenotype is
routinely reported, when prolonged treatments of the DMI fungicide fluconazole can select for
strains showing constitutive overexpression of PDR transporters CDR1 and CDR2 (Morschhäuser
et al., 2007). The activity of these transporters also renders the pathogen resistant to additional
fungicide classes. A similar trend has also been observed in plant pathogenic fungi, whereby
DMI resistant strains exhibiting overexpression of PDR transporters show decreased sensitivity
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to multiple fungicide classes(Nakaune et al., 1998). Indeed, the isolates tested in this study were
from the populations repeatedly exposed to DMIs, and interestingly, the PFR isolates were
collected before application of boscalid at HRCC and HGC. A similar phenomenon has been
reported for DMI resistance and boscalid insensitivity in a plant pathogen Monilinia fructicola by
Chen et al. (2013). Chen et al. demonstrated overexpression of a multidrug transporter is linked
to insensitivity to both propiconazole and boscalid, since boscalid resistance was not
accompanied by target site mutations (Chen et al., 2013). In the current study, we have shown
that practical field resistance to DMI fungicides is also associated with reduced sensitivity to
multiple unrelated fungicides, which is reminiscent of the MDR phenotypes reported by
Kretschmer et al. (2009) for B. cinerea. However, in B. cinerea MDR and fungicide efflux has
been shown to actually have a tangible negative impact on efficacy of fungicides in the field,
though this is the only case in published literature. Though iprodione EC50 and boscalid EC95
values are statistically greater for PFR isolates, we cannot confirm that these isolates are
capable of exhibiting field resistance or reduced efficacy to the respective fungicides, due to lack
of published field data. Field studies to demonstrate the selection of isolates with the MDR
phenotype by non-DMI fungicide applications are on-going and will provide more insight into
how these isolates cause disease in a practical field setting.
Two ABC transporters, ShatrD and ShPDR1, are constitutively overexpressed in the S.
homoeocarpa isolates with an MDR phenotype, and the exact role of ShatrD in this phenotype is
currently unknown. There is currently limited evidence on the role of ShatrD in the reduced
sensitivity to individual fungicides, though its expression is increased following exposure to
propiconazole, but not the two other fungicides used in this study (Figure 2.7). In addition,
induced expression of these two PDR transporters was incrementally increased in response to
an increasing dose of propiconazole, with ShPDR1 showing significantly higher overexpression
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than ShatrD with the highest concentration (5 µg ml-1) of propiconazole exposure. Care must be
taken in interpreting these results, which could imply that ShatrD expression patterns indicate a
lesser role in detoxification of iprodione, boscalid, and higher propiconazole concentrations. In B.
cinerea, overexpression of BcatrD is induced in the presence of iprodione, though BcatrD was
experimentally shown to be unable to efflux this fungicide (Hayashi et al., 2002; Hayashi et al.,
2001). Future research is aimed at ShatrD yeast complementation studies to better understand
substrate specificity. In addition, more detailed studies such as fungicide accumulation assays
with 14C-labeled fungicides and the fungal transformation system for generating gene knockouts will be essential for further functional characterization of PDR transporters in S.
homoeocarpa.
The analysis of coding sequences of ShPDR1 detected nonsynonymous polymorphisms
in two DMI insensitive isolates (WBI7 and HFI40), however, there are no previous reports of
polymorphisms in a coding region of a PDR transporter relating to differential fungicide
sensitivity in plant pathogenic fungi. A similar phenomenon was found for the P. digitatum
PMR1 sequence diversity among a panel of isolates, providing further evidence that PDRs can
exhibit nonsynonymous polymorphism within a species that is not indicative of a phenotypic
difference in fungicide sensitivity (Paloma and Juan, 2011). Of greatest interest is a deletion of
27 amino acids spanning the N-terminus of a partial ABC-signature motif, complete Walker B
motif and partial D-loop in HRS10. At first we surmised this result to be an anomaly, since it was
only observed in one isolate out of eight that were sequenced, but following BLASTX of both
variants of the gene we found PDR transporter sequence variants in other distantly related
fungal species with similar deletions in the Walker B motif in A. kawachii IFO 4308 (GenBank#
GAA90510.1) and Ajellomyces capsulatus (GenBank# EER44595.1). Rai et al. found that
conserved Trp326 and Asp327 of Walker B motif in ABC transporter CDR1 from C. albicans are
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important for nucleotide binding and ATP hydrolysis, respectively (Rai et al., 2006; Rai et al.,
2005). Thus, we hypothesize that the deleted Walker B motif in ShPDR1 of HRS10 may affect the
function of nucleotide binding and ATP hydrolysis, although it is not clear what evolutionary
advantage this deletion would offer. Further yeast complementation experiments will be
necessary to test these hypotheses.
RNA-Seq data of S. homoeocarpa revealed that of seven identified PDR transporters
have high amino acid sequence similarities of greater than 83% with functionally characterized
PDR transporters from B. cinerea (Table 2.3). Surprisingly, ShPDR1 is not shown to have a
putative homolog in B. cinerea, but does share high amino acid similarity to a PDR transporter
from A. kawachii, and clusters with high bootstrap support with PDR transporters from P.
digitatum and A. nidulans (Figure 2.1). In previous phylogenetic analyses S. homoeocarpa is
shown to fall within a group sister to the clade containing B. cinerea and S. sclerotiorum
(Amselem et al., 2011), which are phylogenetically distinct from Penicillium and Aspergillus
species (Schoch et al., 2009). The number of PDR transporter genes in the genomes of related
fungal species can be highly variable, and a plausible explanation is gene loss and differential
gene duplication events among fungal lineages (Lamping et al., 2010).
In light of this and previous studies, there is no doubt that research on the molecular
basis of fungicide resistance stands to benefit tremendously with application of Next-Generation
sequencing tools like RNA-Seq (Cools and Hammond-Kosack, 2012). However, there are few
published papers that utilize RNA-Seq for such purposes, and those that are available are
centered on lab-generated mutants in model fungal species (Sun et al., 2013). From this study
and the previous work of Hulvey et al. (2012), it is clear that de novo RNA-Seq offers great
advantages when applied to unsequenced plant pathogenic fungi, especially when considering
the labor and resources required for genome sequencing and assembly. Most importantly, de
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novo RNA-Seq offers the advantage of identification of mRNAs representing novel genes and for
simultaneously measuring expression of transcripts following exposure to fungicides. When
combined with additional molecular biology tools such as yeast complementation and qPCR,
researchers can begin to quickly make significant progress towards confirmation and discovery
of molecular mechanisms of fungicide resistance by a functional genomics approach.
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Figure 2.7. Relative expression (RE) of ShatrD in the initial panel of eight isolates from five sites
in New England in the before and after of iprodione (1 µg ml-1) and boscalid (10 µg ml-1)
incubation for 1 hour. All bars (white = constitutive RE; dark gray = iprodione induced RE; black =
boscalid induced RE) represent mean RE values. Error bars indicate 1 standard error from the
mean. Isolates with an “I” indicate propiconazole insensitive and with a “S” represent
propiconazole sensitive.
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CHAPTER 3
A GAIN-OF-FUNCTION MUTATION IN A ZINC-FINGER TRANSCRIPTION FACTOR CONTROLLING
XENOBIOTIC DETOXIFICATION GENES RESULTS IN MULTIDRUG RESISTANCE IN A FUNGAL
PLANT PATHOGEN

3.1 Abstract
Continuous deployment of antifungal drugs in treating and preventing diseases caused
by human and plant pathogenic fungi has led to the emergence of multidrug resistance (MDR).
An understanding of MDR mechanisms is essential for combating fungal pathogens, but is
understudied in plant pathogenic fungi. Following RNA-seq analysis of a filamentous fungus,
Sclerotinia homoeocarpa, the causal agent of dollar spot on turfgrasses, MDR and drug sensitive
strains revealed that genes involved in xenobiotic detoxification, the Phase I enzyme
cytochrome P450s (CYP450s) and Phase III ATP-binding cassette (ABC) efflux transporters, were
significantly overexpressed in a MDR strain. We provide evidence that this fungal pathogen
detoxifies xenobiotics through elaborate usage of two phases of genes, CYP450s and ABC
transporters, and overexpression of both genes families are involved in MDR. Furthermore, our
study indicates that a fungal-specific transcription factor (Shxdr1) regulates the expression of
both CYP450s and ABC transporters, and that a gain-of-function mutation in the transcription
factor is responsible for constitutive and induced overexpression of the genes, resulting in
resistance to many types of chemicals. Intriguingly, this regulatory system by Shxdr1 is
somewhat similar to the mammalian PXR nuclear receptor pathway that regulates CYP450s and
transporters for xenobiotic detoxification. This mechanistic understanding of the MDR pathway
in our fungal pathosystem may facilitate the development of new antifungal drugs to control
MDR populations in plant and human pathogenic fungi.
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3.2 Introduction
Despite improvement of antifungal therapies in the last three decades, antifungal
resistance is still of major concern in agriculture and medicine (Vandeputte et al., 2012).
Furthermore, pathogenic fungi have become resistant to not just one but several chemically
unrelated antifungal compounds with distinct modes of action. Elucidation of the molecular
mechanisms for multidrug resistance (MDR) in the model fungus Saccharomyces cerevisiae and
human opportunistic pathogenic fungus Candida glabrata have laid the ground work for
developing novel antifungal treatments (Thakur et al., 2008). However, due to limited
evolutionary conservation of the subfamily of transcription factors for MDR regulation between
Saccharomycotina (ascomycete yeasts) and Pezizomycotina (filamentous ascomycete fungi), the
regulatory systems of MDR mechanisms for filamentous pathogenic fungi such as Aspergillus,
Fusarium, and Sclerotinia have not been determined. Since the emergence of MDR strains in
filamentous human and plant pathogenic fungi has had a profound impact on human health and
agricultural yields, there is an urgent need to elucidate the mechanisms of MDR to develop
novel antifungal treatments.
In S. cerevisiae and C. glabrata, the activating mutation in fungal zinc-cluster
transcription factor Pdr1 (Zn2Cys6) orthologs causes overexpression of ATP-binding cassette
(ABC) efflux transporters, contributing to MDR that impedes treatment of fungal infections. The
Pdr1 orthologs naturally play a pivotal role in xenobiotic signaling by binding chemically diverse
drugs and xenobiotics and activating the expression of multiple efflux transporters. The Pdr1
orthologs were suggested to represent functional analogs of mammalian nuclear receptor
pregnane X receptor (PXR), together with retinoid X receptor (RXR), which directly binds
structurally unrelated xenobiotics and up-regulates transcription of drug-metabolizing enzymes
and drug transporters (Thakur et al., 2008). These include phase I cytochrome P450s (CYP450s)
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enzymes that catalyze the first step of xenobiotic and endobiotic compound modification mainly
through hydroxylation/oxidation reactions (Poulos, 1988; Poulos, 2005), Phase II conjugating
enzymes (UDP-glucuronosyl transferase, sulfotransferase, and glutathione S-transferase) that
add polar molecules onto compounds, which produce water-soluble, non-toxic metabolites
(Wang and LeCluyse, 2003; Xu et al., 2005), and the Phase III system consisting of ABC and other
transmembrane transporters that actively export the compounds across the cytoplasmic
membrane (Ihunnah et al., 2011). Unlike the detailed studies in ascomycete yeasts and
mammalian, relatively little is known about the transcriptional regulation of the xenobiotic
response in filamentous ascomycete fungi.
Sclerotinia homoeocarpa is a filamentous ascomycete fungus and the causal agent of
dollar spot on turfgrasses. Due to extensive use of multiple fungicides, resistance to
benzimidazole, dicarboximide and demethylation inhibitor (DMI) fungicides has been reported
(Detweiler et al., 1983; Koenraadt et al., 1992; Vargas et al., 1992). Recently the emergence of
MDR populations has been reported (Sang et al., 2015). Two ABC efflux transporters, ShatrD and
ShPDR1, were confirmed to be involved in DMI resistance in S. homoeocarpa field isolates
(Hulvey et al., 2012; Sang et al., 2015), and overexpression of ShPDR1 confers MDR to chemically
unrelated fungicides (Sang et al., 2015). Together with these Phase III transporters, RNA-seq
analysis of a MDR field strain of S. homoeocarpa in this study revealed enrichment of CYP450s
associated with Phase I of xenobiotics detoxification system. We show here that detoxification
of different classes of chemicals by the CYP450s and ABC transporters’ activities functions as a
xenobiotic detoxification system in a filamentous ascomycete fungal plant pathogen.
Furthermore, a putative xenobiotic detoxification regulator (ShXDR1) harboring an amino acid
substitution was identified in the MDR field strain. Our results demonstrate the gain-of-function
mutation (M853T) in ShXDR1 is responsible for overexpression of Phase I and III genes, resulting
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in MDR for the field strain of S. homoeocarpa. We suggest that filamentous ascomycete fungi
harboring the central transcription factor, regulating Phase I and III detoxification genes, could
have more nuclear receptor PXR-like pathway than yeast-form fungi (which only regulate Phase
III transporters via Pdr1).

3.3 Materials and Methods
3.3.1 Sclerotinia homoeocarpa Strains
Ten isolates of S. homoeocarpa used in this study were collected from Hickory Ridge
Golf club (Amherst, MA) and were previously characterized in field efficacy, fungicide sensitivity,
and fungicide resistance molecular mechanism studies (Hulvey et al., 2012; Popko et al., 2012;
Sang et al., 2015). Isolates HRS10 and HRI11 were sampled prior to treatment of a
demethylation inhibitor fungicide (propiconazole). Isolates HRS1 to HRS4 were sampled from
plots that received no fungicide treatment and HRI1 to HRI4 were sampled 7 days after
treatment (HRI1 to 4 isolates were considered as “practical field resistance”). HRS10 and HRS1
to HRS4 were considered as fungicide-sensitive isolates based on previous in vitro fungicide
sensitivity assay. HRI11 and HRI1 to HRI4 are considered multidrug resistant (MDR) strains
exhibited reduced sensitivities to propiconazole, iprodione and boscalid (Sang et al., 2015).
3.3.2 RNA Sequencing and Transcript Abundance
An Illumina Hiseq 2000 was used to sequence two biological replicates of each
condition, yielding over 75 million Hiseq 2000 reads for every condition. Hisat2 version 2.0.4 was
used to create the alignment files onto the genome of HRI11, accession no. LNKV00000000.
Predicted transcripts of the recently sequenced Sclerotinia homoeocarpa genomes ((Green et
al., 2016) were used to guide transcript assembly by Cufflinks using the –g flag. Transcript
abundance was estimated by fragments per kilobase of transcript per million fragments mapped
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reads (FPKM). 12,008 total genes were identified from the 28,914 transcripts. Significantly
expressed genes were identified by log2 fold change greater than 1.5, and a P-value below 0.05.
Transcripts with FPKMs below a 0.05 threshold were discarded in the differential expression
analysis. Cluster analysis and heat maps were conducted with the Genesis software (version:
1.7.7) based on the hierarchical and complete linkage clustering method
(http://genome.tugraz.at) (Sturn et al., 2002). For functional annotation, the BLAST2GO analysis
was performed at the http://www. blast2go.org/start_Blast2GO. The predicted S. homoeocarpa
coding sequences were searched for identical sequences by conducting BLASTX search. A cutoff, E≤10-10 was used for BLASTX and annotation.
3.3.3 Volcano Plot for RNA-seq
From the 12,008 genes identified in the transcriptomic analysis, 9,499 genes were found
to have FPKM values equal to or above 0.05. These 9,499 genes were plotted using csVolcano
from cummerBund, significant genes defined by α = 0.05.
3.3.4 Plasmid Construction and Generation of S. homoeocarpa Mutants
For overexpression of Phase I genes (CYP561, CYP65, and CYP68) and Phase III genes
(ShPDR1 and ShatrD), plasmid pYHN3-ptrpC was constructed by cutting pShEFlα and inserting
ptrpC in plasmid pYHN3-pShEF1α (Sang et al., 2017). The full length of five genes amplified from
gDNA of HRI11 was inserted into plasmid pYHN3-ptrpC to generate the plasmid pYHN3-ptrpCCYP561, -CYP65, -CYP68, -ShPDR1, and -ShatrD, respectively. Each plasmid DNA (5 µg) was used
for a polyethylene glycol (PEG)-mediated transformation in the protoplasts from HRS10. The
protoplast generation and PEG-mediated transformation were conducted according to Sang et
al. (Sang et al., 2017).
The transcription factor (TF) ShXDR1 containing a mutation M853T is from the MDR
strain HRI11 and the wild type of TF, Shxdr1, is from HRS10. The ShXDR1 deletion and Shxdr1
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mutants in HRI11 were generated using the split-marker approach and PEG-mediated protoplast
transformation described earlier (Sang et al., 2017). For deletion of ShXDR1, a 1 kb upstream
and downstream region of the ShXDR1 amplified from genomic DNA of HRI11 were inserted into
between hygromycin resistance cassette (PtrpC-hph) in the plasmid Topo-hph (Sang et al., 2017)
to generate the plasmid Topo-ΔShXDR1. Two constructs (1 kb of upstream region of the ShXDR1
and 731 bp of hph; 1 kb of downstream region of the ShXDR1 and 1126 bp of PtrpC-hph) were
amplified from the plasmid Topo-ΔShXDR1. For Shxdr1 mutants, Topo-Shxdr1 was constructed
by cutting upstream region of ShXdr1 in Topo-ΔShXDR1 and inserting the full length of Shxdr1
from HRS10. Two constructs (The full length of the Shxdr1 and 731 bp of hph; 1 kb of
downstream region of the ShXDR1 and 1126 bp of PtrpC-hph) were amplified from the plasmid
Topo-Shxdr1. The purified two constructs (each 2 µg) were used for the PEG-mediated
transformation in the protoplasts from HRI11. For ShXDR1 mutant from HRS10, the 1500 bp of
upstream region and full length of ShXDR1 amplified from gDNA of HRI11 were inserted into
plasmid pYHN3-MCS (Sang et al., 2017) to generate the plasmid pYHN3-ShXDR1. The plasmid
DNA (5 µg) was used for the PEG-mediated transformation in the protoplasts from HRS10.
Lastly, pShPDR1-YFP chimeric mutants were generated for promoter deletion analysis.
Different lengths (303bp, 354bp, 479bp, and 1289bp) of ShPDR1 promoter were amplified from
gDNA of HRI11 and inserted into plasmid pYHN3 (Rech et al., 2007) to generate pYHN3-303bppShPDR1, pYHN3-354bp-pShPDR1, pYHN3-479bp-pShPDR1, and pYHN3-1289bp-pShPDR1. The
plasmid (5 µg) was used for a PEG-mediated transformation in the protoplasts from HRI11. In
addition, HA tagged fusion Shxdr1 mutant was generated for chromatin immunoprecipitation.
The full length of Shxdr1 without stop codon (TAA) from gDNA of HRS10 was fused with HA tag
from plasmid pPAD80 (Delley and Hall, 1999). The HA tagged fusion ShXdr1 was inserted into
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plasmid pYHN3-ptrpC to generate the plasmid pYHN3-ptrpC-Shxdr1HA. The plasmid (5 µg) was
used for a PEG-mediated transformation in the protoplasts from HRS10.
3.3.5 HPLC Analysis
PDB (50 mL) with and without mycelia (approximately 1g) of strain HRS10 and CYP561,
CYP65, and CYP68 overexpressed mutants were supplemented with propiconazole (1 µg ml-1)
and cultured at 25 °C (100 rpm). The sample was prepared at each time point (0, 6, 12, 24, 48,
and 72 h) by a methanol extraction method (Im et al., 2016). An Agilent 1200 Series HPLC
equipped with a diode array detector (DAD) was used for the detection and quantification of
propiconazole. Separation was performed on an Agilent Eclipse XDB C18 column (4.6 mm × 150
mm, 5 micron) using a 12-min linear gradient of ACN in water (50% to 90%) at a flow rate of 1.5
ml min-1. The DAD was set at 220 nm to provide real-time chromatogram, and the UV/Vis
spectra from 190 to 400 nm were recorded for detection of transformation products.
3.3.6 Heterologous Expression of ABC transporters in Yeast
The galactose-inducible expression vector pYES2 (Invitrogen) containing the full-length
cDNA sequences of ShatrD (TCONS_00024506) was transformed into a drug-hypersensitive
Saccharomyces cerevisiae mutant (AD12345678: AD1-8) (Decottignies et al., 1998) to generate
two independent mutants (AD1-8:atrD-1 and -2). The ShPDR1 expressing yeast mutants (AD18:PDR1-1 and -2) and the control yeast mutant containing the empty pYES2 vector (AD1-8pYES2) generated by Sang et al. (Sang et al., 2015) were used in this study. The yeast spot assay
of the ShPDR1 and ShatrD expressing yeast mutants and empty vector mutant was conducted by
the method described in Sang et al. (Sang et al., 2015). Briefly, 5 μL of cell suspension from each
yeast mutant culture at 0.5 OD600 were spotted onto bacto-yeast nitrogen base (YNB) agar
medium lacking uracil, containing 2% galactose and amended without and with fungicides and
plant growth regulators (PGRs). The name of chemicals and their concentrations are as follows:
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Propiconazole (0.002 μg mL-1), iprodione (500 μg mL-1), boscalid (200 μg mL-1), fluxapyroxad (250
μg mL-1), flurprimidol (25 μg mL-1), paclobutrazol (0.1 μg mL-1), and fludioxonil (500 μg mL-1). The
sensitivity of yeast mutants to respective fungicides and PGRs was qualitatively assessed after
incubation at 30°C for 4 days, with exception of fluxapyroxad for 6 days. Two biological
replicates and three technical replicates per biological replicate were performed for each
mutant and treatment.
3.3.7. Probabilistic Variant Detection
To identify variants between 78 putative fungal specific Zn2Cys6 transcription factors
from the MDR strain HRI11 and sensitive strain HRS10, Map Reads to Reference and
Probabilistic Variant Detection on the CLC Genomics Workbench 6 software (Qiagen CLC Bio)
were conducted. 78 transcripts from HRI11 were mapped to 78 transcripts from HRS10 and the
mapped result was used for Probabilistic Variant Detection analysis. The filtering resulted in
variants with following characteristics: i) no ignore non-specific matches, ii) minimum coverage
=1,variant probability = 10, required variant count = 1, and iii) maximum expected variants =1
and genetic code = 1 standard. These filter criteria resulted in identifying 4 variants,
TCONS_00003992 (T2558C), TCONS_00016457 (T891G, C2268G), TCONS_00003660 (G272C).
3.3.8 Quantitative Real-Time RT-PCR
Total RNA of S. homoeocarpa was extracted using the methods detailed in Sang et al.
(Sang et al., 2015). cDNA synthesis from total RNA was conducted with the QuantiTect reverse
transcription kit (Qiagen Inc., USA). The cDNA was diluted eight fold, and 1 µl was used for realtime quantitative PCR with Maxima SYBR Green (Thermo Fisher Scientific, USA). The actin gene
(Shact) was selected as a housekeeping gene and the primers for ShatrD, ShPDR1 and Shact
were described in Hulvey et al. (Hulvey et al., 2012) and Sang et al. (Sang et al., 2015). Other
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primers used in qPCR were described in Table 3.1. The comparative CT method was used for
calculating relative gene expression (Livak and Schmittgen, 2001).
3.3.9 Chemical Sensitivity Assays
In vitro sensitivity assays were conducted on the S. homoeocarpa strains with different
classes of fungicides and plant growth regulator. Flurprimidol EC50 values of all ten field strains
were obtained using the method from Sang et al. (Sang et al., 2015). The concentrations of
flurprimidol were used for measuring EC50 as follows: 0.1, 1, 10, 100, and 1000 μg ml-1. The
propiconazole, iprodione EC50 values and boscalid EC95 values of ten field strains previously used
for Sang et al. (Xu et al., 2005) were reanalyzed in this present study. For in vitro sensitivity tests
of S. homoeocarpa mutants and the control strains (HRS10 and HRI11), all strains were grown
for 3 days at room temperature and agar plugs (5 mm in diameter) were extracted from active
colonies and inoculated on the center of non-amended PDA plates and each chemical amended
PDA plates. After two to five days, pictures of plates were taken and two diameters of colony
were measured using 16EX digital calipers (Mahr, Göttingen, Germany). Relative mycelium
growth (RMG) % of strains was calculated. The experiment was repeated three times.
3.3.10 Chromatin Immunoprecipitation
The procedure for chromatin immunoprecipitation was modified from Boedi et al.
(Boedi et al., 2012). Briefly, S. homoeocarpa mycelia grown in PDB (Potato Dextrose broth,
Becton Dickinson, USA) for 4 days was non-treated or treated with 1 µg/ml of propiconazole for
40 min. The mycelia was fixed with 1 % of formaldehyde for 15 min and incubated with glycine
(125 mM) for 5 min using a shaker 50 rpm. The mycelia were recovered by filtration, rinsed
twice with 20 ml phosphate-buffer saline (PBS), and frozen in liquid nitrogen. The mycelia were
ground to fine power with a mortar and pestle in liquid nitrogen and 100 mg of grinded mycelia
were suspended in 1.5 ml of nuclei lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM NaCl, 1 mM
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EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 1 mM PMSF, Protease inhibitor 1× from
sigma). After the sample was centrifuged at 12,000 × g at 4 °C for 10 min, the chromatin
(supernatant) was transferred to a new tube. The chromatin was subjected to sonication for 25
sec and 12 times at power setting 35 % of a Sonics VibraCell sonicator (Sonics & Materials, USA),
and clarified by centrifugation at 12,000 × g at 4 °C for 5 min. 600 µl of chromatin was incubated
with pre-washed Protein A magnetic beads (Thermo Scientific, USA) at 4 °C for 1 hour and
chromatin was separated from the beads using a magnetic stand. Pre-washed anti-HA magnetic
beads (Thermo Scientific, USA) were added to chromatin and the mixture was incubated at 4 °C
overnight for immunoprecipitation. The bead-bound material was recovered using a magnetic
stand, washed twice in 1 ml of low salt washing buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl, 2
mM EDTA, 0.5% Triton X-100, 0.1% of SDS), twice in 1 ml of high salt washing buffer (20 mM
Tris-HCl pH 8.0, 500 mM NaCl, 2 mM EDTA, 0.5% Triton X-100, 0.1% of SDS), twice in 1 ml of LiCl
washing buffer (10 mM Tris-HCl pH 8.0, 0.5% NP-40, 1 mM EDTA, LiCl·H2O), and twice in 1 ml of
TE (10 mM Tris-HCl pH 8.0, 1 mM EDTA). Beads were then resuspended in elution buffer (1%
SDS, 0.1 M NaHCO3) and incubated with NaCl (5M) at 65 °C overnight to reverse cross-links.
After then, 0.5 M EDTA, 1 M Tris-Hcl (pH 6.5) and 10 mg ml-1 proteinase K was added to the
sample and incubation at 45 °C for 1 hour. DNA from the sample was extracted with chloroform,
precipitated with ethanol, 0.3 M sodium acetate pH 5.2, and 1 µl glycogen (20 mg/ml), and
resuspended in 50 µl ddH2O. The purified DNA was analyzed by quantitative real-time PCR.
3.3.11 Phylogenetic Analysis
The amino acid sequences of S. homoeocarpa CYP561, CYP65, and CYP68, its putative
orthologs in select fungal species from Basic Local Alignment Search Tool (BLAST) in Fungal
Cytochrome P450 Database (FCPD: http://p450.riceblast.snu.ac.kr) and National Center for
Biotechnology Institution (NCBI), CYP561, CYP65, and CYP68 in select plant and animal from
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FCPD, and reported CYP65 and CYP68 genes involved in biosynthesis of secondary metabolites
(Bömke et al., 2008; Hu et al., 2014; Kimura et al., 2003; McCormick et al., 2004; Tudzynski and
Hölter, 1998) obtained from GenBank were used for the phylogenetic analysis. MAFFT v7.110
was used to align amino acid sequences with automated strategy selection and BLOSUM62
scoring matrix parameters (Katoh and Toh, 2008). Neighbor-joining phylogenetic analysis was
conducted using MEGA v5 with the aligned amino acid sequences with the Poisson model,
gamma distributed rates among sites, complete deletion of missing data, and 1,000 bootstrap
replicates (Tamura et al., 2011). For phylogenetic analysis of Shxdr1 orthologs, the amino acid
sequences of Shxdr1, its putative orthologs in select fungal species identified from the BLAST in
NCBI, and the reported transcription factors involved in multidrug resistance (Coste et al., 2006;
Kretschmer et al., 2009; Plesken et al., 2015; Thakur et al., 2008) obtained from GenBank were
used for the phylogenetic analysis. The alignment and neighbor-joining phylogenetic tree were
performed followed by the aforementioned methods.
3.3.12 Silencing of ShXDR1 by Expression of Double Stranded RNA
Each sense and antisense fragment (nucleotides 71-270) of ShXDR1 amplified from
cDNA of strain HRI11 was inserted into the plasmid pFGC1008 (Arabidopsis Biological Resource
Center, Columbus, OH, USA). The sense and antisense fragment from plasmid pFGC1008 was
inserted into plasmid pYHN3-ptrpC to generate the plasmid pYHN3-ptrpC-dsRNAXDR1 that
constitutively overexpresses hairpin double stranded RNA (dsRNA) of target sequences of
ShXDR1. The plasmid DNA (8 µg) was transformed into the protoplast from strain HRI11 using a
PEG-mediated transformation system (Sang et al., 2017). In vitro sensitivity tests of two selected
transformants (HRI11(dsRNA-XDR1)-1 and -2), HRS10, and HRI11 to propiconazole (1 µg ml-1),
iprodione (3 µg ml-1), boscalid (1000 µg ml-1), and flurprimidol (15 µg ml-1) were conducted. The
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expression of CYP561, CYP65, CYP68, ShPDR1, ShatrD, and Shxdr1 was quantified in the
aforementioned four strains.
3.3.13 Statistical Significance Tests
All statistical significance tests were done with Analysis of variance (ANOVA). All
statistical analyses were performed by the JMP software package, version 10.0 (SAS Institute
Inc.).

Table 3.1. Primers used in this study.
Name

Primer Sequence (5’-3’)

Descriptions

Primers for qPCR analysis
QF_CYP561
QR_CYP561

AGATCGATGGGAAGTTTGTCC
GTTCTGGGTTCCGAAATGTTG

Quantify expression of
CYP561 gene

QF_CYP65
QR_CYP65

ATTTCCAGATTATCCGAGCCAG
GAGTGCTATATCCCAGAACGC

Quantify expression of
CYP65 gene

QF_CYP68
QR_CYP68

CAACCCGATCTCATAGACGC
GATCCGGTGCATACTTACCTG

Quantify expression of
CYP68 gene

QF_Shxdr1
QR_Shxdr1

GCTAGATCACGAGCTTGAAGAA
GACGACAACATGGAGGATCAA

Quantify expression of
Shxdr1 gene

QF_10618
QR_10618

TGCATCCAGCGTTCTAGTATTC
CGAACCAGCAGGTTGTTAGTA

Quantify expression of
TCONS_00010618

QF_3057
QR_3057

AATGGCGGGAGTCTGTTG
TCTGATCCAATGCCCAATTCT

Quantify expression of
TCONS_00003057

QF_2727
QR_2727

TCTGCAGTCCGCAACTTATT
GGGATCCGATTCATCTGTCTTC

Quantify expression of
TCONS_00002727

QF_23546
QR_23546

CTTCTACCACCACCCTTTCTAC
TCGACATCAGCACCGATTATAC

Quantify expression of
TCONS_00023546

QF_2372
QR_2372

TTTCCACTACATTGACCGAGACCAT
GCTCCCTCTGTTGATAGCGTGATAG

Quantify expression of
TCONS_00002372

QF_5783
QR_5783

GCTCGAGGAGCTTAAAGAAGT
AGATGGGAATTCGACCATTAGG

Quantify expression of
TCONS_00005783

QF_PDR1ChIP
QR_PDR1ChIP

GTGTTCGATTGTGTTCGATTGT
CTCTCCCATTCCACGGTATTATT

Quantify ShPDR1
promoter enrichment

Primers for generation of different types of mutants
F_ApaI_ ptrpC
ATTTGGGCCCCGTTAACTGATATTGAAGGA
R_NcoI_ ptrpC
ATTCCCATGGTTGGATGCTTGGGTAGAATA
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Amplification of ptrpC
from pYHN3 vector

F_KpnI_CYP561
R_SpeI_CYP561

ATGTGGTACCATGTCTTCCCGTATCCCCAA
GCGCACTAGTTCATTGTTTTCTGGAAGAGAACTTTATGTACA
GTG

Amplification of
CYP561 gene

F_NcoI_CYP65
R_SacI_CYP65

ATGTCCATGGATGTTGTCAGTGGTTGCTCT
ATGTGAGCTCTCAATATAGCCTCGGTGTCA

Amplification of
CYP65 gene

F_KpnI_CYP68
R_NotI_CYP68

ATGCGGTACCATGGAGCCCTTAAAATCTTCAATTGTCCTG
ATGCGCGGCCGCCTACTCAAACTTCAACACTT

Amplification of
CYP68 gene

F_KpnI_ShPDR1
R_SpeI_ShPDR1

ATGCGGTACCATGTCTTTATTAGGGAATCTCAACCCTAAT
ATGCACTAGTTCAAACCTTCGATCGTTTCCC

Amplification of
ShPDR1 gene

F_SacI_ShatrD
R_NotI_ShatrD
R_XhoI_ShatrD

ATGCGAGCTCATGGCGACCTCGACAC
ATTTGCGGCCGCCTATTTCTTCCTAAACCACT
ATGCCTCGAGCTATTTCTTCCTAAACC

Amplification of
ShatrD gene

F_SacI_upxdr1
R_SpeI_upxdr1

ATAAGAGCTCTGCCATGCGAATAAGGA
ACGCACTAGTCACTAATTATCGCATAGTAT

Amplification of
upstream of Shxdr1

F_NotI_downxdr1
R_ApaI_downxdr1

ATTTGCGGCCGCGAGTTCGGTTTTAGCA
ATACGGGCCCACTCTTCGCATTCTCGTCC

F_upxdr1
R_YG

TGCCATGCGAATAAGGAGATGTTCG
GGATGCCTCCGCTCGAAGTA

Amplification of
downstream of
Shxdr1
Amplification of the
upstream of Shxdr1
and split marker

F_HY
R_downxdr1

CGTTGCAAGACCTGCCTGAA
ACTCTTCGCATTCTCGTCCCGGTTC

Amplification of the
downstream of
Shxdr1 and split
marker

F_SacI_xdr1SNP
R_SpeI_xdr1SNP

ATAAGAGCTCGATTGGTTATATGTTAGACAAGG
ACGCACTAGTTTACATTCCACCTTGATGTTG

Amplification of the
partial sequences of
Shxdr1

F_xdr1SNP

GATTGGTTATATGTTAGACAAGGATATCTG

Amplification of the
partial sequences of
Shxdr1 and split
marker with R_YG

F_AscI_dsxdr1
R_SwaI_dsxdr1

ATACGGCGCGCCCCCCACCACAGATCTTCGGGG
GGCCATTTAAATCGTACAAGCGGGTAGTTTTCCATC

Amplification of the
sense of Shxdr1
fragment

F_BamHI_dsxdr1
R_SpeI_dsxdr1

ATCGGGATCCCGTACAAGCGGGTAGTTT
ATGCACTAGTCCCCACCACAGATCTTCG

Amplification of the
antisense Shxdr1
fragment

F_KpnI_Shxdr1
R_BamHI_Shxdr1

ATGCGGTACCATGATGGACTCCATGCATCGTGAAAGGAAT
ATGCGGATCCCATTCCACCTTGATGTTGCA

Amplification of
Shxdr1 without stop
codon

R_NotI_Shxdr1HA

ATTTGCGGCCGCTTAAGCGTAATCTGGAACGTCATAT

Amplification of HA
tagged Shxdr1 with
F_KpnI_ Shxdr1
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F_SacI_1289upPDR1
F_SacI_479upPDR1
F_SacI_354upPDR1
F_SacI_303upPDR1
R_NcoI_upPDR1

ATTTGAGCTCGAGGAGGAGCTTCGTGGAGC
AGCGGAGCTCTGCATATGAAGTTGTTCTAT
ATCGGAGCTCTGGAATGGGAGAGTTCCTC
ATCGGAGCTCTGGAAATGGGCACCAGAAAT
AGCGCCATGGGATGTGCTAGTCAGAGGATA

Amplification of
different lengths of
ShPDR1 promoter

Primers for amplification and sequencing of partial sequence of Shxdr1 gene
F1_Shxdr1
ATTGTGACCTCACGAAGAGTTGTA
R1_Shxdr1
TCATATCAGAAAGTGCTTCTACCG
F2_Shxdr1
R2_Shxdr1

CACATCTCCGGAACAAAGTACC
CGATACTATGCGATAACCGAATG

F3_Shxdr1
R3_Shxdr1

GCCACCTAGTACCAAAAGATGAAG
TCACTAATGCAGAAACAGGAAAGT

F4_Shxdr1
R4_Shxdr1

TCGACTTTCCAATTATGCTATTCA
GAGTTTCTAGTAAATGCGCCTCA

3.4 Results
3.4.1 Differential Gene Expression between S. homoeocarpa Drug Sensitive and MDR Field
Strains
To determine the MDR mechanism in S. homoeocarpa, in vitro sensitivity tests of five
MDR field strains and five drug sensitive field strains to different classes of fungicides (Sang et
al., 2015) and plant growth regulator in this study were conducted. The group of MDR strains
exhibited significant resistance to propiconazole, iprodione, boscalid, and flurprimidol (p<0.001)
than the group of drug sensitive strains (Figure 3.1A). Samples from one of MDR strains, HRI11,
and one of drug sensitive strains, HRS10, before and after exposure to propiconazole (0.1 µg ml1

) for 1 h were used for next generation RNA sequencing (RNA-seq) to profile genome wide

patterns of differential gene expression between these two strains and when exposure to the
fungicide.
RNA-seq identified a total of 28,914 transcripts, corresponding to 12,008 total genes, in
the four conditions for both strains. As described previously by Hulvey et al. (Hulvey et al.,
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2012), the strains HRS10 and HRI11 are putative clones. HRI11’s genome was chosen to be the
reference because its draft genome is more fully complete. To verify the similarity between the
genomes of the two strains, the transcripts were aligned to the whole genomes by BLASTn using
an E-value set to 0.001. Among the 28,914 transcripts, 28,901 transcripts mapped to HRI11’s
genome, and 28,640 mapped to HRS10’s genome. Volcano plots of RNA-seq data indicated that
among the 9,499 genes used in the analysis, 55, 7, 94, and 116 genes were significantly
downregulated and 59, 11, 209, and 152 genes were significantly upregulated in HRS10 vs
HRS10 + Propiconazole, HRI11 vs HRI11 + Propiconazole, HRS10 vs HRI11, and HRS10 +
Propiconazole vs HRI11 + Propiconazole, respectively (Figure 3.2).
209 genes in the MDR strain showed significantly higher expression (log2-fold≥1.5 and
p<0.05) than the genes in the sensitive strain. Of the 209 genes, three major groups of genes
with similar expression patterns were clustered by the analysis of hierarchical clustering of gene
expression patterns (Figure 3.1B). Group A consisted of 13 genes that showed constitutive
overexpression and propiconazole-induced expression in the MDR strain. This group includes
three cytochrome p450s and two ABC transporters, which belong to Phase I and Phase III genes
in xenobiotic detoxification pathway, respectively. The group also includes one
lysophospholipase (phospholipase B1), one cellulose-binding protein, one carbohydrate-binding
protein, one emopamil binding protein, and four hypothetical proteins (Figure 3.1C). We found
that the majority of genes are components of membrane (n=7) and encoded proteins involved
in metabolic processes (n=6), including oxidation reduction- (n=3), catabolic- (n=2),
carbohydrate metabolic- (n=2) processes, transport (n=2), and proteolysis (n=1). Also many
genes were found to be associated with hydrolase- (n=5), oxidoreductase- (n=3), transporter(n=2) activity and showed binding activity for ion (n=3), ATP (n=2), and nucleotide (n=2) (Figure
3.1D).
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Group B consisted of 57 genes that were constitutively overexpressed in the MDR strain
but showed no difference or less reduction of expression in response to propiconazole
compared to the genes in the sensitive strain. This group includes one dioxygenase and one MFS
transporter that are related to xenobiotic detoxification. The cellular component of this group is
membrane (n=19), cell (n=10) and organelle (n=6). The majority of genes are related to
metabolic process (n=29) including oxidation-reduction- (n=7), catabolic- (n=4), carbohydrate
metabolic- (n=5), small molecule metabolic- (n=5), cellular nitrogen compound biosynthetic(n=1), cellular protein modification- (n=2) process, and proteolysis (n=4), and the minority of
genes are transport (n=6) and cellular process (n=8) such as single-organism cellular- (n=6) and
regulation of cellular process (n=1). The genes showed binding activity for nucleotide (n=5), ion
(n=7), and ATP (n=2), and transporter activity (n=5) and catalytic activity (n=28) including
hydrolase- (n=9), oxidoreductase- (n=7), and transferase- (n=7) activity (Figure 3.1D).
Group C consisted of 138 genes that displayed constitutive overexpression and downregulated expression after treatment of propiconazole in the MDR strain. This group includes
xenobiotic detoxification related genes that include one cytochrome 450, one flavin-binding
monoxygenase, one glutathione S-transferase, and three MFS transporters. The cellular
components in this group are membrane (n=32), cell (n=35), organelle (n=20), and
macromolecular complex (n=9). We found that the majority of genes related to metabolic
process (n=52) including oxidation-reduction- (n=16), catabolic- (n=11), carbohydrate metabolic(n=7), small molecule metabolic- (n=6), cellular nitrogen compound biosynthetic- (n=10), cellular
protein modification- (n=6) process, and proteolysis (n=6), and also identified genes related to
transport (n=11) and cellular process (n=37) such as single-organism cellular- (n=15) and
regulation of cellular process (n=9). Furthermore, many genes were found to be associated with
transporter activity (n=6) and catalytic activity (n=53) including hydrolase- (n=19),
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oxidoreductase- (n=17), and transferase- (n=17) activity and showed binding activity for ion
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Figure 3.1. RNA-seq of the drug sensitive strain HRS10 and multidrug resistance (MDR) strain
HRI11 in the absence and presence of a DMI fungicide propiconazole. (A) In vitro sensitivity of
drug sensitive and MDR strains to fungicides and plant growth regulator. Mean values from five
MDR strains and five sensitive strains. EC50 values for propiconazole, iprodione, and flurprimidol
and EC95† values for boscalid are shown for sensitive strains. The values of x fold of EC50 and EC95
values for sensitive strains are shown for MDR strains. Significant differences to mean values of
sensitive strains: *p<0.001. (B) Expression patterns for 209 genes constitutively overexpressed
(log2-fold≥1.5 and p<0.05) in the strain HRI11, compared to the genes in the strain HRS10,
before and after treatment of propiconazole. Red indicates higher relative expression and green
indicates lower relative expression. Three major groups, Group A (n=13), Group B (n=57), and
Group C (n=138), of genes were clustered based on the analysis of hierarchical clustering of on
gene expression patterns. (C) FPKM of 13 genes from Group A in the strains HRS10 and HRI11
before and after exposure to propiconazole. (D) GO classification (biological Process, molecular
function, and cellular component) of genes from Group A, B, and C.

57

signiﬁcant
no signiﬁcant

A

B

HRI11 vs HRI11 + DMI

-log10(p value)

-log10(p value)

HRS10 vs HRS10 + DMI

log2(fold change)

D

HRS10 + DMI vs HRI11 + DMI
-log10(p value)

HRS10 vs HRI11

-log10(p value)

C

log2(fold change)

log2(fold change)

log2(fold change)

Figure 3.2. Volcano plots showing FPKM log2 fold-change versus - log10(p value) in RNA-seq data
of Sclerotinia homoeocarpa drug sensitive strain HRS10 and multidrug resistant strain HRI11
under the conditions of (A) HRS10 vs. HRS10 after treatment (+) of DMI, (B) HRI11 vs. HRI11 +
DMI, (C) HRS10 and HRI11, and (D) HRS10 + DMI vs. HRI11 + DMI. Using a p value of 0.05 as the
cutoff threshold, genes not significantly changed are depicted in black dot and genes
significantly changed are indicated in red dot.
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3.4.2 Involvement of Phase I Cytochrome p450s and Phase III ABC Transporters in Multidrug
Resistance
To confirm whether overexpression of three Phase I enzymes, CYP561, CYP65, and
CYP68, and two Phase III transporters, ShPDR1 and ShatrD, selected from Group A is responsible
for MDR phenotypes, expression of Phase I and III genes was quantified at different
propiconazole exposure time and in response to different classes of fungicides and one plant
growth regulator. In addition, the Phase I and III genes overexpressed mutants from a drug
sensitive strain HRS10 were generated. The expression of CYP561, CYP65, CYP68, ShPDR1, and
ShatrD was induced after treatment of propiconazole between 20-40 min in the strain HRS10
(Figure 3.3A), whose transcriptional response was rapid and transient. These five genes were
also constitutively overexpressed in the MDR strain and induced by propiconazole, boscalid,
flurprimidol, and iprodione in both sensitive and MDR strains (Figure 3.3B).
CYP561, CYP65, and CYP68 overexpressed mutants exhibited significantly
increased level of resistance to propiconazole and flurprimidol than the strain HRS10. CYP65 and
CYP68 overexpressed mutants showed significantly reduced sensitivity to boscalid, and only
CYP561 overexpressed mutant displayed resistance to iprodione (Figure 3.3C). In addition,
overexpression of CYP561, CYP65, and CYP68 led to increases in the biotransformation rate of
propiconazole. Especially, the biotransformation rate constants of propiconazole for 24 h in
CYP561, CYP65, and CYP68 overexpressed HRS10 were 2.6, 3.1, and 3.8-fold higher than those
of propiconazole in HRS10, respectively (Figure 3.3D). The biotransformation activities by three
CYP450s are might be catalyzation of propiconazole to produce hydroxylated (-OH) metabolites
(Mazur et al., 2015). Phase III transporter ShatrD, and ShPDR1 overexpression mutants confer
reduced sensitivities to chemically different fungicides and plant growth regulator than the
strain HRS10 (Figure 3.3E). Heterologous expression of ShPDR1 or ShatrD in a drug-
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hypersensitive yeast mutant (AD1-8) further confirmed that these transporters are involved in
MDR (Figure 3.4). Therefore, overexpression of three CYP450s and two ABC transporters
contributes to multidrug resistance in the MDR strain by the Phase I and III detoxification
pathway.
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Figure 3.3. Phase I CYP450s and Phase III transporters are involved in xenobiotic detoxification
and multidrug resistance. (A) Relative expression (RE) of Phase I genes (CYP561, CYP65, and
CYP68) and Phase III genes (ShPDR1 and ShatrD) before and after exposure to propiconazole (1
μg ml-1) for 10, 20, 40, and 60 min in the strain HRS10. (B) RE of Phase I and Phase III genes
before and after exposure to propiconazole (1 μg ml-1), boscalid (100 μg ml-1), flurprimidol (10
μg ml-1), and iprodione (10 μg ml-1) for 40 min in the strains HRS10 and HRI11 (C) Sensitivity of
strains HRS10 and CYP561, CYP65, and CYP68 overexpressed mutants to fungicides and plant
growth regulator. (D) Propiconazole degradation rate of strains HRS10 and CYP561, CYP65, and
CYP68 overexpressed mutants using HPLC analysis. (E) Sensitivity of strains HRS10 and ShPDR1
and ShatrD overexpressed mutants to fungicides and plant growth regulator.
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Figure 3.4. Heterologous expression of ABC transporter ShPDR1 or ShatrD in a drug
hypersensitive yeast mutant (AD1-8). Sensitivity tests of the yeast strains were performed on
bacto-yeast nitrogen base (YNB) agar medium lacking uracil, containing 2% galactose and
amended with different classes of fungicides and plant growth regulator. The sensitivity assays
of strains AD1-8-pYES2 and AD1-8:PDR1 with propiconazole, iprodione, boscalid, and
flurprimidol were reported in the previous studies (Allan-Perkins et al., 2017; Sang et al., 2015).
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3.4.3 A Gain of Function Mutation in a Xenobiotic Detoxification Regulator, ShXDR1, Leads to
Multidrug Resistance
To find the genetic factor leading to overexpression of three CYP450s and two ABC
transporters in the MDR strain, we firstly compared the upstream regions of CYP561 (1314-bp),
CYP65 (843-bp) and CYP68 (645-bp), ShPDR1 (1566-bp) and ShatrD (1654-bp) between strains
HRS10 and HRI11 using genome sequences generated by Green et al. (Green et al., 2016). The
459-bp upstream region of ShPDR1 and 1000-bp upstream region of ShatrD from strains HRS10
and HRI11 were reported in the previous publications (Hulvey et al., 2012; Sang et al., 2015).
The comparison of five genes upstream regions revealed that the regions of HRS10 and HRI11
are identical. Since the expression patterns of five genes are similar in the strain HRS10 or HRI11
(Figure 3.3A and B), we speculated that the MDR phenotype might be caused by a mutation(s) in
one of fungal specific Zn2Cys6 family, which have been known to be the regulator of ABC
transporters in other fungal systems (Kawashima et al., 2012; Kretschmer et al., 2009; Thakur et
al., 2008). We conducted a probability variant detection analysis between sequences of 78
putative Zn2Cys6 transcription factors from strains HRS10 and HRI11 and found that one of
transcripts (TCONS_00003992) has an aminoacid substitution in the strain HRI11 (Figure 3.5A).
The substitution is methionine (ATG) to threonine (ACG) at codon 853 (M853T) in xenobiotics
detoxification regulator 1, ShXDR1, in strain HRI11, and sequencing of the transcription factor
(Shxdr1) in the five drug sensitive and five MDR strains used in this study indicated that all five
MDR strains contained this mutation, but not in the sensitive strains.
To confirm the ShXDR1 encodes the transcription factor responsible for overexpression
of five Phase I and III genes and multidrug resistance in the MDR strain HRI11, we generated the
ShXDR1 deletion or knockdown and Shxdr1 harboring T853M mutants from the strain HRI11.
ShXDR1 deletion and knockdown and the replacement of ShXDR1 harboring M853T to Shxdr1 in
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the strain HRI11 led to increased sensitivity to propiconazole, iprodione, boscalid, and
flurprimidol (Figure 3.5B and Figure 3.6A) and decreased constitutive expression of five
detoxification genes (Figure 3.5D and Figure 3.6B). Also, the expression of five genes were not
induced by propiconazole in the ShXDR1 deletion mutant and induced by propiconazole in the
HRI11(Shxdr1) mutant that showed similar expression pattern of the sensitive strain HRS10.
Furthermore, to test the M853T mutation is sufficient for the generation of the multidrug
resistance phenotype in the strain HRI11 and to determine whether this mutation is dominant
or recessive gain of function mutation, we transformed a plasmid with upstream (1500-bp) and
full length of ShXDR1 harboring M853T into the strain HRS10. The mutant HRS10(ShXDR1)
exhibited multidrug resistance to different fungicides and the plant growth regulator similar to
the strain HRI11 (Figure 3.5C), and showed constitutive upregulation of the five detoxification
genes (Figure 3.5E). Taken together, these results indicated that the multidrug resistance
phenotype in the strain HRI11 was caused by a dominant gain of function mutation M853T in
ShXDR1.
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Figure 3.5. An activating mutation in a xenobiotic detoxification regulator 1 (ShXDR1) confers
multidrug resistance by constitutive and induced overexpression of Phase I and III genes. (A)
Schematic diagram of the ShXDR1 transcription factor showing an aminoacid substitution
(methionine-to-threonine) in the MDR strains and alignment to the corresponding region of the
mutation in sensitive (sen) and MDR strains. (B) Sensitivity of strains HRS10, HRI11,
HRI11(ΔShXDR1) and HRI11(Shxdr1) to fungicides and plant growth regulator. (C) Sensitivity of
strains HRS10, HRI11, HRS10(ShXDR1)-1 and- 2 to fungicides and plant growth regulator. (D)
Relative expression (RE) of Phase I genes (CYP561, CYP65, and CYP68) and Phase III genes
(ShPDR1 and ShatrD) before and after exposure to propiconazole (1 μg ml-1) for 40 min in the
strain HRS10, HRI11, HRI11(ΔShXDR1) and HRI11(Shxdr1). (E) RE of Phase I genes and Phase III
genes before and after exposure to propiconazole (1 μg ml-1) for 40 min in the strain HRS10,
HRI11, HRS10(ShXDR1)-1 and -2.
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Figure 3.6. In vitro chemical sensitivity and gene expression assay of ShXDR1 knock-down
mutants from the multidrug resistance strain HRI11 (A) Sensitivity of strains HRS10, HRI11,
HRI11(dsRNA-XDR1)-1 and-2 to fungicides and plant growth regulator. (B) Relative expression
(RE) of Phase I genes (CYP561, CYP65, and CYP68), Phase III genes (ShPDR1 and ShatrD), and
transcription factor Shxdr1 before and after exposure to propiconazole (1 μg ml-1) for 40 min in
the strain HRS10, HRI11, HRI11(dsRNA-XDR1)-1 and-2.
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3.4.4 Interaction of Shxdr1 on a Promoter of ShPDR1 and Additional Shxdr1 Target Gene
Regulon
To identify the Shxdr1 binding site in the promoter region of ShPDR1, 5ʹ deletions in
each promoter were cloned in frame with the yellow fluorescent protein (YFP) reporter gene in
pYHN3 (Rech et al., 2007) and the resulting plasmids were transformed into the strain HRI11. A
twofold increase in relative expression of YFP was observed when the mutant HRI11-1289bppShPDR1 containing the 1289 bp upstream region of ShPDR1 and YFP chimeric construct was
exposed to propiconazole for 40 min. A deletion of the region between -1289 bp and -479 bp
with respect to the ATG initiation codon had no effect on either constitutive YFP gene
expression or propiconazoe-induced YFP gene expression. Further deletion of the 5ʹ end of the
promoter between -479 bp and -354 bp had dramatic effect on the constitutive and
propiconazole-induced YFP gene expression. This observation suggested the presence of a
region containing an element participating in constitutive overexpression of ShPDR1 due to
ShXDR1 binding to this region and induced expression of ShPDR1 by the propiconazole
treatment (Figure 3.7A). Chromatin immunoprecipitation (ChIP) experiments using HA antibody
directed against the DNA-binding domain of Shxdr1 confirmed that this protein is bound to the
promoter region between -448 bp and -341 bp in strain HRS10 (Figure 3.7B). The results from
promoter deletion and ChIP analysis suggested the putative binding motif between -373 bp and
-355 bp (5ʹ-CGGCTGTTCAATAATACCG-3ʹ). Using the MEME motif discovery tool, consensus
inverted repeat sequences CGG(N12 or N13)CCG was found upstream of three CYP450s and
ShatrD, implying that Shxdr1 is bound to the XRE in the promoter region of three CYP450s and
ShatrD for the regulation of xenobiotic detoxification (Figure 3.8).
In addition to three CYP450s and two ABC transporters, four more genes from Group A
(Figure 3.1A) were confirmed to be regulated by Shxdr1. The genes are emopamil binding

66

(TCONS_00010618), cellulose-binding family II (TCONS_0003057), lysophospholipase
(TCONS_00002727), and hypothetical protein (TCONS_00023546). A BLASTX search revealed
that the hypothetical protein shares low homology with 1-aminocyclopropane-1-carboxylate
(ACC) deaminase from Streptomyces rubellomurinus (accession number WP_045693734) and
were identified by an E-value of 0.78 and coding sequence coverage of 47%. The query
sequence shares 30% of amino acid identity with ACC deaminase (32 out of 106). These four
genes were constitutively overexpressed and induced by propiconazole in the MDR strain HRI11,
but decreased expression in the mutant HRI11(∆ShXDR1) and overexpressed in HRS10(ShXDR1)
(Figure 3.7C). The consensus inverted repeat sequences CGG(N11 or N13)CCG was found the
upstream of these four genes using the MEME motif discovery tool (Figure 3.8).

67

A

ATG
1289bppShPDR1

YFP

pShPDR1

-1289

No treatment
Propiconazole

479bp-pShPDR1

-479

354bp-pShPDR1

-354

303bp-pShPDR1
-303

0

5

10

Rela9ve expression of YFP

10
8
6
4
2
0

5
0

HRS10HA HRS10HA-P

25
20
15
10
5
0
HR
HR
S1
0
I1
1( HR
HR ΔS I1
1
h
S1 X
0( DR
Sh 1)
XD
R1
)

12

HR
HR
S1
0
I1
1( HR
HR ΔS I1
S1 hX 1
0( DR
Sh 1)
XD
R1
)

RE of emopamil binding
(TCONS_00010618)

C

10

30
25
20
15
10
5
0

70
60
50
40
30
20
10
0

No treatment
Propiconazole

HR
HR
S1
0
I1
1( HR
HR ΔS I1
h
S1 X 1
D
0(
Sh R1)
XD
R1
)

HRS10HA HRS10HA-P

15

RE of hypothe9cal protein
(TCONS_00023546)

1

20

HR
HR
S1
0
I1
1( HR
HR ΔS I1
S1 hX 1
0( DR
Sh 1)
XD
R1
)

Fold Enrichment

2

0

No an9body
an9-HA

ShPDR1

RE of Cellulose-binding
family II (TCONS_00003057)

Fold Enrichment

Shact (ac9n)
3

RE of Lysophospholipase
(TCONS_00002727)

B

Figure 3.7. Detection of xenobiotic-responsive element (XRE) and interaction between Shxdr1
and the promoter region of Shxdr1 target gene regulon. (A) Promoter deletion analysis of
pShPDR1-YFP chimeric constructs. The promoter 5ʹ deletion in ShPDR1 are schematized with
their corresponding plasmid construct and S. homoeocarpa mutants. Relative expression (RE) of
YFP is given for each mutant before and after exposure to propiconazole. The black region in 479 bp of upstream of ShPDR1 indicates the potential promoter region containing the ShXDR1
binding motif. (B) Chromatin immunoprecipitation (ChIP) analysis of HA-tagged fusion Shxdr1
occupancy on promoters of ShPDR1 in the absence and presence of propiconazole. The
presence of the promoter region of ShPDR1 or Shact (as a negative control) sequence was
assayed by quantitative PCR. The Y-axis depicts the fold enrichment over a mock
immunoprecipitation control that lacks HA antibody. (C) Relative expression (RE) of four
additional Shxdr1 target gene regulon before and after exposure to propiconazole (1 μg ml-1) for
40 min in the strains HRS10, HRI11, HRI11(ΔShXDR1) and HRS10(ShXDR1).
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Figure 3.8. The sequences and locations of putative binding motifs for Shxdr1 in the promoter
regions of Shxdr1 target gene regulon.
3.5. Discussion
Our systematic analysis of MDR in S. homoeocarpa using RNA-seq and genetic
modification approaches have revealed key factors for xenobiotic detoxification. We have
shown the functional role of Phase I enzymes, CYP561, CYP65, and CYP68, and Phase III
transporters, ShPDR1 and ShatrD. A zinc-finger transcription factor Shxdr1 regulates the
detoxification of various chemicals through xenobiotics-induced expression of CYP450s and ABC
transporters. Furthermore, a gain of function mutation in ShXDR1 is responsible for
overexpression of Phase I and III genes, contributing to MDR in S. homoeocarpa field stains.
RNA-seq analysis of drug sensitive and MDR strains indicated that constitutively
overexpressed genes in the MDR strain were typically involved in xenobiotic detoxification
(Figure 3.1C and Figure 3.9A). However, many of constitutively overexpressed genes in the MDR
strain were not induced by propiconazole, and only thirteen transcripts (Group A) including
three CYP450s and two ABC transporters showed the propiconazole-induced expression pattern
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in the MDR strain. These Phase I and III genes are rapidly and transiently activated in response
to structurally different chemicals. Overexpression of CYP561, CYP65, and CYP68 is involved in
resistance to propiconazole and flurprimidol and differently confer resistance to boscalid and
iprodione, but ABC transporter overexpressed mutants exhibited broad-spectrum resistance to
chemicals. Blast search in Fungal Cytochrome P450 Database (FCPD:
http://p450.riceblast.snu.ac.kr) and phylogenetic analysis revealed that CYP561 and CYP65
belong to clan CYP65, and CYP68 belongs to clan CYP68 (Figure 3.10A). The functional
classification of clan CYP65 and CYP68 was determined to be secondary metabolism like
mycotoxin trichothecene biosynthesis by CYP65 and gibberellin biosynthesis by CYP68 (Moktali
et al., 2012; Tudzynski, 2005). However, our findings add an additional function of clan CYP65
and CYP68 with xenobiotic metabolism. Our study suggests that the activities of Phase I CYP561,
CYP65, and CYP68 contribute to biotransformation of xenobiotics, and Phase III ShPDR1 and
ShatrD are involved in excretion of xenobiotics or their metabolites. Further study of Phase I and
II enzymes identified propiconazole-induced dioxygenase (TCONS00002372) and glutathione Stransferase (TCONS00005783) that might be associated with oxidation and conjugation steps,
respectively, but both genes are not a Shxdr1 target gene regulon (Figure 3.9B).
We found the xenobiotic detoxification regulator Shxdr1 has two highly conserved
domains in comparison with Pdr1 from S. cerevisiae and Tac1 from Candida albicans (Figure
3.11B). The first conserved domain is a cysteine-rich motif at the N-terminus, which is possibly
involved in zinc-dependent binding to DNA, and the other domain is a part of xenobiotic binding
domain (XDB) in the middle of the protein, which possibly binds to xenobiotics (Thakur et al.,
2008). This suggests that Shxdr1 may activate expression of Phase I and III genes through direct
binding of xenobiotics. Furthermore, phylogenetic analysis reveals that Shxdr1 orthologs are
conserved in genomes of filamentous ascomycete fungi capable of xenobiotic detoxification
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(Figure 3.11A). Thakur et al. provided the evidences of mechanistic similarity for MDR regulation
between fungal zinc cluster Pdr1 orthologs and the mammalian PXR nuclear receptor (Thakur et
al., 2008), indicating that the emergence of nuclear receptor-like ligand-dependent gene
regulatory mechanisms occurred early in eukaryotic evolution (Näär and Thakur, 2009).
However, Pdr1 orthologs do not regulate the expression of Phase I enzymes that are the main
factor for xenobiotic detoxification by PXR regulation. This might be because of extensive
CYP450 gene loss in ascomycete yeasts (Chen et al., 2014). Thus this fungal group contains small
CYPomes with the absence of some globally or locally conserved CYP families including clan
CYP65 and CYP68 (Chen et al., 2014; Moktali et al., 2012), while filamentous ascomycete fungi
including S. homoeocarpa comprise the large number of CYP family/subfamilies (Chen et al.,
2014; Durairaj et al., 2016). Our results revealing the regulation of CYP450s and ABC
transporters by Shxdr1 indicate that the fungal transcription factor is mechanistically analogous
to PXR that regulates CYP450s (especially CYP3A), and the P-glycoprotein family of ABC
transporters (Kliewer et al., 2002; Westlind-Johnsson et al., 2003). Intriguingly, the fungal
CYP561 family in clan CYP65 is phylogenetically close to two human CYP3A43 identified as
belonging to CYP561 family and both group of proteins share the amino acid sequences in
conserved protein domain family CypX (COG2124) (Figure 3.10B). In addition, both S.
homoeocarpa CYP450s and human CYP3A enzymes have the ability to detoxify propiconazole
(Mazur et al., 2015), and upregulation of CYP450s and ABC transporters by ShXDR1/PXR are
main factors for multidrug resistance in S. homoeocarpa and human cancer (Chen et al., 2012;
Qiao et al., 2013; Robbins and Chen, 2014). This evidence suggests that the set of three
components, CYP450s, ABC transporters, and Shxdr1/PXR, are key factors for xenobiotic
detoxification and might have evolved from early eukaryotes.
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In this study, we determined a dominant gain of function mutation (M853T) in ShXDR1
renders constitutive overexpression of Phase I and III genes responsible for multidrug resistance.
C. albicans azole resistant strains also contain a gain-of-function mutation in the activation
domain of Tac1 (N972D, N997D and G980E, respectively) that confers constitutive up-regulation
of the ABC-transporter CDR1 and CDR2, resulting in increased antifungal resistance (Coste et al.,
2006; Sasse et al., 2011; Znaidi et al., 2007). In addition, an activation mutation (F815S) in Pdr1
of S. cerevisiae enhances occupancy of co-activator complexes at the ABC transporter PDR5
promoter accompanied by loss of contact between histones and DNA. It also alters chromatin
structure at both promoter and coding sequences of PDR5 (Gao et al., 2004). Since the mutation
in ShXDR1 occurs in the C-terminal region that harbors the transcriptional activation domain,
the mutation might affect the interaction between ShXDR1 and a co-activator or repressor. The
activation domain of Pdr1 interacts with the KIX domain of the gal11 mediator coactivator,
which recruits RNA polymerase II for transcription of ABC transporters (Thakur et al., 2008). We
identified a putative co-activator gal11 (TCONS_00010521) containing a gal11 coactivator
domain (accession no. cd12191), but gal11 was not a co-activator of Shxdr1, which was
confirmed by gal11 deletion mutants in the MDR strain. Further studies will mine the candidate
coactivators that potentially interact with Shxdr1 and compare the interaction of any
coactivators between Shxdr1 and ShXDR1.
Additional Shxdr1 regulons are four genes encoding for emopamil binding,
phospholipase B1, cellulose-binding family II, and hypothetical protein, respectively. Emopamil
binding proteins (EBPs) are integral membrane proteins of the endoplasmic reticulum and binds
sigma ligands and structurally diverse drugs and fungicides on the emopamil binding domain
(EBD) (Gioti et al., 2008). The protein may contribute to Phase III of the xenobiotic detoxification
system because EBPs share similar structural features with drug transporters, and have a high
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content of aromatic amino acid residues in transmembrane segments (Hanner et al., 1995),
which have been suggested to be involved in drug transport by the P-glycoprotein (Pawagi et al.,
1994). In addition, both phospholipase B1 (Plb1) and cellulose-binding family II are enzymes
involved in hydrolysis of glycerophospholipids and celluose, respectively (Carrard et al., 2000;
Cox et al., 2001). Although the Phase I reaction may occur by hydrolysis, the involvement of Plb1
and cellulose-binding family II in xenobiotic detoxification is unknown.
Our elucidation of multidrug resistance mechanisms may aid in the discovery of new
target genes for fungicides to control DMI (azole)-resistant or MDR populations in plant and
human filamentous pathogenic fungi. For example, the detailed molecular knowledge of the
MDR mechanisms in C. glabrata facilitated the discovery of a small-molecule iKIX1 that inhibits
the interaction of the Pdr1 activation domain with the Gal11A KIX domain for re-sensitizing
drug-resistant C. glabrata to azole antifungals (Nishikawa et al., 2016; Thakur et al., 2008).
Furthermore, the results describing a mutation in the regulator from this study will be used to
develop a detection tool for fungicide resistant populations that will allow for better
management of dollar spot on golf courses. Our work will provide the foundation for
investigating MDR mechanisms regulated by a xenobiotic detoxification regulator in other
clinically or agriculturally significant pathogenic fungi, such as Aspergillus fumigatus, Fusarium
oxysporum, and Zymoseptoria tritici.
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Figure 3.9. Phase I dioxygenase and Phase II glutathione S trasnferase. (A) Xenobiotic response
and metabolism genes constitutively upregulated in a Sclerotinia homoeocarpa multidrug
resistance (MDR) strain HRI11. (B) Relative expression (RE) of Phase I dioxygenase
(TCONS_00002372) and Phase II glutathione S transferase (TCONS_00005783) before and after
exposure to propiconazole (1 μg ml-1) for 10, 20, 40, and 60 min in the strains HRS10 and HRI11
and before and after exposure to propiconazole (1 μg ml-1) for 40 min in HRI11(ΔShXDR1).
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Figure 3.10. Phylogenetic analysis of clan CYP65 and CYP68 and comparison of fungal and
human CYP561 motifs. (A) Neighbor-Joining tree for amino acid sequences of clan CYP65 and
CYP68 in fungi, animal, and plant with Sclerotinia homoeocarpa CYP561, CYP65, and CYP68.
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Asterisks indicate CYP450s known to be involved with biosynthesis of secondary metabolites.
The scale bar represents the number of amino acid substitutions per site. Bootstrap values are
for 1,000 replicates. (B) Sequence logos of the conserved CYP motifs from the fungi CYP561 and
their comparison against human CYP561 (CYP3A43).
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Figure 3.11. Phylogenetic analysis of Shxdr1 homologs in ascomycetes fungi and alignment of
DNA binding domain and xenobiotic binding domain from Shxdr1 and other known transcription
factors. (A) Neighbor-Joining tree for amino acid sequences of Shxdr1 homologs and other
fungal specific transcription factors known to be involved with multidrug resistance (*). The
scale bar represents the number of amino acid substitutions per site. Bootstrap values are for
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1,000 replicates. (B) The alignment of aminoacid sequences of DNA binding domain and
xenobiotic binding domain in Shxdr1, Candida albicans Tac1, and Saccharomyces cerevisiae
Pdr1. Asterisks (*) indicate identical amino acids and colons (:) indicate similar amino acids
among transcription factors compared.
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CHAPTER 4
MOLECULAR MECHANISMS INVOLVED IN QUALITATIVE AND QUANTITATIVE RESISTANCE TO
THE DICARBOXIMIDE FUNGICIDE IPRODIONE IN SCLEROTINIA HOMOEOCARPA FIELD ISOLATES

4.1 Abstract
The dicarboximide fungicide class is commonly used to control Sclerotinia homoeocarpa,
the causal agent of dollar spot on turfgrass. Despite frequent occurrences of S. homoeocarpa
field resistance to iprodione (dicarboximide active ingredient), the genetic mechanisms of
iprodione resistance have not been elucidated. In this study, 15 field isolates (seven suspected
dicarboximide-resistant, three multi-drug resistance (MDR)-like, and five dicarboximidesensitive) were used for sequence comparison of a histidine kinase gene Shos1 of S.
homoeocarpa. The suspected dicarboximide-resistant isolates displayed non-synonymous
polymorphisms in codon 366 (isoleucine to asparagine) in the Shos1, while the MDR-like and
sensitive isolates did not. Further elucidation of the Shos1 function using polyethylene glycolmediated protoplast transformation indicated that S. homoeocarpa mutants (Shos1I366N) from a
sensitive isolate gained resistance to dicarboximides but not phenylpyrrole and polyols. The
deletion of Shos1 resulted in higher resistance to dicarboximide and phenylpyrrole, and higher
sensitivity to polyols than Shos1I366N. Levels of dicarboximide sensitivity in the sensitive isolate,
Shos1I366N and Shos1 deletion mutants were negatively correlated to values of iprodione
induced-expression of ShHog1, the last kinase in the high-osmolarity glycerol pathway.
Increased constitutive and induced expression of the ATP-binding cassette multidrug efflux
transporter ShPDR1 was observed in six of seven dicarboximide-resistant isolates. In conclusion,
S. homoeocarpa field isolates gained dicarboximide resistance through the polymorphism in
Shos1 and the overexpression of ShPDR1.
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4.2 Introduction
Dollar spot, caused by Sclerotinia homoeocarpa (F. T. Bennett), is one of the most
common and economically important diseases of cool-season turfgrass species worldwide
(Smiley et al., 2005). Proper cultural management practices to turfgrass are often ineffective for
complete dollar spot control. Therefore, multiple fungicide applications are often needed
throughout the growing season to manage dollar spot and maintain high turf quality. However,
repeated use of fungicides have led to the development of fungicide resistance in S.
homoeocarpa populations (Smiley et al., 2005). Resistance to the benzimidazole and
dicarboximide fungicide classes and reduced sensitivity to the sterol demethylation inhibitor
(DMI) class have been reported in S. homoeocarpa field populations across North America (Cole
et al., 1968; Detweiler et al., 1983; Jo et al., 2006; Miller et al., 2002; Popko et al., 2012; Putman
et al., 2010). Resistance mechanisms for benzimidazole and DMI fungicides were previously
elucidated in S. homoeocarpa (Hulvey et al., 2012; Koenraadt et al., 1992; Sang et al., 2015),
whereas the genetic mechanism(s) of dicarboximide resistance remain poorly understood.
Dicarboximide fungicides were initially introduced to control Botrytis cinerea in the late
1970s (Cui et al., 2002) and are now used to control a variety of Sclerotinia spp., Monilinia spp.
and Alternaria spp. (Detweiler et al., 1983; Hutton, 1988; Yoshimura et al., 2004). Iprodione and
vinclozolin are two dicarboximide active ingredients that have been registered to control dollar
spot for the last three decades and played an important role in controlling benzimidazole and
DMI resistant populations (Detweiler et al., 1983). Dicarboximide field resistance has been
reported in many plant pathogenic fungi such as B. cinerea (Beever and Brien, 1983; Leroux et
al., 2002; Talma, 1982), M. fructicola (Ritchie, 1983), Sclerotium cepivorum (Littley and Rahe,
1984) and A. alternata (Hutton, 1988). Genetic mechanisms responsible for dicarboximide
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resistance in B. cinerea have been well documented and were associated with the amino acid
changes in the putative target gene of iprodione, Bos1, which encodes a class III histidine kinase
(HK) involved in osmotic and oxidative stress (Ma et al., 2007). In parallel, laboratory-induced
iprodione-resistant mutants have shown cross-resistance to a phenylpyrrole fungicide,
fludioxonil, and hypersensitivity to osmotic stress. Both iprodione and fludioxonil are known to
affect the osmotic signal transduction cascade, but involvement of the mutations in Bos1 in the
cascade remains unresolved (Fillinger et al., 2012).
The first occurrence of iprodione field resistance in S. homoeocarpa was confirmed in
the early 1980s by Detweiler et al. (1983). Since then, S. homoeocarpa isolates exhibiting
resistance or reduced sensitivity to iprodione in monitored studies have been identified in the
United States and Italy (Bishop et al., 2008; Jo et al., 2006; Mocioni et al., 2011; Putman et al.,
2010). Putman et al. sampled 1,352 isolates from golf courses in the New England region and
reported iprodione sensitivity to be quantitatively distributed for the majority of isolates, but
also reported a small number of “outlier” isolates with significantly reduced in vitro sensitivity
levels (Putman et al., 2010). Despite reports of qualitative and/or quantitative resistance to
iprodione in S. homoeocarpa, the molecular mechanisms of resistance remain largely unknown.
Furthermore, dicarboximide resistance mechanisms conferred by qualitative (disruptive or
discrete) and quantitative (multi-step or continuous) resistance within the same fungal
pathogen have not been investigated.
To examine genetic factors that contribute to a wide range of S. homoeocarpa iprodione
sensitivity, we mined the osmosensing HK gene, Shos1, from transcriptomic data previously
generated by Hulvey et al. (2012). The Shos1 gene shares significant sequence similarity with the
Bos1 gene from B. cinerea, Mfos1 gene from M. fructicola, and Shk1 gene from S. sclerotiorum,
which have all been known to play an important role in mediating qualitative resistance to
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iprodione (Duan et al., 2013; Ma et al., 2006; Ma et al., 2007). Additionally, an ATP-binding
cassette (ABC) transporter, ShPDR1, in S. homoeocarpa was previously reported to be associated
with mediating quantitative resistance to iprodione (Sang et al., 2015). Sang et al. (2015)
reported that S. homoeocarpa field isolates with reduced in vitro sensitivity to propiconazole,
boscalid (SDHI: succinate dehydrogenase inhibitor) and iprodione displayed constitutive
overexpression of two ABC transporters (ShatrD and ShPDR1) and only ShPDR1 expression was
induced in response to iprodione. ShPDR1 complemented a yeast ABC transporter deletion
mutant in the presence of the aforementioned three chemicals using a yeast heterologous
expression system (Sang et al., 2015). However, the direct function of the ShPDR1 gene in regard
to dicarboximide resistance in S. homoeocarpa has not been elucidated by means of genetic
transformation.
The main goal of this study was to investigate the genetic determinants explaining a
wide range of iprodione sensitivity using S. homoeocarpa field isolates, which were sampled
from the aforementioned published studies (Detweiler et al., 1983; Putman et al., 2010; Sang et
al., 2015). The resistance determinants were validated using a genetic transformation system
based on a split-marker approach, which was developed for the first time in S. homoeocarpa.
The specific objectives were: 1) to sequence the Shos1 gene of S. homoeocarpa field isolates for
potential polymorphisms associated with qualitative resistance to iprodione, 2) to quantify in
vitro sensitivities of isolates to iprodione, fludioxonil, propiconazole and osmotic stress, 3) to
analyze the relative expression of ShPDR1 in isolates before and after iprodione exposure, and 4)
to validate the function of the genes by generating Shos1I366N, Shos1-knockout, and ShPDR1
overexpression mutants from a sensitive S. homoeocarpa isolate and by quantifying ShHog1
gene expression (last kinase of the high- osmolarity glycerol (HOG) pathway) with Shos1
generated mutants.
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4.3 Materials and Methods
4.3.1 Fungal Isolates
The origins of the 15 S. homoeocarpa isolates used in this study are described below.
One isolate (MI), which has been previously confirmed to exhibit field resistance to iprodione
(Detweiler et al., 1983), was collected from a creeping bentgrass putting green in Michigan. Six
isolates with the highest iprodione EC50 values (the mean effective concentration for reduction
of 50% mycelial growth relative to the control) were selected from a total of 387 isolates
assayed in a New England monitoring study (Putman et al., 2010). The origins of these six
suspected dicarboximide-resistant isolates are as follows: CT34 (West Hartford, CT), CT45 and
CT47 (Wethersfield, CT), CT91 (Enfield, CT), CT189 (Simsbury, CT), and NY2 (Newburgh, NY). In
addition, eight isolates collected from four golf courses with prior fungicide exposure and one
baseline location, all previously characterized in field efficacy, fungicide sensitivity, and fungicide
resistance mechanism studies (Popko et al., 2012; Sang et al., 2015), were chosen. Isolates
HRS10, SMS23, SMI27, JTS30, and HFS35 are considered dicarboximide-sensitive based on
previous in vitro fungicide sensitivity assay (Popko et al., 2012; Sang et al., 2015). Isolates WBI7,
HRI11, and HFI40 are considered MDR-like isolates and have been previously confirmed to
exhibit reduced sensitivities to three chemically unrelated fungicides: propiconazole, iprodione
and boscalid (Popko et al., 2012; Sang et al., 2015). All isolates were maintained on PDA (potato
dextrose agar) (Difco Laboratories, USA) slant tubes at 4°C until the study was performed.
4.3.2 DNA Extraction, PCR Amplification and Sequencing
Genomic DNA was extracted from all isolates using the methods previously described by
Saitoh et al. (2006) and Hulvey et al. (2012). The osmosensing HK gene, Shos1, (Contig 4083;
Accession No.: JW817408) was mined from S. homoeocarpa transcriptomic data (BioProject:
PRJNA167377) generated by Hulvey et al. (2012). Five primer sets were designed from Shos1 to
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amplify and sequence the full-length of Shos1 gene (4,280 bp) for ten isolates (CT34, CT45, CT91,
CT189, NY2, MI, HRI11, HFS40, SMS23 and JTS30) and the six 1490-bp HAMP repeats in the
Shos1 gene for five isolates (CT47, WBI7, HRS10, SMI27 and HFS40) using Primer3 (Rozen and
Skaletsky, 2000) (Table 4.1). PCR reaction conditions followed the procedures of Sang et al.
(2015). PCR amplicons were purified using ExoSAP-IT PCR cleanup reagent (Affymetrix, USA) and
sequenced at the Genomic Resource Laboratory (University of Massachusetts, Amherst, MA).
4.3.3 Sequence and Phylogenetic Analyses
BLASTX and Pfam domain searches of the 3942-bp Shos1 coding sequence were
conducted. Analyses of the full-length Shos1 genomic sequence from ten isolates and the six
HAMP repeats of Shos1 sequences from fifteen isolates for an intron and single nucleotide
polymorphism (SNP) detection were performed using MEGA v5 (Tamura et al., 2011). The fulllength amino acid sequences of Shos1 and the reported osmosensing HK amino acid sequences
of other species obtained from GenBank were used for the phylogenetic analysis. Amino acid
sequences were aligned using MAFFT v7.110 with automated strategy selection and BLOSUM62
scoring matrix parameters (Katoh and Toh, 2008). The aligned amino acid sequences were
imported into MEGA v5, and a Neighbor-joining phylogenetic analysis was performed with the
Poisson model, gamma distributed rates among sites, complete deletion of missing data, and
1,000 bootstrap replicates (Tamura et al., 2011).
4.3.4 In Vitro Fungicide Sensitivity and Osmotic Stress Assays
In vitro sensitivity assays for all fifteen isolates were conducted on fludioxonil,
iprodione, propiconazole, and NaCl amended minimal medium (MM, 1L; 10 g glucose, 1.5 g
K2HPO4, 2 g KH2PO4, 1 g (NH4)2SO4, 0.5 g MgSO4•7H2O, 2 g yeast extract, and 12.5 g agar) as per
Sang et al. (2015). The iprodione and propiconazole EC50 values of five dicarboximide-sensitive
isolates and three MDR (multi-drug resistance)-like isolates previously used in Sang et al. (2015)
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were reestimated in this present study. Isolates were previously stored on PDA slant tubes (4°C)
and transferred to PDA and grown for 2 days at room temperature. Agar plugs (5 mm in
diameter) were extracted from active colonies and inoculated on the edge of non-amended MM
plates; iprodione (0.01, 0.1, 1, 10, and 100 μg ml-1), fludioxonil (0.001, 0.01, 0.1, 1, and 10 μg ml1

), propiconazole (0.001, 0.01, 0.1, 1, and 10 μg ml-1) and NaCl (0.5 and 1 M) amended MM

plates. After eight days of incubation, the diameter from agar plug to the colony margin was
measured using 16EX digital calipers (Mahr, Göttingen, Germany). Two separate experiments
and four replicates (Petri plates) per each experiment were performed for each
isolate/concentration. Iprodione, fludioxonil and propiconazole EC50 values and relative mycelial
growth (RMG) % of isolates on NaCl amended medium were calculated as per Jo et al. (2006).
4.3.5 RNA Extraction, cDNA Synthesis and Relative Quantification of ShPDR1 and ShHog1
Expression
The ABC transporter, ShPDR1 was selected for this study, because overexpression of
ShPDR1 was positively correlated with reduced sensitivities to chemically unrelated fungicide
classes including dicarboximide (Sang et al., 2015). For analysis of ShPDR1 expression levels, RNA
samples were extracted from seven suspected dicarboximide-resistant isolates and two
dicarboximide-sensitive isolates (SMS23 and JTS30) before and after exposure (1 hour) to
iprodione (1 µg ml-1) in this present study using the methods detailed in Sang et al. (2015).
Previously obtained CT (cycle threshold) values of ShPDR1 and actin gene (Shact) for three MDRlike (WBI7, HRI11, and HFI40) and three dicarboximide-sensitive isolates (HRS10, SMI27, HFS35)
were used for the purpose of comparison (Sang et al., 2015). Expression of hog1-type mitogenactivated protein kinase, ShHog1, mined from S. homoeocarpa genomic data (Bioproject:
PRJNA302176) generated by Green et al. (2016) was also analyzed. RNA extraction was
performed on the isolate and mutants in the absence and presence of iprodione (10 µg ml-1) and
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propiconazole (1 µg ml-1) for 1 hour. cDNA synthesis from each sample of RNA was performed
with the QuantiTect reverse transcription kit (Qiagen Inc., USA). For relative quantification of
ShPDR1 and ShHog1 expression, the actin gene (Shact) was selected as a housekeeping gene.
The primers for ShPDR1 and Shact were described in Sang et al. (2015) and the primer set for
ShHog1 was described in Table 4.1. Relative gene expression was calculated using the
comparative CT method (Livak and Schmittgen, 2001). All experiments were performed with two
biological replicates and three technical replicates per each biological replicate for each
isolates/treatments.
4.3.6 Construction of Vectors for Shos1-knockout, Shos1I366N and Overexpression of ShPDR1
The hygromycin resistance cassette, PtrpC-hph, was amplified from pYHN3 (Rech et al.,
2007) using F_ptrpC and R_hph and was cloned into pCR2.1-TOPO (Invitrogen, USA) resulting in
the plasmid Topo-hph. A 1 kb upstream flanking sequence of Shos1 was amplified from genomic
DNA (gDNA) of isolate HRS10 using primer F_KpnI_upos1 and R_SpeI_upos1. The amplicon was
inserted into KpnI and SpeI sites of the plasmid Topo-hph to generate the plasmid Topo-hphupos1. Subsequently, a 1 kb downstream flanking sequence of Shos1 amplified from gDNA of
isolate HRS10 using the primers F_NotI_downos1 and R_ApaI_downos1 was inserted into NotI
and ApaI sites of the plasmid Topo-hph-upos1 to generate the plasmid Topo-ΔShos1. As a result,
the Shos1 deletion vector Topo-ΔShos1 was constructed by inserting 1 kb of two flanking
sequences of the Shos1 gene into both sides of PtrpC-hph in the Topo-hph vector. Two
constructs were amplified with primers, F_upos1/R_YG and F_HY/R_downos1, respectively,
each containing a 1 kb of upstream flank of the Shos1 and 731 bp of hph or 1 kb of downstream
flank of the Shos1 and 1126 bp of PtrpC-hph (Figure 4.1A). Two constructs were gel purified
using the Zymoclean Gel DNA Recovery Kit (Zymo Research, USA). For construction of Shos1I366N
vector, the full length of Shos1 genomic DNA from dicarboximide-resistant isolates CT45 was
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amplified using a primer set F_KpnI_Shos1 and R_SpeI_Shos1. The purified Shos1 fragment was
inserted into KpnI and SpeI sites of the plasmid Topo-ΔShos1 to generate the plasmid TopoShos1I366N. Both constructs were amplified with primers, F_Shos1/R_YG and F_HY/R_downos1,
respectively.
To construct a gene overexpression plasmid for S. homoeocarpa (pYHN3-pShEF1α),
plasmid pYHN3 (Rech et al., 2007) was modified by insertion of a multiple cloning site from
pYES2 (Invitrogen, USA) using primer set F_NcoI_MCS and R_SpeI_MCS, and 1 kb of the
upstream region of elongation factor 1 alpha (ShEF1α) from gDNA of isolate HRS10 using primer
set F_ApaI_ShpEF1α and R_NcoI_ShpEF1α. The full length of ShPDR1 coding region amplified
from plasmid pYES2-ShPDR1(Sang et al., 2015) using F_KpnI_PDR1 and R_SpeI_PDR1 was
inserted into the vector pYHN3-pShEF1α, which resulted in a ShPDR1 overexpression vector
pYHN3-pShEF1α-ShPDR1. Primers used for plasmid construction were described in Table 4.1.
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Figure 4.1. Generation and validation of Shos1-knockout S. homoeocarpa mutants. (A) Gene
knockout strategy for Shos1. Short arrows indicates primer binding sites. (B) Primer pair
F2_Shos1/R3_Shos1 was used to amplify the partial region of Shos1 gene (1,700 bp). (C) Primer
pair F_ptrpC/R_hph was used to amplify the hygromycin resistance cassette (ptrpC-hph) (1,391
bp). (D) Primer pair F_detect_upos1/R_YG was used to amplify the left homologous arm with a
partial fragment of the connecting area (2,021 bp). (E) Primer pair F_HY/R_dectect_downos1
was used to amplify the right homologous arm with a partial fragment of the connecting area
(2,270 bp).
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Table 4.1. Primers used in this study.
Primer name
F1_Shos1
R1_Shos1

Primer sequence (5'-3')
TAACTATTCCGATCGAATTCCGAACAT
AGATCACCTCTAGCAACAGCAGTAACG

Description
Amplification and sequencing primer for
partial sequences of Shos1

F2_Shos1
R2_Shos1

GGAACAAGCGCTTAACCTTTTGGAGGT
TTCGGTTAGGTCTCTCCATGTGCCTTC

Same as above

F3_Shos1
R3_Shos1

GCGACATAGCGATTGTTACGACTGCTG
GAGACATGTTGGCCAAGAACTCGGACT

Same as above

F4_Shos1
R4_Shos1

GAACTGAAACGAAAAATCAACCAGATG
GAGCAGATTGGTATGTTGTTCGGAAT

Same as above

F5_Shos1
R5_Shos1

CCTCTTCATCGACAAAGGACACACT
CGAAAAGAAAAGAAATAAGGTGGAGCA

Same as above

F_ptrpC
R_hph

CGTTAACTGATATTGAAGGAGCATTTT
CTATTCCTTTGCCCTCGGACG

Amplification of the hygromycin resistance
cassette (ptrpC-hph)

F_KpnI_upos1
R_SpeI_upos1

ATTTGGTACCTGTACATTGGTGCTTGTAACC
ATTTACTAGTCTTCGACCGAGGGATTGCA

Amplification of upstream of Shos1

F_NotI_downos1
R_ApaI_downos1

ATGTGCGGCCGCTGAGGTTTAACCCAATGTGA
ATTTGGGCCCGTCAGTCCCATGTCGGCATC

Amplification of downstream of Shos1

F_upos1
R_YG

TGTACATTGGTGCTTGTAACCTC
CGTTGCAAGACCTGCCTGAA

Amplification of upstream of Shos1 and
part of hph for split marker transformation

F_HY
R_downos1

TACTTCGAGCGGAGGCATCC
GTCAGTCCCATGTCGGCATC

F_KpnI_Shos1
R_SpeI_Shos1

ATAAGGTACCATGTGTGAGGAAACGTTAGC
ATTCACTAGTTCAGCTGCTGTGTGCACGCA

Amplification of downstream of Shos1 and
part of ptrpC-hph for split marker
transformation
Amplification of the full length of Shos1

F_Shos1

ATGTGTGAGGAAACGTTAGCCG

Amplification of the Shos1 and part of hph
for split marker transformation with R_YG

F_detect_upos1

ATCAGCAACTGCCCACATCTTG

Amplification of the upstream of Shos1 and
part of hph for the detection of
transformants with R_YG

R_detect_downos1

CAGAATATTGCATGCATGCGACG

Amplification of the downstream of Shos1
and part of ptrpC-hph for the detection of
transformants with F_HY

F_NcoI_MCS
R_SpeI_MCS

ATTTCCATGGAAGCTTGGTACCGAGCTC
AGCTACTAGTTCTAGATGCATGCTCGAG

Amplification of MCS from pYES2 vector

F_ApaI_pShEF1α
R_NcoI_pShEF1α

ATTTGGGCCCCCTGCTGTTACCAAGTATAG
ATTCCCATGGCTTGGCGGGTTTCTATGAATC

Amplification of promoter of ShEF1α

F_KpnI_PDR1

Amplification of ShPDR1 gene from
pYES2-ShPDR1

R_SpeI_PDR1

ATGCGGTACCATGTCTTTATTAGGGAATCTCAA
CCCTAAT
ATGCACTAGTTCAAACCTTCGATCGTTTCCC

QF_ShHog1
QR_ShHog1

CATGCTCACATGGCAGAAATAC
TGGTCCTTTCCTGGGAATAATG

Quantify expression of Shhog1
gene
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4.3.7 Protoplast Preparation and Transformation of S. homoeocarpa
The method for protoplast preparation and transformation of S. homoeocarpa was
modified from Rollins (2013). In brief, mycelia of S. homoeocarpa isolate HRS10 were grown on
PDA for four days and then inoculated in a 50 ml falcon tube (USA Scientific Inc., USA) containing
25 ml of potato dextrose broth (PDB) (Becton Dickinson, USA) and incubated for four days at
23°C without agitation. The mycelia were collected from four layers of sterile cheesecloth in a
funnel, and washed with sterile water and then with protoplast buffer (0.8 M MgSO4·7H2O, 0.2
M C6H5Na3O7·2H2O, pH 5.5). The washed mycelia were cut into smaller pieces and placed into a
sterile 250-ml Erlenmeyer flask. 200 mg of lysing enzymes from Trichoderma harzianum (SigmaAldrich, USA) were dissolved in 3 ml of buffer (1 M sorbitol, 50 mM sodium citrate, pH 5.8) and
17 ml of protoplast buffer were added to the mycelium-containing Erlenmeyer flask. The flask
was incubated at 28°C with 100 rpm of agitation on a shaker for 3 h. The solution containing
protoplasts was filtered through sterile cheesecloth and was collected in a sterile 250-ml
Erlenmeyer flask. Next, 30 ml of 0.6 M KCl was added to the cheesecloth and was collected in
the flask containing protoplast. The protoplast solution was transferred into a 50-ml falcon tube
and centrifuged for 10 min at 4°C (3,000 × g). The pelleted protoplasts were washed twice with
10 ml of STC buffer (1 M sorbitol, 50 mM Tris, pH 8, 50 mM CaCl2·2H2O). 500 µl of protoplast
solution (1 × 107 protoplasts/ml in STC buffer), 6.25 µl of dimethyl sulfoxide, 31.25 µl of heparin
(5 mg ml-1 prepared in STC buffer), and 125 µl of polyethylene glycol (PEG) solution (40% PEG
3350, 50 mM Tris, pH 8, 0.6 M KCl, 50 mM CaCl2) were added to a 1.5 ml microcentrifuge tube
and then stored at -80°C.
For the transformation of S. homoeocarpa, protoplasts stored at -80°C were thawed on
ice and 2 µg of split marker construct or 4 µg of plasmid was added to the tube. The tube was
incubated on ice for 60 min, and then 1 ml of PEG solution was added. The mixture was
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incubated at room temperature for 20 min. The protoplasts were transferred into a 15-ml
screw-cap falcon tube (USA Scientific Inc., USA) and 5 ml of regeneration medium (RM) (239.6 g
of sucrose, 0.5 g of yeast extract per liter) were added. The tube was incubated for 12-16 hours
at room temperature on a Bigger Bill™ digital oscillator (Thermo Scientific Thermolyne, USA) at
150 rpm. The tube was centrifuged at 2,500 x g for 10 min at 4°C, and the supernatant was
discarded. The protoplasts were resuspended with 200 ml STC buffer in the tube and were
spread on regeneration agar medium containing 100 µg ml-1 of hygromycin B (Invitrogen, USA).
Upon selection on hygromycin media for 4-8 days at 23°C, transformants were obtained and
then hyphal-tip transferred to PDA containing 100 µg ml-1 of hygromycin B at least three times.
4.3.8 In Vitro Sensitivity Assays and Pathogenicity Tests of Shos1-knockout, Shos1I366N, and
ShPDR1 Overexpressed Mutants
In vitro sensitivity assays were conducted on the two Shos1-knockout mutants
(HRS10(∆Shos1)-1 and -2), two Shos1I366N mutants (HRS10(Shos1I366N)-1 and -2), two PDR1
overexpression mutants (HRS10(ShPDR1OX)-1 and -2) and four isolates (HRS10, HRI11, CT45 and
NY2) with iprodione, vinclozolin, and fludioxonil. Shos1-knockout, Shos1I366N and ShPDR1
overexpression mutants and HRS10 were also used for in vitro sensitivity assays with NaCl, KCl,
glucose, D-sorbitol, and H2O2. An agar plug (diameter, 4 mm) from each isolate grown on PDA
for three days was inoculated on non-amended MM, iprodione (1.5, 3, 15, and 25 μg ml-1),
vinclozolin (1 and 5 μg ml-1), fludioxonil (0.1 μg ml-1), NaCl (0.4 M), KCl (0.2 M), glucose (1 M), Dsorbitol (1.2 M), and H2O2 (10 M) amended MM. For the calculation of RMG (%) value, the agar
plug from each isolate was also inoculated on the individual MM. After the plates had been
incubated at 25°C, RMG of each isolate was measured after 42, 62 and 144 hours and pictures
were taken as well. The experiment was repeated three times.
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For testing pathogenicity, creeping bentgrass (cv. Penncross) was grown in a greenhouse
at 18°C day and 16°C night temperatures with a 12 h photoperiod and at 70% relative humidity.
Six leaf blades from 2-month-old bentgrass plants were excised and placed on sterile watersaturated filter paper (Whatman, UK) in 9-cm petri dishes. An agar plug (4 mm in diameter)
extracted from active mycelial colonies of S. homoeocarpa isolates (HRS10, HRI11, and CT45)
and Shos1-knockout, Shos1I366N, and ShPDR1OX transformants grown on PDA was inoculated on
the center of leaf blades. Inoculated leaf blades were incubated at 23°C at 100% relative
humidity in the culture room. The diameter of the infected lesion on individual leaf blades was
measured two days after inoculation. The whole experiment was repeated twice.
4.3.9 Statistical Analysis of In Vitro Sensitivity Assay and Quantitative PCR Data
For statistical analysis of in vitro sensitivity, field isolates examined were categorized
into three groups according to presence/absence of I366N mutation and overexpression of
ShPDR1 in Table 4.2. First, Group 1 (dicarboximide-resistant isolates: CT34, CT45, CT47, CT91,
CT189, NY2 and MI) contained the I366N mutation in Shos1 and Groups 2 and 3 (MDR-like
isolates: WBI7, HRI11 and HFI40) and (dicarboximide-sensitive isolates: HRS10, SMI27, SMS23,
JTS30 and HFS35) did not contain I366N in Shos1, were compared. Furthermore, Group 2
showing constitutive and induced overexpression of ShPDR1 and Group 3 showing no
constitutive and induced overexpression of ShPDR1 were compared. Analysis of variance
(ANOVA) and Fisher’s Protected LSD were conducted to compare mean EC50 and RMG % values
between the aforementioned Groups. ANOVA was conducted on relative expression (RE) values
for ShPDR1 between Group 1 and Group 2 and between Group 1 and Group 3. Linear regression
analysis was conducted with iprodione EC50 values and log10-transformed mean RE values of
ShPDR1 constitutive expression for all 15 isolates.
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ANOVA and Fisher’s Protected LSD were conducted to compare mean RMG % values
among ten isolates (HRS10, HRI11, CT45, NY2, and two Shos1I366N, two Shos1-kockout, two
ShPDR1 overexpression mutants), RMG % values among four isolates (HRS10, HRI11, and two
ShPDR1 overexpression mutants), RMG % values among four isolates (HRS10, and Shos1I366N,
Shos1-kockout, ShPDR1 overexpression mutants), and mean lesion diameter among nine
isolates (HRS10, HRI11, CT45, and two Shos1I366N, two Shos1-kockout, two ShPDR1
overexpression mutant). Lastly, ANOVA was conducted on fold induction values for ShHog1
expression between HRS10 and Shos1I366N mutant and between HRS10 and Shos1-kockout
mutant. All statistical analyses were conducted by JMP software package, version 10.0 (SAS
Institute Inc., Cary, NC).

4.4 Results
4.4.1 Sequence and Phylogenetic Analyses
The histidine kinase gene, Shos1 from S. homoeocarpa was characterized by BLAST search,
Pfam domain, phylogenetic analyses and sequencing to detect potential polymorphisms
associated with dicarboximide resistance. A BLASTX search revealed that Shos1 shares high
homology with the following three genes encoding a histidine kinase two-component regulatory
system: Shk1 from S. sclerotiorum (accession no.: EDN97840), Mfos1 from M. fructicola
(accession no.: ABF60145) and Bos1 from B. cinerea (accession no.: AFQ90105). These genes
have been reported to mediate resistance to the dicarboximide fungicide class (Cui et al., 2004;
Cui et al., 2002; Duan et al., 2013; Ma et al., 2006; Ma et al., 2007; Oshima et al., 2002) and were
identified by an E-value of 0 and coding sequence coverage of 99%. The Shos1 sequence shares
94% of amino acid identity with Shk1 (1,234 out of 1,310), Mfos1 (1,237 out of 1,317) and Bos1
(1,234 out of 1,316). Six HAMP repeat domains, one kinase domain and one response regulator
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domain were detected by a Pfam domain search. Phylogenetic analysis showed that Shos1,
Shk1, Mfos1 and Bos1 are placed in the same clade and were supported by a high bootstrap
value (100%) in Figure 4.2. The Shos1 coding sequence from HRI11 was deposited in GenBank
with accession number KM576215.
Comparison of sequences obtained from genomic DNA sequencing and transcriptomic
data indicated that the 4,280 bp of Shos1 is interrupted by six introns. The SNP detection
analysis of the full length of Shos1 gene from ten isolates indicated that only polymorphisms at
codon 366, located in the second repeat of HAMP domain of Shos1, are perfectly correlated to
suspected dicarboximide-resistant isolates. Further sequence analysis of six HAMP repeats
(1,490 bp) in the Shos1 gene from fifteen isolates revealed that ATC at codon 366 in MDR-like
and sensitive isolates was replaced by AAT in resistant isolates CT34, CT45, CT47, CT91, and
CT189 and by AAC in resistant isolates MI and NY2. However, these altered nucleotides
encoding the same amino acid change an isoleucine to an asparagine at codon 366 (I366N)
shown in Figure 4.3.
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Figure 4.2. Neighbor-Joining tree for amino acid sequences of osmosensing histidine kinase
genes in sixteen fungi spp. including S. homoeocarpa. The scale bar represents the number of
amino acid substitutions per site. Bootstrap values are for 1,000 replicates.
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Figure 4.3. (A) Schematic diagram of the partial Shos1 gene structure showing the location of
primers used in this study. The vertical arrow indicates a substitution at amino acid position 366
of the Shos1 gene in dicarboximide-resistant isolates of S. homoeocarpa. (B) Alignment of partial
deduced amino acid sequence of Shos1 gene from dicarboximide-resistant (Shos1-DR), MDR
(multi-drug resistance)-like (Shos1-MDR), and dicarboximide-sensitive (Shos1-DS) isolates of S.
homoeocarpa. The shaded letters indicate the change at amino acid position 366 correlated
with resistance to iprodione in dicarboximide-resistant isolates. Asterisks indicate identical
amino acids among the isolates compared.
4.4.2 Sensitivity of S. homoeocarpa Isolates to Fungicides and Osmotic Stress
The in vitro sensitivity of 15 individual field isolates to iprodione (dicarboximide),
propiconazole (DMI), fludioxonil (phenylpyrrole), and NaCl (osmotic stress) were assayed and
presented in Table 4.2. Furthermore mean EC50 values among Group 1 (dicarboximideresistant), Group 2 (multi-drug resistance-like) and Group 3 (dicarboximide-sensitive) were
compared to correlate genetic determinants with their sensitivity levels. The mean iprodione
EC50 values for Group 1 (isolates containing I366N mutation in Shos1) were significantly higher
than mean iprodione EC50 values of Groups 2 and 3 (isolates that did not contain I366N mutation
in Shos1). In addition, Group 2 (isolates that overexpressed ShPDR1) had significantly higher
mean iprodione EC50 values than Group 3 isolates. Although Group 1 had statistically higher
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mean fludioxonil EC50 values than combined Groups 2 and 3, the EC50 values were numerically
low in all individual isolates and most likely biologically insignificant (Table 4.2). The mean
propiconazole EC50 values in Group 2 were significantly higher than the ones in Group 3.
The mean RMG % values in Group 1 on 0.5 M NaCl amended MM were significantly
higher than those of both Groups 2 and 3, however isolate MI in Group 1 had a similar RMG
value to Group 3 isolates. There is no statistical difference among the three Groups on 1 M NaCl
amended MM (Table 4.2).

Table 4.2. In vitro sensitivity of Sclerotinia homoeocarpa isolates to fungicides and NaCl and
mean comparison of the sensitivity among three groups of isolates.
Groups
Isolates

CT34
CT45
CT47
CT91
CT189
MI
NY2
HRI11
HFI40
WBI7
SMI27
HRS10
HFS35
JTS30
SMS23

a

Amino acid
Overexpression
d
substitution I366N
of ShPDR1
in Shos1
Group 1 (dicarboximide-resistant)
+
+
+
+
+
+
+
+
+
+
+
+
+
Group 2 (multi-drug resistance-like)
+
+
+
Group 3 (dicarboximide-sensitive)
-

EC50 values (μg/ml)

b

c

RMG (%)
0.5 M
1M
of
of
NaCl
NaCl

Iprodie
one

Fludioxonil

Propiconf
azole

2.186
1.660
2.177
1.501
2.291
2.097
1.310

0.006
0.003
0.005
0.002
0.004
0.008
0.003

0.412
0.383
0.354
0.825
0.361
0.318
0.140

26.9
19.5
21.0
17.1
28.1
12.7
21.2

8.1
6.9
3.7
3.1
8.0
2.1
1.4

0.761
0.757

0.005
0.002

0.753
0.604

8.6
17.8

3.0
4.6

0.824

0.003

0.544

10.6

2.9

0.550
0.526
0.540
0.524
0.398

0.002
0.001
0.001
0.002
0.001

0.199
0.016
0.025
0.020
0.068

6.7
11.8
14.1
13.0
9.0

2.0
2.1
5.0
3.4
1.4

Group 1 vs
Groups 2 +3
h
P value

1.89 a
0.61 b
***

g

0.004 a
0.002 b
**

0.40
0.28
NS

20.9 a
11.5 b
***

4.7
3.1
NS

Group 2 vs
Group 3
h
P value

0.78 a
0.51 b
***

0.003 a
0.001 b
**

0.63 a
0.07 b
***

12.3
10.9
NS

3.5
2.8
NS
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4.4.3 Quantitative RT-PCR Analysis of ShPDR1
To test the possible involvement of ShPDR1 overexpression in iprodione resistance,
mean RE values of ShPDR1 in Group 1 isolates were compared with mean RE values of Groups 2
and 3. Group 1 (mean = 10.69 ± SE 0.68) showed significantly higher constitutive RE values of
ShPDR1 than Group 3 (mean = 1.40 ± SE 0.72) (P < 0.0001), but wasn’t significantly different
from Group 2 (mean = 9.02 ± SE 1.15) (P = 0.25). In the presence of iprodione (1 µg ml-1), Group
1 isolates exhibited increased RE of ShPDR1 with the exception of isolate NY2. In contrast,
increased RE of ShPDR1 was not observed in isolates JTS30 and SMS23 (Group 3), behaving as
the other dicarboximide sensitive isolates previously characterized for ShPDR1 expression (Sang
et al. 2015) (Figure 4.4).
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Figure 4.4. Relative expression (RE) of ShPDR1 in fifteen field isolates before and after exposure
to iprodione (1 µg ml-1) for 1 hour. Light and dark gray bars indicate mean constitutive RE values
and mean iprodione induced RE values, respectively. Error bars represent one standard error
from the mean. For comparison purposes, ShPDR1 expression values of MDR (multi-drug
resistance)-like and three dicarboximide-sensitive isolates adapted from Sang et al. (2015) were
reanalyzed and presented.
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4.4.4 Linear Regression of ShPDR1 Expression and EC50 Values for Iprodione
The linear regression analysis was performed to examine whether the constitutive
expression of ShPDR1 is correlated with the iprodione sensitivity. The linear relationship
between log10-transformed mean RE values for ShPDR1 and EC50 values of iprodione was
significant (P = 0.0058). The dicarboximide resistant isolates (triangles) with both ShPDR1
overexpression and Shos1 mutation, except for isolate NY2, showed higher iprodione EC50 values
than MDR-like isolates (diamonds) with ShPDR1 overexpression alone (Figure 4.5).

Figure 4.5. Relationship between log10 relative expression (RE) values of ShPDR1 and iprodione
EC50 values for 15 field Sclerotinia homoeocarpa isolates. Triangles denote dicarboximide
resistant isolates (Group 1), diamonds denote MDR (multi-drug resistance)-like isolates (Group
2), and dots denote dicarboximide sensitive isolates (Group 3).
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4.4.5 Generation of Shos1-knockout, Shos1I366N, and ShPDR1 Overexpression Mutants of S.
homoeocarpa
For functional validation of Shos1 and ShPDR1 genes, we generated Shos1-knockout,
Shos1I366N, and ShPDR1 overexpression mutants from a sensitive S. homoeocarpa isolate HRS10.
Among 24 hygromycin-resistant transformants, three Shos1-knockout mutants were confirmed
by PCR with four primer pairs (Table 4.1). A 1,700 bp partial region in the Shos1 gene was only
amplified in isolate HRS10 using the primer pair, F2_Shos1 and R3_Shos1 (Figure 4.1B). A pair of
primers, F_ptrpC and R_hph, were used to amplify a 1391 bp region of PtrpC-hph, which was
only detected in three Shos1-knockout mutants HRS10(∆Shos1)-1, 2, and 3 (Figure 4.1C). A 2,021
bp section of the left flanking region and a 2,270 bp section of right flanking region were
amplified in three Shos1-knockout mutants using two pairs of primers, F_detect_upos1/R_YG
and F_HY/R_dectect_downos1, respectively (Figure 4.1D and E).
Three Shos1I366N mutants out of 18 hygromycin-resistant transformants were confirmed
by the aforementioned method using primer sets F_ptrpC/R_hph, F5_Shos1/R_YG, and
F_HY/R_dectect_downos1 (Table 4.1). The analysis of the full-length sequence of Shos1 gene
from three Shos1I366N mutants indicated that ATC at codon 366 in isolate HRS10 was replaced by
AAT in the three mutants.
Two ShPDR1 overexpression mutants that exhibited the highest RMG values on
iprodione (1.5 µg ml-1) were selected out of 45 hygromycin-resistant transformants. The total
RNA of two ShPDR1 overexpression mutants HRS10(ShPDR1OX)-1 and -2, and HRS10 were
extracted for comparison of the relative expression of ShPDR1. The HRS10(ShPDR1OX)-1 and -2
mutants showed 3- to 5.6-fold increased expression of ShPDR1 over the sensitive isolate HRS10.
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4.4.6 In Vitro Sensitivity to Fungicides, Osmotic and Oxidative Stress, and Pathogenicity Tests
of Shos1-knockout and Shos1I366N, and ShPDR1 Overexpression Mutants of S. homoeocarpa
The previously described mutants and field isolates were assayed on different fungicide
classes, osmotic, and oxidative stresses. The HRS10(∆Shos1)-1 and -2 mutants,
HRS10(Shos1I366N)-1 and -2 mutants, and dicarboximide-resistant isolates (NY2 and CT45)
showed resistance to iprodione at 3 µg ml-1 and vinclozolin at 1 µg ml-1 (Figure 4.6A).
Furthermore, Shos1-knockout mutants and CT45 containing the mutation in Shos1 and
overexpression of ShPDR1 showed resistance to iprodione at 15 µg ml-1, however only Shos1knockout mutants showed resistance to iprodione at 25 µg ml-1, vinclozolin at 5 µg ml-1, and
fludioxonil at 0.1 µg ml-1. Since Shos1-knockout and Shos1I366N mutants and dicarboximideresistant isolates grew quickly on media amended with 1.5 µg ml-1 of iprodione, only four strains
per plate (HRS10(ShPDR1OX)-1 and -2, HRS10, and HRI11) were compared at this concentration.
ShPDR1 overexpression mutants HRS10(ShPDR1OX)-1 and -2 and MDR-like isolate (HRI11)
showed reduced sensitivity to iprodione at 1.5 µg ml-1 (Figure 4.6A). For osmotic and oxidative
stresses, only the Shos1-knockout mutants showed increased sensitivity to glucose at 1 M and
sorbitol at 1.2 M (Figure 4.6B).
In addition, the pathogenicity of mutants and field isolates mentioned above was assayed
on detached leaf of creeping bentgrass. All isolates and mutants were able to cause infection on
leave blades ranging 19-22 mm of average lesion size 2 days after inoculation but no statistical
difference was observed (P = 0.65).
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Figure 4.6. Sensitivity of S. homoeocarpa isolates to fungicides, osmotic stress, and oxidative
stress. (A) Sensitivity to different fungicides. 1: HRS10; 2: HRI11; 3: HRS10(ShPDR1OX)-1; 4:
HRS10(ShPDR1OX)-2; 5: HRS10(Shos1I366N)-1; 6: HRS10(Shos1I366N)-2; 7: HRS10(ΔShos1)-1; 8:
HRS10(ΔShos1)-2; 9: CT45; 10: NY2. The pictures were taken 42 h after growing the isolates on
minimal medium (MM) without and with iprodione, vinclozolin, and fludioxonil. *The picture of
plate with 1.5 μg ml-1 of iprodione were taken after 144 h. 1: HRS10; 2: HRI11; 3:
HRS10(ShPDR1OX)-1; 4: HRS10(ShPDR1OX)-2. (B) Sensitivity to osmotic stress (generated by
glucose, sorbitol, NaCl, and KCl) and oxidative stress (generated by H2O2). 1: HRS10; 2:
HRS10(ShPDR1OX)-1; 3: HRS10(Shos1I366N)-1; 4: HRS10(ΔShos1)-1. The pictures were taken 62 h
after growing the isolates on MM without and with glucose, sorbitol, NaCl, KCl, and H2O2.

102

4.4.7 Relative Expression of ShHog1 in Shos1-knockout and Shos1I366N Mutants
The function of Shos1 was further characterized by quantifying expression of ShHog1 in
Shos1 mutants and the sensitive isolate. The qRT-PCR assay indicated that ShHog1 expression
was up-regulated by iprodione treatment in HRS10 (6 fold increase), HRS10(Shos1I366N)-1 (4.4
fold increase), and HRS10(∆Shos1)-1 (1.4 fold increase), which were statistically significant (P <
0.0001). Propiconazole treatment did not induce expression of ShHog1 in HRS10 and
HRS10(∆Shos1)-1, however, ShHog1 expression was up-regulated in HRS10(Shos1I366N)-1 by 1.6
fold (Figure 4.7).

Figure 4.7. Relative expression (RE) of ShHog1 in HRS10, HRS10(Shos1I366N)-1 and
HRS10(ΔShos1)-1 before and after treatment with iprodione (10 µg ml-1) and propiconazole (1
µg ml-1) for 1 hour. White bars indicate mean constitutive RE values, Light gray bars indicate
mean iprodione induced RE values, and dark gray bars indicate mean propiconazole induced RE
values. Error bars represent one standard error from the mean.
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4.5 Discussion
This study reports both qualitative and quantitative types of iprodione resistance in S.
homoeocarpa field isolates: an amino acid substitution in the histidine kinase (HK) gene Shos1
and the overexpression of the ABC transporter gene ShPDR1, respectively. Specifically, the
isolates with the highest iprodione EC50 values examined in this study contain the two
aforementioned factors, and the MDR-like isolates exhibiting lower levels of iprodione
resistance exhibit quantitative overexpression of the ShPDR1 only. Our findings were validated
by an analysis of Shos1I366N, ∆Shos1, and ShPDR1 overexpression mutants from a dicarboximidesensitive isolate. The Shos1I366N mutants exhibiting resistance to iprodione indicated that the
mutation (I366N) is a qualitative determinant of iprodione resistance, and ShPDR1
overexpression mutants revealed that the level of ShPDR1 expression contributes to a
quantitative determent of reduced iprodione sensitivity.
In dicarboximide field resistant isolates, an amino acid substitution at codon 366 in
Shos1 from a hydrophobic isoleucine to a hydrophilic asparagine results in decreased
hydrophobicity in the region of this residue. So, it is plausible that the binding affinity of
dicarboximide fungicides to Shos1 is affected directly. The I366N mutation does not affect the
sensitivity of S. homoeocarpa to fludioxonil and osmotic stress, which suggests the effect of
mutation is likely specific to dicarboximides. On the other hand, the Shos1 deletion mutants
exhibited as higher level of resistance to dicarboximide fungicides than Shos1I366N mutants and
resistant to a fludioxonil fungicide as well. The resistant phenotype to both fungicides has been
reported in the class III histidine kinases (HKs) deletion mutants in many other fungal spp.,
Neurospora crassa, Magnaporthe grisea, Cochliobolus heterostrophus, B. cinerea, and S.
sclerotiorum (Duan et al., 2013; Fujimura et al., 2000; Motoyama et al., 2005; Schumacher et al.,
1997; Viaud et al., 2006; Yoshimi et al., 2004). Additionally, the Shos1-knockout mutants showed
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a strong growth reduction on polyols (sorbitol and glucose), but not on salt (NaCl and KCl)
(Figure 4.6). The HK deletion mutants exhibited different sensitivities to osmotic stress
depending on fungal species (Duan et al., 2013), with little understanding of the biological and
ecological reasons. For example, the mutants of M. oryzae and Fusarium oxysporum show a
higher sensitivity to polyols stress than to salt (Motoyama et al., 2005; Rispail and Pietro, 2010),
but the mutants of N. crassa, C. heterostrophus, B. cinerea, and S. sclerotiorum display increased
sensitivity to salt stress than to polyols (Alex et al., 1996; Duan et al., 2013; Viaud et al., 2006;
Yoshimi et al., 2004). For oxidative stress, gene inactivation of Shk1 from S. sclerotiorum confers
hypersensitivity to H2O2 (Duan et al., 2013), whereas the HK deletion mutants in B. cinerea and S.
homoeocarpa did not exhibit increased sensitivity to oxidative stress (Viaud et al., 2006) (Figure
4.6). In addition, the HKs in F. oxysporum, B. cinerea, and Alternaria brassicicola are required for
full pathogenicity (Cho et al., 2009; Rispail and Pietro, 2010; Viaud et al., 2006), but not in S.
homoeocarpa like M. grisea and S. sclerotiorum (Duan et al., 2013; Motoyama et al., 2005).
Although S. homoeocarpa is closely related to S. sclerotiorum and B. cinerea, the function of HK
in osmotic and oxidative stresses, and virulence shares or differs among these fungal species.
The present study provided further insight on the mechanisms on differential sensitivity
of Shos1I366N and Shos1-knockout mutants to iprodione by quantifying the expression of ShHog1.
The increased iprodione resistance level in the Shos1 deletion mutant over the Shos1I366N
mutant was correlated with the decreased iprodione-induced ShHog1 expression (Figure 4.6 and
Figure 4.7). Since HK is the upstream factor in an osmotic signaling system, the mutants lacking
HK do not occur phosphorylation of HOG MAPK caused by fungicides (Tanaka and Izumitsu,
2010; Yoshimi et al., 2005). In addition, translocation of phosphorylated Hog1 to the nucleus is
preceded by the increased expression of Hog1 gene (Marques et al., 2006). The dicarboximide
mode of action suggested by Tanaka et al. (2010) was that the fungicide targeting HK induces
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abnormal phosphorylation of the HOG1 MAPK, which alters downstream gene expression.
Therefore, the Shos1 deletion mutant may not affect expression or phosphorylation of ShHog1
after exposure to iprodione, resulting in high resistance to iprodione. On the other hand, the
Shos1I366N mutant was still able to regulate ShHog1 expression but less than the wild strain.
Therefore, lower levels of improper hog1-downstream gene expression may occur in response
to iprodione. In order to fully understand the function of the mutation (I366N) and HK in S.
homoeocarpa, further studies on the manipulation of genes from the HOG pathway such as
homologous genes of B. cinerea (BcSak1, BcOs4, BcOs5, BcRrg1, and BcSkn7) (Liu et al., 2008;
Segmüller et al., 2007; Yan et al., 2011; Yan et al., 2010; Yang et al., 2012; Yang et al., 2015) and
downstream genes of the pathway are required.
From the data presented, six out of seven dicarboximide-resistant isolates of S.
homoeocarpa with the I366N substitution in Shos1 exhibited constitutive and induced
overexpression of ShPDR1. Dicarboximide-resistant isolate NY2 had the lowest level of
insensitivity to iprodione among dicarboximide-resistant isolates and did not exhibit induced
expression of ShPDR1 (Figure 4.4). The Shos1I366N mutants that did not overexpress ShPDR1 also
exhibited a lower iprodione resistance level than the iprodione-resistant isolate (CT45) that
contained both resistance factors (Figure 4.6). Furthermore, overexpression of ShPDR1 in a
sensitive isolate resulted in reduced sensitivity to iprodione (Figure 4.6). These results suggest
ShPDR1 overexpression may play a role in the additive or quantitative resistance development in
dicarboximide-resistant isolates, but contributes less than the I366N substitution in Shos1.
However, additional studies are needed to test these hypothesis using a larger and more diverse
pool of dicarboximide-resistant field isolates.
This study and our previous studies, which have investigated the genetic determinants
of multi-drug and DMI resistance (Hulvey et al., 2012; Sang et al., 2015), indicate that S.
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homoeocarpa has evolved multiple mechanisms of resistance to a specific fungicide and
multiple fungicides. Understanding the mechanisms of fungicide resistance in this pathogen
contributes to the information for evolution of other sterile fungi. This study also illustrated the
use of a PEG-mediated protoplast transformation system in S. homoeocarpa for the first time
and this methodology could be utilized to study the genetics and biology of S. homoeocarpa
with the recent release of transcriptomic and genomic sequences of S. homoeocarpa (Green et
al., 2016; Hulvey et al., 2012; Orshinsky et al., 2012). Our findings indicate that the I366N
mutation in Shos1 and/or overexpression of ShPDR1 are conferring in vitro iprodione resistance,
but not pathogenicity; however, we have not confirmed to what extent these genetic
determinants are associated with decreased iprodione field efficacy, which is under
investigation. Findings from this study will be utilized for developing a molecular diagnostic tool
for detection of iprodione resistance, which will help management of dollar spot on golf
courses.
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CHAPTER 5
DYNAMICS OF A SCLEROTINIA HOMOEOCARPA POPULATION WITH MULTIPLE FUNGICIDE
RESISTANCE UNDER PRESENCE AND ABSENCE OF SELECTION PRESSURES

5.1 Abstract
Dollar spot, caused by Sclerotinia homoeocarpa, is one of the most significant diseases
of cool-season turfgrass on golf courses. Resistance to the benzimidazole and dicarboximide
classes and reduced sensitivity to the sterol demethylation inhibitor (DMI) fungicide class in S.
homoeocarpa populations has been reported in the United States. Moreover, the occurrence of
S. homoeocarpa populations with multiple fungicide resistance (MFR) is a growing problem.
Field efficacy tests were conducted to determine the best options to control a S. homoeocarpa
population with MFR on two different locations in a fairway at Wethersfield Country Club
(WCC), Connecticut in 2014, 2015, and 2016. The S. homoeocarpa population contained a
combination of four different phenotypes among isolates with differing resistance profiles to the
benzimidazole, dicarboximide and DMI fungicide classes. Furthermore, to understand the
population dynamic in response to fungicide applications and overwintering effects, in vitro
sensitivity assays of S. homoeocarpa isolates sampled at four times (directly before fungicide
treatment; 7 days after treatment; 21 days after the last treatment; and following winter) were
conducted using thiophanate-methyl (benzimidazole), iprodione (dicarboximide), and
propiconazole (DMI). The succinate dehydrogenase inhibitor (SDHI) fluxapyroxad (low and high
rates), boscalid (high rate), fluazinam (an uncoupler of phosphorylation), and the fourway
mixture of chlorothalonil, tebuconazole, iprodione and thiophanate-methyl provided better
dollar spot control than the dicarboximides (iprodione and vinclozolin) or DMIs (low rate of
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propiconazole). Propiconazole or iprodione application selected isolates with both DMI and
dicarboximide resistance (DMI-R/Dicar-R), but controlled isolates with both DMI and
benzimidazole resistance (DMI-R/Ben-R). In contrast, boscalid selected DMI-R/Ben-R isolates,
but controlled DMI-R/Dicar-R isolates. Previously selected DMI-R/Dicar-R or DMI-R/Ben-R
isolates by fungicides decreased after overwintering. In addition, the proportion of isolates with
DMI, dicarboximide, and benzimidazole resistance (DMI-R/Dicar-R/Ben-R) decreased regardless
of fungicide treatments. Our improved understanding of a population with multiple resistance in
response to multiple fungicides and overwintering effects in this study will help develop
effective fungicide resistance management strategies and potentially delay the emergence of
future resistant populations.

5.2. Introduction
Dollar spot, caused by an ascomycete filamentous fungus Sclerotinia homoeocarpa F.T.
Bennett, is the most important and economically challenging turfgrass disease in the United
States (Smiley et al., 2005). The disease causes damage to creeping bentgrass (Agrostis palustris
Huds.) and annual bluegrass (Poa annua L.) on golf course putting greens, tee boxes, and
fairways (Latin, 2011; Walsh et al., 1999). Multiple fungicide applications are required to
maintain acceptable turf quality throughout the growing season (Walsh et al., 1999). As a result,
S. homoeocarpa fungicide resistance has developed to at least three classes of fungicides,
benzimidazole, dicarboximide, and demethylation inhibitor (DMI), and populations recent with
multidrug resistance have also been observed (Detweiler et al., 1983; Sang et al., 2015; Vargas
et al., 1992; Warren et al., 1974).
A recent monitoring study reported S. homoeocarpa populations with a wide range of
reduced sensitivities to dicarboximide, DMI and benzimidazole fungicides on golf courses in New
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England (Putman et al., 2010). Furthermore, a select number of golf courses included S.
homoeocarpa populations with high levels of reduced iprodione sensitivity. Putman et al.
suggested these populations were “outliers” at the time of the study (Putman et al., 2010).
These “outlier” isolates were determined by Sang et al. to be iprodione resistant isolates that
harbor two types of resistance mechanisms: polymorphisms in the histidine kinase gene Shos1
(a putative target gene of dicarboximide, qualitative resistance); and overexpression of an efflux
transporter ShPDR1 (quantitative resistance) (Sang et al., 2017). For a better understanding of
the practical implications of iprodione fungicide resistance levels, field efficacy experiments
were initiated in 2014 at a golf course with an “outlier” population to determine whether
dicarboximide field efficacy failure existed. The S. homoeocarpa population in this golf course is
a unique population that contains a combination of four different phenotypes with differing
fungicide resistance profiles to the benzimidazole, dicarboximide and DMI fungicide classes.
Emergence of multiple fungicide resistant S. homoeocarpa isolates have become an
urgent problem to the turf industry (Bishop et al., 2008; Golembiewski et al., 1995; Jo et al.,
2006; Koch et al., 2009; Ok et al., 2011; Putman et al., 2010). Therefore, a better understanding
of S. homoeocarpa populations with multiple fungicide resistance (MFR) is needed for
developing effective resistance management strategies. Application of fungicide rotations or
tank-mixing with multi-site mode of action fungicides (chlorothalonil or fluazinam) is
recommended for combating a site-specific fungicide resistant S. homoeocarpa population or
delaying the development of resistant populations. Together with this management strategy, a
better understanding of reversion of a resistant population, overwintering effects of previous
fungicide applications, and persistence of a reverted population will facilitate development of an
accurate and cost-effective method to control resistant populations and delay the emergence of
further MFR populations.
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Our objectives of this study are (i) to find the best fungicide options to control a S.
homoeocarpa population with MFR by assessing field efficacy in 2014, 2015, and 2016, (ii) to
determine the dynamics of a S. homoeocarpa population with four isolate phenotypes by
fungicide selection, and (iii) to determine how persistent the selected resistant populations will
be in the absence of fungicide pressures (overwintering).

5.3. Materials and Methods
5.3.1 Experimental Plots
Field efficacy testing and isolate collection of S. homoeocarpa was conducted at
Wethersfield Country Club (WCC, Wethersfield, CT) in 2014, 2015, and 2016. The S.
homoeocarpa populations on WCC exhibit a different combination of sensitivities to
benzimidazole, dicarboximide, and DMI fungicides (Table 5.1). Experimental plots in 2014 and
2015 were located in the same exact fairway location and the 2016 plot was located at a
different site on the same fairway. Both plots consist of creeping bentgrass and annual bluegrass
mowed (3 times per week) at fairway height (1.3 cm). A randomized complete block design with
three replications was used to arrange the experimental plot. Each plot was 3 x 6 feet with 1
foot buffer strips between each plot. The sites were annually provided with 82.9-117.4 kg N ha2,
and turfgrass weeds and insects were managed by chemical controls at the discretion of the
superintendent.

111

Table 5.1. Fungicide sensitivity of S. homoeocarpa isolates collected from the location 1 and 2 of
fairway at a golf course in Connecticut in 2014, 2015, and 2016.
Sensitivity to fungicidesa
Genotype name
DMI
Dicarboximide
Benzimidazole
DMI-R
I
S
S
DMI-R/Dicar-R
I
R
S
DMI-R/Ben-R
I
S
R
DMI-R/Dicar-R/Ben-R
I
R
R
a
I refers to insensitive to DMI fungicides, meaning a quantitative resistance. S and R refer to
sensitive and resistant to the fungicides, respectively.

5.3.2 2014, 2015, and 2016 Field Efficacy
Treatments for field efficacy tests included boscalid (Emerald 70WG, BASF Corporation),
fluxapyroxad (Xzemplar 2.51SC, BASF Corporation), fluazinam (Secure 4.17SC, Syngenta Crop
Protection), iprodione (Chipco 26GT 2SC, Bayer), propiconazole (Banner MAXX II 1.3ME,
Syngenta Crop Protection), vinclozolin (Curalan EG 50WG, BASF Corporation), the mixture of
chlorothalonil, iprodione, thiophanate methyl, tebuconazole (Enclave 5.3F, Quali-Pro) and a turf
pigment (Foursome, Quali-Pro) and an untreated control (Table 5.2). All single product
treatments were applied at 0.28 or 0.38 kg a.i. ha-1 for boscalid, 0.20 or 0.25 kg a.i. ha-1 for
fluxapyroxad, 0.80 kg a.i. ha-1 for fluazinam, 3.05 kg a.i. ha-1 for iprodione, 0.5 or 1.0 kg a.i. ha-1
for propiconazole, 1.53 kg a.i. ha-1 for vinclozolin, and 3.43 kg a.i. ha-1 of chlorothalonil, 1.44 kg
a.i. ha-1 iprodione and thiophanate-methyl, and 0.34 kg a.i. ha-1 tebuconazole which was applied
as a fourway combination fungicide (Enclave) tankmixed with 1.27 L ha-1 of turf pigment
(Foursome) on a 21-day application interval, except for the fourway mixture with turf pigment
on 14-day application interval in 2014 (Table 5.2). The fourway mixture will be referred to as
Enclave for the sake of brevity. Fungicides were treated at a nozzle pressure of 40 psi using a
CO2 pressurized boom sprayer equipped with two flat-fan XR Teejet 8004VS nozzles. Individual
dollar spot infection centers per plot were counted approximately every 7 days for disease
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severity ratings. Area Under the Disease Progress Curve (AUDPC) calculated according to
Campbell and Madden (Campbell and Madden, 1990). Fisher’s protected LSD was conducted to
compare AUDPC values among treatments. All statistical analyses were performed by the JMP
software package, version 10.0 (SAS Institute Inc.).

Table 5.2. List of treatments applied, rates, and dates applied and sampled on the location 1 of
fairway in 2014 and 2015 and the location 2 of fairway in 2016.
Treatments
Rate
Application dates
Sampling dates
−1
(kg a.i. ha )
2014
2015
2016
2014
2015
2016
Untreated
-a
6/16,
8/18,
6/6,
Iprodione
3.05
6/16,
8/18,
6/6,
8/6,
9/18,
8/18,
Propiconazole
0.5
7/8,
9/11
6/30,
9/5
10/5,
9/1
1.0
7/30,
7/21,
6/6/16b
Boscalid
0.28
8/19
8/11
0.38
Vinclozolin
1.53
-c
Fluazinam
0.80
Fluxapyroxad
0.20
0.25
Chlorothalonil +
3.43
6/16,
iprodione +
1.44
7/1,
thiophanate
1.44
7/15,
methyl +
7/30,
tebuconazole +
0.34
8/11
d
foursome
1.27
a
No fungicide application was made on untreated plots.
b
Overwintered samples were collected on the location 1 in fairway in 2016.
c
No sampling was made on vinclozolin, fluazinam, enclave, and fluxapyroxad treated plots.
d
L ha-1
5.3.3 Isolate Collection and In Vitro Fungicides Sensitivity Tests
S. homoeocarpa isolates were collected immediately prior to first application of each
year (2014-2016), 7 days after third application (2014), second application (2015), and fourth
application (2015), 21 days after final application (2014-2016), and following winter 2015 to
monitor changes in the population in response to fungicide applications and overwintering
effects. Overwintering samples for 2014 were initial samples for 2015, and overwintering
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samples for 2016 will be collected in June 2017. The initial or overwintering sampling was
performed when approximately 10 dollar spot infection centers per plot were observed in 2014,
2015, and 2016. Sampling data is described in Table 5.2. Ten samples were collected from
different individual infection centers in the untreated, boscalid (both rates), propiconazole (both
rates), and iprodione treated plot by selecting individual grass blades from individual dollar spot
infection centers that exhibited bleached hourglass lesions. For sampling 7 days after treatment
(7-DAT), the samples were taken from grass blades with active mycelia or recently developed
lesions. Fungal isolation followed the procedures according to Popko et al. (Popko et al., 2012).
The cultures of S. homoeocarpa isolated from grass blades on acidified potato dextrose agar (39
g of PDA, Difco Laboratories) and 1 ml of 85% lactic acid (Fisher Scientific) per 1 liter of distilled
water and were transferred to PDA and grown for 2 to 3 days at 22-24°C.
Pure cultures of S. homoeocarpa were used for in vitro sensitivity assays on PDA
amended with propiconazole (1 µg/mL), iprodione (10 µg/mL), and thiophanate-methyl (TM;
1000 µg/mL). Commercial formulations of each fungicide were added to autoclaved PDA that
had been cooled to 55-58 °C. Non-amended PDA were poured into 90 mm Petri-dishes (Krackler
Scientific), and propiconazole, iprodione, and TM amended PDA were poured into 60 mm Petridishes (Krackler Scientific). Agar plugs (5 mm in diameter) from pure cultures of S. homoeocarpa
isolates were placed on the center of fungicide amended and unamended PDA Petri plates. The
fungal isolates were replicated twice on fungicide amended and unamended PDA plates. The
four phenotypes of the isolates: DMI insensitive (DMI-R), DMI and dicarboximide resistance
(DMI-R/Dicar-R), DMI and benzimidazole resistance (DMI-R/Ben-R), and DMI, dicarboximide,
and benzimidazole resistance (DMI-R/Dicar-R/Ben-R) were qualitatively determined by the
ability to grow on 1 µg mL-1 of propiconazole, 10 µg mL-1 of iprodione, or 1000 µg mL-1 of TM (Jo
et al., 2006; Popko et al., 2013; Sang et al., 2017). The proportion of the four isolate phenotypes
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was calculated as follows: (number of each isolate phenotype/ total number of isolates) × 100.
Fisher’s protected LSD was conducted to compare proportion (%) values among four isolate
phenotypes within sample time. Repeated measures Multivariate Analysis of Variance
(MANOVA) was performed on the isolate phenotype proportions for each treatment from 2014Initial to 2016-Initial at the location 1 and location 2 (2016-Initial to 2016-Final).

5.4 Results
5.4.1 Field Efficacy
Dollar spot infection centers were observed in early/mid-June in 2014 and 2016. In
contrast, dollar spot infection centers were not observed until mid-August, 2015. The number of
dollar spot infection centers on the untreated plots increased from late July to early September
in 2014, and early July to August in 2016, but unfavorable conditions (cool and dry) in 2015
caused lower dollar spot severity.
AUDPC was significantly different among treatments for all three years (P < 0.001). In
2014 and 2015, AUDPC values of both rates of fluxapyroxad, boscalid (0.38 kg a.i. ha-1),
fluazinam, and the Enclave treatment were numerically lower than boscalid (0.28 kg a.i. ha-1),
both rates of propiconazole, vinclozolin, and iprodione. Boscalid (0.28 kg a.i. ha-1) and
propiconazole (1.0 kg a.i. ha-1) provided less control than the aforementioned treatments, but
moderately better control than iprodione, vinclozolin, and propiconazole (0.5 kg a.i. ha-1).
In 2016, AUDPC values of both rates of fluxapyroxad and boscalid, fluazinam, and
Enclave were significantly lower than the values of both rates of propiconazole, iprodione, and
vinclozolin. Both rates of propiconazole, iprodione and vinclozolin were all statistically similar
(Table 5.3).
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Table 5.3. ANOVA of area under disease progress curve (AUDPC) values on the location 1 of
fairway in 2014 and 2015 and the location 2 of fairway in 2016.
Rate
AUDPCa
−1
Treatments
(kg a.i. ha )
201420152016Location 1
Location 1
Location 2
Untreated
5906ab
1041a
11211a
Iprodione
3.05
1410b-d
378bc
7022b
Vinclozolin
1.53
1936bc
612ab
6200b
Propiconazole
0.5
2037b
537bc
5922b
1.0
1033b-d
168bc
5051b
Boscalid
0.28
1362b-d
145c
2299c
0.38
378b-d
83c
1896c
Fluazinam
0.80
325b-d
92c
1298c
Fluxapyroxad
0.20
126d
89c
1017c
0.25
240cd
98c
778c
Chlorothalonil +
3.43
369b-d
85c
1127c
iprodione +
1.44
thiophanate methyl
1.44
+ tebuconazole +
0.34
foursome
1.27c
a
AUDPC represents mean number of dollar spot infection center from 16 June to 10 Sept. 2014,
18 Aug. to 5 Oct. 2015, and 6 June to 1 Sept. 2016.
b
Means in a column followed by the same letter are not significantly different according to
Fisher’s protected least significant difference test (α = 0.05).
c
L ha-1

5.4.2 Isolate Phenotype Proportions with Different Combinations of Fungicide Resistance in
Response to Fungicides and Overwintering Effects
The 2014-Initial S. homoeocarpa population displayed a higher proportion of DMIR/Ben-R and DMI-R/Dicar-R/Ben-R isolates than the proportion of DMI-R and DMI-R/Dicar-R
isolates. The 2016-Initial sampling had a higher proportion of DMI-R isolates than DMI-R/Dicar-R
isolates (except for boscalid (0.5 kg a.i. ha-1) plots), and the DMI-R/Ben-R or DMI-R/Ben-R/DicarR isolate phenotypes were at the lowest proportion among all isolate phenotypes or absent.
DMI-R/Ben-R/Dicar-R isolates disappeared over the growing season in 2014 and 2016 (Figure
5.1).
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The proportion of DMI-R/Ben-R isolates on the untreated plots decreased and the
proportion of DMI-R isolates increased after 2014-2015 overwintering. The S. homoeocarpa
population on the untreated plots in 2015 showed a similar proportion to the Initial population
in 2016, despite these being different plot locations. The untreated isolate phenotype
proportion did not significantly change during the 2016 growing season according to repeated
measures MANOVA and this was the only treatment that did not significantly change from the
Initial to Final sample times in either plot location (Figure 5.1A).
After treatment of both boscalid rates, the proportion of DMI-R/Ben-R isolates
increased in the 2014-7-DAT and 2015-Final sample times, and also in the 2016-7-DAT sample
time. Boscalid provided excellent control of dollar spot in 2015 and recently infected dollar spot
lesions were not observed on either rate of boscalid treated plots at the 2015-7-DAT sample
time. The proportion of DMI-R/Ben-R isolates selected by boscalid decreased after
overwintering in 2014-2015 or 2015-2016. The proportion of DMI-R isolates increased after
overwintering in 2014-2015 at location 1. The proportion of DMI-R/Dicar-R isolates decreased or
was not detected by the both rates of boscalid treatments at the both locations (Figure 5.1B and
C).
After propiconazole (both rates) or iprodione applications, the proportion of DMIR/Dicar-R isolates increased in all sample times. On the other hand, the proportion of DMIR/Ben-R and DMI-R decreased or was completely eliminated by propiconazole (both rates) or
iprodione treatments. After overwintering, the proportion of DMI-R/Dicar-R isolates decreased
but the proportion of DMI-R isolates increased in every sample time with the exception of 2016Initial sample time on the propiconazole (0.5 kg a.i. ha-1) treated plots for location 1 (Figure
5.1D, E and F).
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Figure 5.1. Isolate phenotype proportions on untreated (A) and boscalid (0.28 kg a.i. ha−1) (B),
boscalid (0.38 kg a.i. ha−1) (C), propiconazole (0.5 kg a.i. ha−1) (D), propiconazole (1.0 kg a.i. ha−1
(E), and iprodione (3.05 kg a.i. ha−1) (F) treated plots on location 1 of fairway in 2014 and 2015,
2016-Initial and on location 2 fairway in 2016. Initial, 7DAT, and Final refer to initial sampling
before fungicide application, 7 days after treatment of fungicide, and 21 days after final
treatment of fungicide, respectively. Isolate phenotypes: DMI insensitive (DMI-R), DMI and
dicarboximide resistance (DMI-R/Dicar-R), DMI and benzimidazole resistance (DMI-R/Ben-R),
and DMI, dicarboximide, and benzimidazole resistance (DMI-R/Dicar-R/Ben-R).
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5.5. Discussion
The occurrence and spread of MFR S. homoeocarpa populations in the New England
region has contributed to challenges in dollar spot control (Putman et al., 2010). In this study,
we provide better understanding of dynamics of a S. homoeocarpa population with MFR in
response to fungicides with different modes of action, and changes in fungicide sensitivity over
the winter in the absence of fungicide treatments. Our results indicated that (i) fluxapyroxad,
fluazinam, boscalid (0.38 kg a.i. ha-1), and Enclave controlled the population very well but
iprodione, vinclozolin and propiconazole (0.5 kg a.i. ha-1) controlled dollar spot poorly, (ii) DMIR/Dicar-R isolates were most frequently selected by iprodione or propiconazole applications and
DMI-R/Ben-R isolates only were selected by boscalid applications, and (iii) the selected DMIR/Dicar-R or DMI-R/Ben-R isolates decreased after overwintering and DMI-R/Dicar-R/Ben-R
isolates decreased regardless of fungicide treatments.
All S. homoeocarpa isolates collected from WCC are insensitive to the DMI fungicide
class. Constant selection pressure (three DMI applications per year) may have contributed to a
unimodal DMI insensitive population distribution on WCC. Popko et al. (Popko et al., 2012)
observed the highly homogenous and unimodal S. homoeocarpa population distribution with
DMI insensitivity in Wintonbury Hills Golf Club (Bloomfield, CT). This population was also
exposed to constant and high selection pressure (five DMI application per year). The DMI-R
isolate phenotype in this study was dominant among four isolate phenotypes in the absence of
selection pressure (overwintering). DMI insensitive strains in some fungal species are less
competitive than sensitive strains (Al-Mughrabi and Gray, 1995; Holmes and Eckert, 1995; Koller
and Scheinpflug, 1987). Moreover, a reduction in DMI insensitive S. homoeocarpa isolates at
Hickory Ridge Country Club (Hadley, MA) was observed following overwintering, except isolates
collected from plots treated with the high rate (0.88 kg a.i. ha-1) of propiconazole (Allan-Perkins
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et al., 2017). In contrast, our results indicated that the frequency of DMI-R isolates increased
following winter due to the absence of fungicide sensitive isolates and presence of potentially
less competitive of double or triple MFR isolates.
The DMI-R/Ben-R isolate phenotype was observed at a higher frequency in boscalid
plots (both rates) in location 1 and 2. This was the only treatment to maintain this phenotype,
despite the absence of a DMI or benzimidazole fungicide. To understand the selection of DMIR/Ben-R isolates by boscalid, in vitro sensitivity testing of 2014 final samples collected from
boscalid treated plots (both rates) on 500 and 1000 µg ml-1 boscalid was conducted but the
mean relative growth mycelium (%) were not statistically different among three phenotypes of
isolates (DMI-R/Dicar-R/Ben-R isolates were absence). The result suggested that selection of
DMI-R/Ben-R isolates was not because of their sensitivity to boscalid. Further study is warranted
to determine why DMI-R/Ben-R isolates were selected by boscalid. After overwintering, DMIR/Ben-R isolates decreased in plots untreated and treated with both boscalid rates. Our
observation contradicts the study of Vargas (1994) indicating the persistence of S. homoeocarpa
isolates with benzimidazole and DMI resistance (Vargas, 1994). Botrytis cinerea field strains also
showed long persistence of high benzimidazole resistance frequency without selection pressure,
suggesting that benzimidazole-resistant isolates may not suffer a fitness penalty (Myresiotis et
al., 2007). Furthermore, benzimidazole-resistant Venturia inaequalis strains were as competitive
as the sensitive strains under the absence of selection pressure (McGee and Zuck, 1981).
Decreased DMI-R/Ben-R isolates in this study might be due to the isolates with different
mutation(s) in the benzimidazole target β-tubulin gene, which causes decreased stability of
microtubules after assembly and reduces fitness and increases temperature sensitivity (Davidse,
1986).
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After application of iprodione or propiconazole, the proportion of DMI-R/Dicar-R
isolates significantly increased and most likely caused reduced dicarboximide or DMI efficacy in
the population. The number of dollar spot infection centers with DMI-R/Dicar-R isolates
increased over the growing season due to continuous selection pressure with the same mode of
action fungicide and less competition from isolates with different phenotypes. The DMI-R/DicarR isolates from WCC were previously confirmed to contain two fungicide resistance
mechanisms: a mutation (I366N) in the histidine kinase gene Shos1 and overexpression of the
multidrug transporter ShPDR1, which confers iprodione resistance and reduced sensitivity to
propiconazole, iprodione, and boscalid, respectively (Sang et al., 2015; Sang et al., 2017). These
two resistance mechanisms might play a role in the selection of DMI-R/Dicar-R isolates by
iprodione or propiconazole. However, there might be additional unknown factors that
contribute to the selection of DMI-R/Dicar-R isolates by propiconazole since all isolate
phenotypes in location 1 and 2 are insensitive to propiconazole. Decreased DMI-R/Dicar-R
isolates and increased DMI-R isolates on propiconazole or iprodione treated plots following
overwintering could be due to DMI-R/Dicar-R isolates that were less competitive than DMI-R
isolates in the absence of fungicide pressure. An in vitro competition study between
dicarboximide sensitive and resistant Botrytis cinerea strains indicated that the proportion of
dicarboximide resistant strains was decreased without dicarboximide fungicide exposure
(Gullino and Garibaldi, 1981). Dicarboximide resistant B. cinerea strains with some mutation(s)
in a target histidine kinase gene contributed to hypersensitivity to osmotic stress and reduced
fitness (Fillinger et al., 2012). S. homoeocarpa isolates sampled from WCC with a mutation
(I366N) in Shos1 did not have increased sensitivity to osmostic stress, reduced mycelia growth,
or reduced pathogenicity on creeping bentgrass (Sang et al., 2017). However, some DMI/Dicar-R
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isolates with loss of function mutation(s) in Shos1 may have existed in the population and
decreased after overwintering.
The initial S. homoeocarpa population in 2014 contained a high proportion of DMIR/Ben-R and DMI-R/Dicar-R/Ben-R isolates. The fungicide spray record obtained from the
superintendent indicated that iprodione and chlorothalonil were applied on location 1 in 2014
six weeks prior to Initial sampling. Furthermore, boscalid and chlorothalonil were the last
application made in the fall of 2013 targeting dollar spot. This combination of fungicide
applications applied prior may have selected two phenotypes (DMI-R/Dicar-R/Ben-R and DMIR/Ben-R) harboring benzimidazole resistance. Since DMI-R/Ben-R isolates decreased by
iprodione treatments in this study, chlorothalonil and boscalid might be the factors to increase
the frequency of two phenotypes, but further field and lab experiments will be necessary to
determine the reasons for the selection of two phenotypes. High frequency of DMI-R/DicarR/Ben-R isolates in the initial plots decreased or were not observed regardless of selection
pressure. The reduced/absence of the phenotype may be due to reduced fitness and
competitiveness by mutations in both the benzimidazole and dicarboximide target genes. The
dual benzimidazole and dicarboximide resistant Monilinia fructicola isolates were also less
competitive than single resistant isolates (Sanoamuang and Gaunt, 1995). However, B. cinerea
isolates with resistance to both benzimidazole and dicarboximide were prevalent and persisted
in ornamental crops due to the stability of mutations conferring benzimidazole and
dicarboximide resistance (LaMondia and Douglas, 1997; Yourman and Jeffers, 1999).
The overall proportion of DMI-R/Dicar-R isolates is inversely related to the proportion
of S. homoeocarpa isolates with benzimidazole resistance (DMI-R/Ben-R). Our study indicated
that propiconazole and iprodione provided control of the DMI/Ben-R isolates. Both fungicides
have been widely used to combat the benzimidazole resistant S. homoeocarpa populations
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(Detweiler et al., 1983; Vargas et al., 1992). Boscalid provided control of the DMI-R/Dicar-R
isolates, suggesting that newly registered SDHI fungicides are a good option to suppress
dicarboximide resistant populations. However, the selection of DMI-R/Ben-R isolates by boscalid
could be a potential problem for the dollar spot management. The differential selection of each
isolate phenotype by a single mode of action fungicide implies that rotation with different mode
of action fungicides and use of multi-site fungicides as rotation/tank-mix partners is essential to
effectively manage S. homoeocarpa populations with different fungicide resistance
combinations.
The proportion changes of the S. homoeocarpa population with four resistant
phenotypes by fungicide pressures and overwintering effects were a novel study that has not
been previously reported and provides valuable information to turf practitioners for effective
dollar spot management. Vargas et al. stated S. homoeocarpa with DMI, benzimidazole, and
dicarboximide resistance may pose the most difficult resistance control problem (Vargas et al.,
1992), but the disappearance of these MFR isolates without fungicide pressure implies that
cultural practices to reduce fungicide applications are a crucial tool to prevent further
development of “super” MFR S. homoeocarpa isolates like the B. cinerea isolate with resistance
to seven different site-specific fungicides (Fernández-Ortuño et al., 2015). Our results presented
in this study did not include the overwintering samples from the dollar spot population on the
location 2 of fairway, thus we will collect the samples on early June 2017 and test the sensitivity
of isolates to the three fungicide classes to validate the results are repeatable.
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